%% This BibTeX bibliography file was created using BibDesk.
%% http://bibdesk.sourceforge.net/


%% Created for mjswat at 2013-09-25 13:14:52 +0100 


%% Saved with string encoding Unicode (UTF-8) 


@string{jgr = {J.~Geophys.~Res.}}


@webpage{CDICS:2013,
	Author = {{CDISC}},
	Date-Added = {2013-09-25 12:59:00 +0100},
	Date-Modified = {2013-09-25 13:14:51 +0100},
	Keywords = {{CDISC}},
	Lastchecked = {September 2013},
	Month = {September},
	Title = {{The Clinical Data Interchange Standards Consortium; link: www.cdisc.org}},
	Url = {http://www.cdisc.org/},
	Urldate = {http://www.cdisc.org/},
	Year = {2013}}

@techreport{CDISC:2011a,
	Author = {{CDISC SDM-XML Technical Committee}},
	Date-Added = {2013-09-11 22:30:05 +0100},
	Date-Modified = {2013-09-12 13:18:46 +0100},
	Institution = {{Clinical Data Interchange Standards Consortium, Inc}},
	Title = {{CDISC Study Design Model in XML (SDM-XML), Version 1.0}},
	Year = {2011}}

@techreport{MonolixOverview:2012,
	Author = {Lavielle, Marc and {Lixoft Team}},
	Date-Added = {2013-09-10 19:21:10 +0100},
	Date-Modified = {2013-09-10 19:21:10 +0100},
	Institution = {{INRIA Saclay} \& Lixoft},
	Title = {{MLXTRAN, A Brief Overview}},
	Year = {2012}}

@article{Ribba:2012uq,
	Abstract = {PURPOSE: To develop a tumor growth inhibition model for adult diffuse low-grade gliomas (LGG) able to describe tumor size evolution in patients treated with chemotherapy or radiotherapy.
EXPERIMENTAL DESIGN: Using longitudinal mean tumor diameter (MTD) data from 21 patients treated with first-line procarbazine, 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea, and vincristine (PCV) chemotherapy, we formulated a model consisting of a system of differential equations, incorporating tumor-specific and treatment-related parameters that reflect the response of proliferative and quiescent tumor tissue to treatment. The model was then applied to the analysis of longitudinal tumor size data in 24 patients treated with first-line temozolomide (TMZ) chemotherapy and in 25 patients treated with first-line radiotherapy.
RESULTS: The model successfully described the MTD dynamics of LGG before, during, and after PCV chemotherapy. Using the same model structure, we were also able to successfully describe the MTD dynamics in LGG patients treated with TMZ chemotherapy or radiotherapy. Tumor-specific parameters were found to be consistent across the three treatment modalities. The model is robust to sensitivity analysis, and preliminary results suggest that it can predict treatment response on the basis of pretreatment tumor size data.
CONCLUSIONS: Using MTD data, we propose a tumor growth inhibition model able to describe LGG tumor size evolution in patients treated with chemotherapy or radiotherapy. In the future, this model might be used to predict treatment efficacy in LGG patients and could constitute a rational tool to conceive more effective chemotherapy schedules.},
	Author = {Ribba, Benjamin and Kaloshi, Gentian and Peyre, Mathieu and Ricard, Damien and Calvez, Vincent and Tod, Michel and Cajavec-Bernard, Branka and Idbaih, Ahmed and Psimaras, Dimitri and Dainese, Linda and Pallud, Johan and Cartalat-Carel, St{\'e}phanie and Delattre, Jean-Yves and Honnorat, J{\'e}r{\^o}me and Grenier, Emmanuel and Ducray, Fran{\c c}ois},
	Date-Added = {2013-09-07 12:31:42 +0200},
	Date-Modified = {2013-09-07 12:31:42 +0200},
	Doi = {10.1158/1078-0432.CCR-12-0084},
	Journal = {Clin Cancer Res},
	Journal-Full = {Clinical cancer research : an official journal of the American Association for Cancer Research},
	Mesh = {Adolescent; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Glioma; Humans; Male; Models, Biological; Neoplasm Staging; Reproducibility of Results; Tumor Burden; Young Adult},
	Month = {Sep},
	Number = {18},
	Pages = {5071-80},
	Pmid = {22761472},
	Pst = {ppublish},
	Title = {A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy},
	Volume = {18},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/1078-0432.CCR-12-0084}}

@manual{NONMEM:2006aa,
	Address = {Ellicott City, Maryland, USA},
	Author = {Beal, S L and Sheiner L B and Boeckmann A J (Eds.)},
	Date-Added = {2011-08-25 11:10:09 +0100},
	Date-Modified = {2013-06-26 17:05:17 +0100},
	Organization = {{Icon Development Solutions}},
	Title = {{NONMEM Users Guides, (1989-2006)}},
	Year = {2006}}

@techreport{PREDPP:2011,
	Author = {Beal, Stuart L. and Boeckmann, Alison J. and Sheiner, Lewis B.},
	Date-Added = {2012-12-04 15:17:13 +0000},
	Date-Modified = {2013-02-27 18:50:50 +0000},
	Institution = {NONMEM Project Group, University of San Francisco},
	Title = {{NONMEM Users Guide Part VI, PREDPP Guide}},
	Year = {November 1992}}

@techreport{NONMEM:2009,
	Author = {Beal, Stuart L. and Sheiner, Lewis B. and Boeckmann, Alison J. and Bauer, Robert J.},
	Date-Added = {2012-02-28 11:31:26 +0000},
	Date-Modified = {2013-03-04 19:29:09 +0000},
	Institution = {{Icon Development Solutions, Ellicott City, MD, USA}},
	Month = {June},
	Title = {{NONMEM User's Guides. (1989-2009)}},
	Year = {2009}}

@url{POPIX:2013,
	Author = {{Inria POPIX}},
	Date-Added = {2012-03-12 12:52:30 +0000},
	Date-Modified = {2013-07-23 19:25:34 +0100},
	Lastchecked = {23 July 2013},
	Title = {{Mixed Effects Models for the Population Approach - Wiki Popix}},
	Url = {http://popix.lixoft.net/},
	Urldate = {http://popix.lixoft.net/},
	Year = {2013},
	Bdsk-Url-1 = {http://popix.lixoft.net/}}

@techreport{Keizer:2011aa,
	Author = {Keizer, Ron and Karlsson, Mats},
	Date-Added = {2013-08-06 19:18:27 +0100},
	Date-Modified = {2013-08-06 19:18:27 +0100},
	Institution = {Uppsala Pharmacometrics Research Group, Uppsala},
	Title = {Stochastic models},
	Year = {2011}}

@techreport{Keizer:2013aa,
	Author = {Keizer, Ron and Karlsson, Mats},
	Date-Added = {2013-01-23 19:20:42 +0000},
	Date-Modified = {2013-08-06 19:18:37 +0100},
	Institution = {Uppsala Pharmacometrics Research Group, Uppsala},
	Title = {Stochastic models},
	Year = {2013}}

@webpage{NIST:2012,
	Author = {{NIST/SEMATECH}},
	Date-Added = {2013-07-23 19:18:04 +0100},
	Date-Modified = {2013-07-23 19:18:04 +0100},
	Lastchecked = {11 March 2012},
	Title = {e-Handbook of Statistical Methods, Section 6.5.2},
	Url = {http://www.itl.nist.gov/div898/handbook/},
	Urldate = {http://www.itl.nist.gov/div898/handbook/},
	Year = {2012},
	Bdsk-Url-1 = {http://www.itl.nist.gov/div898/handbook/}}

@techreport{Lavielle:2013a,
	Author = {Lavielle, Marc},
	Date-Added = {2013-06-25 15:40:44 +0100},
	Date-Modified = {2013-06-25 15:41:52 +0100},
	Institution = {{INRIA Saclay}},
	Title = {{WP6.1: Some examples of complex administrations with the Clinical Trial Simulator}},
	Year = {February 2, 2013}}

@article{Chan:2005fk,
	Abstract = {The purpose of the study was to describe the population pharmacokinetics of levodopa in patients with Parkinson's disease studied in 5 trials (10 occasions) over 4 years. Twenty previously untreated Parkinsonian patients were investigated. Each trial consisted of a 2-hr IV infusion of levodopa (1 mg/kg/h) with concomitant oral carbidopa given on two occasions separated by 72 hr with no levodopa in between. This trial design was repeated at 6, 12, 24 and 48 months. A two-compartment pharmacokinetic model with central volume (V1), peripheral volume (V2), clearance (CL) and inter-compartmental clearance (CL(ic)) was used to fit plasma levodopa concentrations. The model accounted for levodopa dosing prior to each trial and endogenous levodopa synthesis. Population parameter estimates (geometric mean) and population parameter variability (PPV; SD of normal distribution) were V1 11.4 l/70 kg (0.44), CL 30.9 l/h/70 kg (0.25), V2 27.3 l/70 kg (0.27), and CL(ic) 34.6 l/h/70 kg (0.48). PPV was partitioned into between subject variability (BSV) which was 0.12 V1, 0.13 CL, 0.15 V(2), 0.28 CL(ic), within trial variability (WTV) which was 0.16 V1, 0.13 CL, 0.08 V2, 0.18 CL(ic) and between trial variability (BTV) which was 0.40 V1, 0.17 CL, 0.21 V2, 0.34 CL(ic.) Neither structural nor random levodopa pharmacokinetic parameters were associated with the time course of development of fluctuation in motor response. Variability in levodopa pharmacokinetic parameters (particularly V1) may result in variability in plasma levodopa concentrations that could contribute to fluctuations in motor response.},
	Author = {Chan, Phylinda L S and Nutt, John G and Holford, Nicholas H G},
	Date-Added = {2013-05-13 11:14:03 +0100},
	Date-Modified = {2013-05-13 11:14:03 +0100},
	Doi = {10.1007/s10928-005-0039-x},
	Journal = {J Pharmacokinet Pharmacodyn},
	Journal-Full = {Journal of pharmacokinetics and pharmacodynamics},
	Mesh = {Administration, Oral; Adult; Aged; Carbidopa; Clinical Trials as Topic; Cohort Studies; Computer Simulation; Dopa Decarboxylase; Dopamine Agents; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Levodopa; Longitudinal Studies; Male; Middle Aged; Models, Biological; Parkinson Disease},
	Month = {Aug},
	Number = {3-4},
	Pages = {307-31},
	Pmid = {16320098},
	Pst = {ppublish},
	Title = {Importance of within subject variation in levodopa pharmacokinetics: a 4 year cohort study in Parkinson's disease},
	Volume = {32},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10928-005-0039-x}}

@techreport{Monolix4.1.4UserGuide:2012,
	Author = {Lixoft},
	Date-Added = {2013-03-22 13:55:17 +0000},
	Date-Modified = {2013-03-22 13:55:17 +0000},
	Institution = {Lixoft},
	Title = {Monolix 4.1.4 - {User Guide}},
	Year = {2012}}

@book{Iverson:2007fk,
	Address = {Oxford},
	Annote = {LDR    02856cam  22005054a 4500
001    14627822
005    20120214103111.0
008    061106s2007    enkab    bf   001 0 eng  
906    $a7$bcbc$corignew$d1$eecip$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $ajc00 2006-11-09$djc15 2006-11-09$ejc15 2006-11-09 to Dewey$aaa27 2006-11-09$aps05 2007-11-20 1 copy rec'd., to CIP ver.; ASSSIGN TO SCIENCE READING ROOM$fsc02 2008-01-18 Z-CipVer$gsc02 2008-01-18 to BCCD$axh13 2009-06-30 copy 2 added$trf13 2012-02-14 c. 3 to CALM
010    $a  2006037192
016 7  $a101291682$2DNLM
020    $a9780195176339 (cloth : alk. paper)
020    $a0195176332 (cloth : alk. paper)
035    $a(OCoLC)ocm76141825
035    $a(OCoLC)76141825
040    $aDNLM/DLC$cDLC$dBAKER$dNLM$dBTCTA$dC#P$dYDXCP$dDLC$dWaU$dDLC
042    $apcc
050 00 $aR119$b.A533 2007
060 00 $a2007 F-849
060 10 $aWZ 345$bA511 2007
082 00 $a808/.06661$222
245 00 $aAMA manual of style :$ba guide for authors and editors.
246 30 $aManual of style
246 30 $aGuide for authors and editors
250    $a10th ed. /$bCheryl Iverson (chair) ... [et al.].
260    $aOxford ;$aNew York :$bOxford University Press,$cc2007.
300    $axi, 1010 p. :$bill., map ;$c26 cm.
500    $aRev. ed. of: American Medical Association manual of style. 9th ed. c1998.
500    $a"JAMA & Archives Journals, American Medical Association."
504    $aIncludes bibliographical references and index.
505 0  $aTypes of articles -- Manuscript preparation -- References -- Visual presentation of data -- Ethical and legal considerations -- Editorial assessment and processing -- Grammar -- Punctuation -- Plurals -- Capitalization -- Correct and preferred usage -- Non-english words, phrases, and accent marks -- Medical indexes -- Abbreviations -- Nomenclature -- Eponyms -- Greek letters -- Units of measure -- Numbers and percentages -- Study design and statistics -- Mathematical composition -- Typography -- Manuscript editing and proofreading -- Glossary of publishing terms -- Resources.
650  0 $aMedical writing$vHandbooks, manuals, etc.
650  0 $aAuthorship$vStyle manuals.
650 12 $aWriting.
700 1  $aIverson, Cheryl.
710 2  $aAmerican Medical Association.
730 0  $aAmerican Medical Association manual of style.
730 0  $aJAMA & archives journals.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip074/2006037192.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0723/2006037192-d.html
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy0723/2006037192-b.html
952    $aPrev. ed.: LCCN 97-19246
991    $br-SciRR$hR119$i.A533 2007$tCopy 1$wGenBib
},
	Author = {Iverson, Cheryl},
	Call-Number = {R119},
	Date-Added = {2013-03-12 18:06:15 +0000},
	Date-Modified = {2013-03-12 18:06:15 +0000},
	Dewey-Call-Number = {808/.06661},
	Edition = {10th ed.},
	Genre = {Medical writing},
	Isbn = {9780195176339 (cloth : alk. paper)},
	Library-Id = {2006037192},
	Publisher = {Oxford University Press},
	Title = {AMA manual of style: a guide for authors and editors},
	Url = {http://www.loc.gov/catdir/toc/ecip074/2006037192.html},
	Year = {2007},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/toc/ecip074/2006037192.html}}

@manual{PKBUGS:1999,
	Address = {Imperial College School of Medicine, London},
	Author = {Lunn DJ and Wakefield J and Thomas A and Best N and Spiegelhalter D},
	Date-Added = {2013-03-08 18:19:57 +0000},
	Date-Modified = {2013-03-08 18:21:51 +0000},
	Title = {{PKBugs User Guide (version 1.1)}},
	Year = {1999}}

@manual{SADAPT:2008,
	Address = {{Berkeley, CA}},
	Author = {Bauer RJ},
	Date-Added = {2013-03-08 18:15:49 +0000},
	Date-Modified = {2013-03-08 18:15:49 +0000},
	Title = {{S-ADAPT/MCPEM user's guide (Version 1.56). Software for Pharmacokinetic, Pharmacodynamic and Population Data Analysis}},
	Year = {2008}}

@manual{PhoenixNLME:2011,
	Author = {Pharsight},
	Date-Added = {2013-03-08 18:04:31 +0000},
	Date-Modified = {2013-03-08 18:16:49 +0000},
	Title = {{Phoenix NLME Software Review}},
	Year = {2011}}

@book{SimBiologyToolbox:2012,
	Address = {Natick, Massachusetts},
	Author = {{MATLAB/SimBiology}},
	Date-Modified = {2013-03-08 18:22:56 +0000},
	Publisher = {The MathWorks Inc.},
	Title = {version 4.2 (R2012b)},
	Year = {2012}}

@misc{JAGS:2003aa,
	Author = {Plummer, Martyn},
	Date-Added = {2013-03-04 19:58:37 +0000},
	Date-Modified = {2013-03-04 20:01:35 +0000},
	Journal = {{Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003)}},
	Month = {March},
	Title = {{JAGS: A Program for Analysis of Bayesian Graphical Models Using Gibbs Sampling}},
	Year = {2003}}

@article{Lunn:2009fk,
	Abstract = {BUGS is a software package for Bayesian inference using Gibbs sampling. The software has been instrumental in raising awareness of Bayesian modelling among both academic and commercial communities internationally, and has enjoyed considerable success over its 20-year life span. Despite this, the software has a number of shortcomings and a principal aim of this paper is to provide a balanced critical appraisal, in particular highlighting how various ideas have led to unprecedented flexibility while at the same time producing negative side effects. We also present a historical overview of the BUGS project and some future perspectives.},
	Author = {Lunn, David and Spiegelhalter, David and Thomas, Andrew and Best, Nicky},
	Date-Added = {2013-03-04 19:56:35 +0000},
	Date-Modified = {2013-03-04 19:56:35 +0000},
	Doi = {10.1002/sim.3680},
	Journal = {Stat Med},
	Journal-Full = {Statistics in medicine},
	Mesh = {Bayes Theorem; Data Interpretation, Statistical; Models, Statistical; Software},
	Month = {Nov},
	Number = {25},
	Pages = {3049-67},
	Pmid = {19630097},
	Pst = {ppublish},
	Title = {The BUGS project: Evolution, critique and future directions},
	Volume = {28},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/sim.3680}}

@techreport{Swat:2013aa,
	Author = {Swat, Maciej Jacek and Moodie, Stuart},
	Date-Added = {2013-03-04 19:34:32 +0000},
	Date-Modified = {2013-03-22 13:57:34 +0000},
	Institution = {EMBL-EBI},
	Title = {{Use Cases with Matlab Implementation}},
	Year = {2013}}

@techreport{NLMEcons:2008,
	Author = {{NLME Consortium}},
	Date-Added = {2013-03-04 19:27:10 +0000},
	Date-Modified = {2013-03-04 19:27:10 +0000},
	Institution = {{Novartis Pharma AG, Novo Nordisk A/S, Servier and Uppsala University}},
	Month = {June},
	Title = {{Pharmacometrics Markup Language (PharML), Level 1, Version 1}},
	Year = {2008}}

@misc{sbmll3v1c,
	Author = {Michael Hucka and Frank T. Bergmann and Stefan Hoops and Sarah M. Keating and Sven Sahle and James C. Schaff and Lucian P. Smith and Darren J. Wilkinson},
	Howpublished = {Available via the World Wide Web at \url{http://sbml.org/Documents/Specifications}},
	Title = {{The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 1 Core}},
	Year = 2010}

@misc{ninemlspec,
	Author = {Anatoli Gorchetchnikov and Ivan Raikov and Mike Hull and Yann Le Franc},
	Howpublished = {Available via the World Wide Web at \url{http://software.incf.org/software/nineml/wiki/nineml-specification}},
	Institution = {INCF Task Force on Multi-Scale Modeling},
	Title = {{Network Interchange for Neuroscience Modeling Language (NineML) Specification Version 0.1}},
	Year = 2010}

@misc{sedmll1v1,
	Author = {Dagmar Waltemath and Frank T. Bergmann and Richard Adams and Nicolas Le Nov{\`e}re},
	Howpublished = {Available via the World Wide Web at \url{http://http://sedml.org/specifications.html}},
	Title = {{Simulation Experiment Description Markup Language (SED-ML): Level 1 Version 1}},
	Year = 2011}

@book{Kernighan:1988:CPL:576122,
	Author = {Kernighan, Brian W. and Ritchie, Dennis M.},
	Date-Modified = {2013-03-04 19:40:45 +0000},
	Edition = {2nd},
	Isbn = {0131103709},
	Publisher = {Prentice Hall Professional Technical Reference},
	Title = {The C Programming Language},
	Year = {1988}}

@book{Parr:2010uq,
	Address = {Raleigh, N.C.},
	Annote = {LDR    01228cam  22003137a 4500
001    16599342
005    20110810073009.0
008    110105s2010    ncua     b    001 0 eng  
906    $a7$bcbc$ccopycat$d2$encip$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $bxe09 2011-01-05 z-processor 2 copies to USGEN$axh77 2011-01-13 to USPL/STM$ehh06 2011-08-10 telework to BCCD (two copies)
010    $a  2010284599
015    $aGBA985131$2bnb
016 7  $a015357898$2Uk
020    $a9781934356456 (pbk.)
020    $a193435645X (pbk.)
035    $a(OCoLC)ocn419869921
040    $aUKM$cUKM$dBTCTA$dYDXCP$dBWX$dC#P$dLML$dDLC
042    $alccopycat
050 00 $aQA76.7$b.P375 2010
082 04 $a005.133$222
100 1  $aParr, Terence$q(Terence John)
245 10 $aLanguage implementation patterns :$bcreate your own domain-specific and general programming languages /$cTerence Parr.
260    $aRaleigh, N.C. :$bPragmatic Bookshelf,$cc2010.
300    $axix, 374 p. :$bill. ;$c23 cm.
490 1  $aThe pragmatic programmers
504    $aIncludes bibliographical references (p. [359]-360) and index.
650  0 $aDomain-specific programming languages.
830  0 $aPragmatic programmers.
},
	Author = {Parr, Terence},
	Call-Number = {QA76.7},
	Date-Added = {2013-02-28 12:56:18 +0000},
	Date-Modified = {2013-02-28 12:56:18 +0000},
	Dewey-Call-Number = {005.133},
	Genre = {Domain-specific programming languages},
	Isbn = {9781934356456 (pbk.)},
	Library-Id = {2010284599},
	Publisher = {Pragmatic Bookshelf},
	Series = {The pragmatic programmers},
	Title = {Language implementation patterns: create your own domain-specific and general programming languages},
	Year = {2010}}

@book{Aho:1986fk,
	Address = {Reading, Mass.},
	Annote = {LDR    00904cam  2200265 a 4500
001    2859937
005    19870402000000.0
008    850627s1986    maua     b    001 0 eng  
035    $9(DLC)   85015647
906    $a7$bcbc$corignew$d1$eocip$f19$gy-gencatlg
010    $a   85015647 
020    $a0201100886 :$c$30.00
040    $aDLC$cDLC$dDLC
050 00 $aQA76.76.C65$bA37 1986
082 00 $a005.4/53$219
100 1  $aAho, Alfred V.
245 10 $aCompilers, principles, techniques, and tools /$cAlfred V. Aho, Ravi Sethi, Jeffrey D. Ullman.
260    $aReading, Mass. :$bAddison-Wesley Pub. Co.,$cc1986.
300    $ax, 796 p. :$bill. ;$c24 cm.
504    $aBibliography: p. [752]-779.
500    $aIncludes index.
650  0 $aCompilers (Computer programs)
700 1  $aSethi, Ravi.
700 1  $aUllman, Jeffrey D.,$d1942-
991    $bc-GenColl$hQA76.76.C65$iA37 1986$p00000385037$tCopy 1$wBOOKS
},
	Author = {Aho, Alfred V and Sethi, Ravi and Ullman, Jeffrey D.},
	Call-Number = {QA76.76.C65},
	Date-Added = {2013-02-28 12:55:12 +0000},
	Date-Modified = {2013-02-28 12:55:12 +0000},
	Dewey-Call-Number = {005.4/53},
	Genre = {Compilers (Computer programs)},
	Isbn = {0201100886},
	Library-Id = {85015647},
	Publisher = {Addison-Wesley Pub. Co.},
	Title = {Compilers, principles, techniques, and tools},
	Year = {1986}}

@techreport{Bertrand:2008,
	Author = {Bertrand, Julie and Mentr{\'e}, France},
	Date-Added = {2013-02-27 18:45:45 +0000},
	Date-Modified = {2013-02-27 18:45:45 +0000},
	Institution = {{INSERM U738}, Paris Diderot University},
	Title = {Mathematical Expressions of the Pharmacokinetic and Pharmacodynamic Models implemented in the {Monolix} software},
	Year = {September 2008}}

@techreport{Monolix4.1Tutorial:2012,
	Author = {Lixoft},
	Date-Added = {2013-02-26 14:02:40 +0000},
	Date-Modified = {2013-02-26 14:02:40 +0000},
	Institution = {Lixoft},
	Title = {Monolix 4.1 - {MLXTRAN Tutorial}},
	Year = {2012}}

@conference{Copenhagen:2013,
	Author = {{DDMoRe/Copenhagen meeting}},
	Date-Added = {2013-02-25 13:22:12 +0000},
	Date-Modified = {2013-02-25 13:31:42 +0000},
	Title = {{MML/Technical meeting}},
	Year = {2013}}

@techreport{Smith:2012aa,
	Author = {Smith, Mike and Holford, Nick},
	Date-Added = {2013-02-14 13:38:05 +0000},
	Date-Modified = {2013-02-14 13:40:45 +0000},
	Institution = {{Pfizer \& Uppsala University}},
	Title = {{Warfarin PK Rosetta Stone}},
	Year = {December 10, 2012}}

@article{Sakia:1992fu,
	Author = {Sakia, R. M.},
	Date-Added = {2013-01-17 11:02:16 +0000},
	Date-Modified = {2013-01-17 11:22:49 +0000},
	Journal = {The Statistician},
	Pages = {169-178},
	Title = {The Box-Cox transformation technique: a review},
	Volume = {41},
	Year = {1992}}

@techreport{Lavielle:2011b,
	Author = {Lavielle, Marc},
	Date-Added = {2013-01-15 15:45:56 +0000},
	Date-Modified = {2013-01-15 15:45:56 +0000},
	Institution = {{INRIA Saclay}},
	Month = {September},
	Title = {The mixed effects models},
	Year = {September 16, 2011}}

@electronic{MLXTRAN4.1.4Specification:2012,
	Author = {Lixoft},
	Date-Added = {2012-12-12 11:19:55 +0000},
	Date-Modified = {2012-12-12 11:19:55 +0000},
	Institution = {Lixoft},
	Title = {Monolix 4.1.4 - {Project MLXTRAN}},
	Year = {2012}}

@techreport{Lavielle:2012,
	Author = {Lavielle, Marc and Grevel, Joachim},
	Date-Added = {2012-12-12 10:51:07 +0000},
	Date-Modified = {2012-12-12 10:51:07 +0000},
	Institution = {{INRIA Saclay}},
	Title = {{WP}6.1 {Clinical Trial Simulator}: Prototype 02. {D}escription of Capabilities},
	Year = {June 12, 2012}}

@article{Le-Tourneau:2009fk,
	Abstract = {Phase I clinical trials are an essential step in the development of anticancer drugs. The main goal of these studies is to establish the recommended dose and/or schedule of new drugs or drug combinations for phase II trials. The guiding principle for dose escalation in phase I trials is to avoid exposing too many patients to subtherapeutic doses while preserving safety and maintaining rapid accrual. Here we review dose escalation methods for phase I trials, including the rule-based and model-based dose escalation methods that have been developed to evaluate new anticancer agents. Toxicity has traditionally been the primary endpoint for phase I trials involving cytotoxic agents. However, with the emergence of molecularly targeted anticancer agents, potential alternative endpoints to delineate optimal biological activity, such as plasma drug concentration and target inhibition in tumor or surrogate tissues, have been proposed along with new trial designs. We also describe specific methods for drug combinations as well as methods that use a time-to-event endpoint or both toxicity and efficacy as endpoints. Finally, we present the advantages and drawbacks of the various dose escalation methods and discuss specific applications of the methods in developmental oncotherapeutics.},
	Author = {Le Tourneau, Christophe and Lee, J Jack and Siu, Lillian L},
	Date-Added = {2012-12-12 10:29:57 +0000},
	Date-Modified = {2012-12-12 10:29:57 +0000},
	Doi = {10.1093/jnci/djp079},
	Journal = {J Natl Cancer Inst},
	Journal-Full = {Journal of the National Cancer Institute},
	Mesh = {Antineoplastic Agents; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Screening Assays, Antitumor; Humans; Medical Oncology; Neoplasms; Research Design; Tumor Markers, Biological; United States},
	Month = {May},
	Number = {10},
	Pages = {708-20},
	Pmc = {PMC2684552},
	Pmid = {19436029},
	Pst = {ppublish},
	Title = {Dose escalation methods in phase I cancer clinical trials},
	Volume = {101},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/jnci/djp079}}

@book{Dobson:2002uq,
	Address = {Boca Raton},
	Annote = {LDR    01201cam  2200277 a 4500
001    12506644
005    20080320095439.0
008    010817s2002    flua     b    001 0 eng  
906    $a7$bcbc$corignew$d1$eocip$f20$gy-gencatlg
925 0  $aacquire$b1 shelf copy$xpolicy default
955    $ato ASCD pc23 2001-08-17$cjp20 2001-08-20 to subj$djp99 2001-08-20$ejp85 2001-08-20 to Dewey$aaa07 2001-09-05$aps09 2002-04-18 bk rec'd, to CIP ver.$fpv10 2002-04-23 CIP ver to BCCD
010    $a  2001047417
020    $a1584881658 (pbk. : alk. paper)
040    $aDLC$cDLC$dDLC
050 00 $aQA276$b.D589 2002
082 00 $a519.5/35$221
100 1  $aDobson, Annette J.,$d1945-
245 13 $aAn introduction to generalized linear models /$cAnnette J. Dobson.
250    $a2nd ed.
260    $aBoca Raton :$bChapman & Hall/CRC,$cc2002.
300    $avii, 225 p. :$bill. ;$c24 cm.
490 1  $aChapman & Hall/CRC texts in statistical science series
504    $aIncludes bibliographical references (p. [215]-219) and index.
650  0 $aLinear models (Statistics)
830  0 $aTexts in statistical science.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0646/2001047417-d.html
},
	Author = {Dobson, Annette J.},
	Call-Number = {QA276},
	Date-Added = {2012-12-05 13:20:17 +0000},
	Date-Modified = {2012-12-05 13:20:17 +0000},
	Dewey-Call-Number = {519.5/35},
	Edition = {2nd ed},
	Genre = {Linear models (Statistics)},
	Isbn = {1584881658 (pbk. : alk. paper)},
	Library-Id = {2001047417},
	Publisher = {{Chapman \& Hall/CRC}},
	Series = {{Chapman \& Hall/CRC texts in statistical science series}},
	Title = {An introduction to generalized linear models},
	Url = {http://www.loc.gov/catdir/enhancements/fy0646/2001047417-d.html},
	Year = {2002},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/enhancements/fy0646/2001047417-d.html}}

@book{Wang:2006,
	Annote = {LDR    01201cam  2200277 a 4500
001    12506644
005    20080320095439.0
008    010817s2002    flua     b    001 0 eng  
906    $a7$bcbc$corignew$d1$eocip$f20$gy-gencatlg
925 0  $aacquire$b1 shelf copy$xpolicy default
955    $ato ASCD pc23 2001-08-17$cjp20 2001-08-20 to subj$djp99 2001-08-20$ejp85 2001-08-20 to Dewey$aaa07 2001-09-05$aps09 2002-04-18 bk rec'd, to CIP ver.$fpv10 2002-04-23 CIP ver to BCCD
010    $a  2001047417
020    $a1584881658 (pbk. : alk. paper)
040    $aDLC$cDLC$dDLC
050 00 $aQA276$b.D589 2002
082 00 $a519.5/35$221
100 1  $aDobson, Annette J.,$d1945-
245 13 $aAn introduction to generalized linear models /$cAnnette J. Dobson.
250    $a2nd ed.
260    $aBoca Raton :$bChapman & Hall/CRC,$cc2002.
300    $avii, 225 p. :$bill. ;$c24 cm.
490 1  $aChapman & Hall/CRC texts in statistical science series
504    $aIncludes bibliographical references (p. [215]-219) and index.
650  0 $aLinear models (Statistics)
830  0 $aTexts in statistical science.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0646/2001047417-d.html
},
	Author = {Wang, Dualao and Bakhai, Ameet},
	Date-Added = {2012-11-07 09:55:46 +0000},
	Date-Modified = {2012-12-05 13:22:40 +0000},
	Publisher = {{Remedica}},
	Title = {{Clinical Trials: a Practical Guide to Design, Analysis, and Reporting}},
	Year = {2006},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/enhancements/fy0646/2001047417-d.html}}

@book{Agresti:2002fk,
	Address = {New York},
	Annote = {LDR    01452cam  2200301 a 4500
001    12835081
005    20061204110121.0
008    020627s2002    nyua     b    001 0 eng  
906    $a7$bcbc$corignew$d1$eocip$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $apc24 2002-06-27 to ASCD$ajp00 2002-06-28 CIP recd$cjp20 2002-07-01 to subj$djp99 2002-07-02$ejp10 2002-07-02 to Dewey$aaa07 2002-07-03$aps11 2002-07-30 bk rec'd, to CIP ver.$ajp00 2002-08-02$fjp10 2002-08-29 (rev jp20) to sl$gjp10 2002-08-30 to BCCD$ajp10 2002-10-11 to BCCD
010    $a  2002068982
020    $a0471360937 (acid-free paper)
040    $aDLC$cDLC$dDLC
050 00 $aQA278$b.A353 2002
082 00 $a519.5/35$221
100 1  $aAgresti, Alan.
245 10 $aCategorical data analysis /$cAlan Agresti.
250    $a2nd ed.
260    $aNew York :$bWiley-Interscience,$cc2002.
300    $axv, 710 p. :$bill. ;$c24 cm.
440  0 $aWiley series in probability and statistics
504    $aIncludes bibliographical references (p. 655-688) and indexes.
650  0 $aMultivariate analysis.
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/bios/wiley042/2002068982.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/description/wiley034/2002068982.html
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/wiley024/2002068982.html
991    $br-SciRR$hQA278$i.A353 2002$tCopy 1$wGenBib
},
	Author = {Agresti, Alan},
	Call-Number = {QA278},
	Date-Added = {2012-11-07 09:54:31 +0000},
	Date-Modified = {2012-11-07 09:54:31 +0000},
	Dewey-Call-Number = {519.5/35},
	Edition = {2nd ed},
	Genre = {Multivariate analysis},
	Isbn = {0471360937 (acid-free paper)},
	Library-Id = {2002068982},
	Publisher = {Wiley-Interscience},
	Title = {Categorical data analysis},
	Url = {http://www.loc.gov/catdir/bios/wiley042/2002068982.html},
	Year = {2002},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/bios/wiley042/2002068982.html}}

@webpage{DavidianLecture:2009,
	Author = {Davidian, Marie},
	Date-Added = {2012-10-23 17:38:26 +0100},
	Date-Modified = {2013-01-23 19:16:06 +0000},
	Lastchecked = {October 2012},
	Title = {{ST 762, Nonlinear Models for Univariate and Multivariate Response, Lecture Notes}},
	Url = {http://www.stat.ncsu.edu/people/davidian/courses/st762/},
	Urldate = {http://www.stat.ncsu.edu/people/davidian/courses/st762/},
	Year = {2009},
	Bdsk-Url-1 = {http://www.stat.ncsu.edu/people/davidian/courses/st762/}}

@book{Ette:2007uq,
	Annote = {LDR    01915cam  22004694a 4500
001    14385084
005    20080717190026.0
008    060519s2007    njua     b    001 0 eng  
906    $a7$bcbc$corignew$d1$eecip$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicydefault, Sel/sdb 2008-07-15
955    $ajc00 2006-05-22$djc15 2006-05-23$ejc15 2006-05-23 to Dewey$aaa27 2006-05-24$aps15 2008-07-14 2 copies rec'd., to CIP ver.$fpv21 2008-07-17 Z-CipVer two copies to BCCD
010    $a  2006016629
015    $aGBA696249$2bnb
016 7  $a101277062$2DNLM
016 7  $a013601793$2Uk
020    $a9780471677833
020    $a0471677833
035    $a(OCoLC)ocm69391418
035    $a(OCoLC)69391418
040    $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dC#P$dYDXCP$dUKM$dMUQ$dNLGGC$dDLC
042    $apcc
050 00 $aRS187$b.P4553 2007
060 10 $aQV 744$bP5363 2007
082 00 $a615/.1$222
084    $a44.38$2bcl
245 00 $aPharmacometrics :$bthe science of quantitative pharmacology /$cedited by Ene I. Ette, Paul J. Williams.
260    $aHoboken, N.J. :$bJohn Wiley & Sons,$cc2007.
300    $axix, 1205 p. :$bill. ;$c26 cm.
504    $aIncludes bibliographical references and index.
650  0 $aPharmacology.
650  0 $aPharmacokinetics.
650 12 $aChemistry, Pharmaceutical$xmethods.
650 12 $aDrug Evaluation$xmethods.
650 22 $aModels, Theoretical.
650 22 $aPharmacoepidemiology$xmethods.
650 22 $aPharmacokinetics.
650 22 $aTechnology, Pharmaceutical$xmethods.
700 1  $aEtte, Ene I.
700 1  $aWilliams, Paul J.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0614/2006016629.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0739/2006016629-d.html
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy0739/2006016629-b.html
},
	Author = {Ette, Ene I and Williams, Paul J},
	Date-Added = {2012-10-08 13:04:06 +0100},
	Date-Modified = {2012-10-08 13:10:44 +0100},
	Publisher = {John Wiley \& Sons},
	Title = {Pharmacometrics: the science of quantitative pharmacology},
	Year = {2007},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/toc/ecip0614/2006016629.html}}

@techreport{EMA:1998,
	Author = {{EMEA}},
	Date-Added = {2012-10-08 11:01:14 +0100},
	Date-Modified = {2012-12-12 10:56:05 +0000},
	Institution = {{European Medicines Agency}},
	Title = {{ICH Topic E 9 - Statistical Principles for Clinical Trials}},
	Year = {September, 1998}}

@article{Bizzotto:2011fk,
	Abstract = {Mixed-effect Markov chain models have been recently proposed to characterize the time course of transition probabilities between sleep stages in insomniac patients. The most recent one, based on multinomial logistic functions, was used as a base to develop a final model combining the strengths of the existing ones. This final model was validated on placebo data applying also new diagnostic methods and then used for the inclusion of potential age, gender, and BMI effects. Internal validation was performed through simplified posterior predictive check (sPPC), visual predictive check (VPC) for categorical data, and new visual methods based on stochastic simulation and estimation and called visual estimation check (VEC). External validation mainly relied on the evaluation of the objective function value and sPPC. Covariate effects were identified through stepwise covariate modeling within NONMEM VI. New model features were introduced in the model, providing significant sPPC improvements. Outcomes from VPC, VEC, and external validation were generally very good. Age, gender, and BMI were found to be statistically significant covariates, but their inclusion did not improve substantially the model's predictive performance. In summary, an improved model for sleep internal architecture has been developed and suitably validated in insomniac patients treated with placebo. Thereafter, covariate effects have been included into the final model.},
	Author = {Bizzotto, Roberto and Zamuner, Stefano and Mezzalana, Enrica and De Nicolao, Giuseppe and Gomeni, Roberto and Hooker, Andrew C and Karlsson, Mats O},
	Date-Added = {2012-10-08 10:38:14 +0100},
	Date-Modified = {2012-10-08 10:38:14 +0100},
	Doi = {10.1208/s12248-011-9287-4},
	Journal = {AAPS J},
	Journal-Full = {The AAPS journal},
	Mesh = {Humans; Logistic Models; Markov Chains; Models, Biological; Multicenter Studies as Topic; Multivariate Analysis; Polysomnography; Predictive Value of Tests; Randomized Controlled Trials as Topic; Reproducibility of Results; Sleep Initiation and Maintenance Disorders; Sleep Stages; Time Factors},
	Month = {Sep},
	Number = {3},
	Pages = {445-63},
	Pmc = {PMC3160167},
	Pmid = {21691915},
	Pst = {ppublish},
	Title = {Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis},
	Volume = {13},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1208/s12248-011-9287-4}}

@techreport{Monolix4.0ChatelLavielle,
	Author = {Chatel, Kaelig and Lavielle, Marc},
	Date-Added = {2012-10-07 15:37:33 +0100},
	Date-Modified = {2012-10-07 15:47:55 +0100},
	Institution = {Lixoft},
	Title = {MONOLIX 4.0 - {MLXTRAN} for continuous and discrete data models},
	Year = {2012}}

@techreport{Monolix4.2.1UserGuide:2012,
	Author = {Lixoft},
	Date-Added = {2012-10-05 14:56:20 +0100},
	Date-Modified = {2013-03-04 19:35:59 +0000},
	Institution = {Lixoft},
	Title = {Monolix 4.2.1 - {User Guide}},
	Year = {2012}}

@url{CDICS:2011,
	Author = {{CDISC consortium}},
	Date-Added = {2012-10-05 14:55:13 +0100},
	Date-Modified = {2012-12-12 11:41:30 +0000},
	Keywords = {{CDISC consortium}},
	Title = {{CDISC Clinical Research Glossary, http://www.cdisc.org/cdisc-glossary}},
	Urldate = {http://www.cdisc.org/cdisc-glossary},
	Year = {2011}}

@techreport{Monolix4.1.4Tutorial:2012,
	Author = {Lixoft},
	Date-Added = {2012-10-05 14:49:53 +0100},
	Date-Modified = {2013-03-04 19:26:43 +0000},
	Institution = {Lixoft},
	Title = {Monolix 4.1.4 - {Model MLXTRAN Tutorial}},
	Year = {2012}}

@article{Frame:2003uq,
	Abstract = {Mixture modeling within the context of pharmacokinetic (PK)/pharmacodynamic (PD) mixed effects modeling is a useful tool to explore a population for the presence of two or more subpopulations, not explained by evaluated covariates. At present, statistical tests for the existence of mixed populations have not been developed. Therefore, a simulation study was undertaken to evaluate mixture modeling with NONMEM and explore the following questions. First, what is the probability of concluding that a mixed population exists when there truly is not a mixture (false positive significance level)? Second, what is the probability of concluding that a mixed population (two subpopulations) exists when there is truly a mixed population (power), and how well can the mixture be estimated, both in terms of the population parameters and the individual subjects classification. Seizure count data were simulated using a Poisson distribution such that each subject's count could decrease from its baseline value, as a function of dose via an Emax model. The dosing design for the simulation was based on a trial with the investigational anti-epileptic drug pregabalin. Four hundred and forty seven subjects received pregabalin as add on therapy for partial seizures, each with a baseline seizure count and up to three subsequent seizure counts. For the mixtures, the two subpopulations were simulated to differ in their Emax values and relative proportions. One subpopulation always had its Emax set to unity (Emax hi), allowing the count to approach zero with increasing dose. The other subpopulation was allowed to vary in its Emax value (Emax lo = 0.75, 0.5, 0.25, and 0) and in its relative proportion (pr) of the population (pr = 0.05, 0.10, 0.25, and 0.50) giving a total of 4.4 = 16 different mixtures explored. Three hundred data sets were simulated for each scenario and estimations performed using NONMEM. Metrics used information about the parameter estimates, their standard errors (SE), the difference between minimum objective function (MOF) values for mixture and non-mixture models (MOF (delta)), the proportion of subjects classified correctly, and the estimated conditional probabilities of a subject being simulated as having Emax lo (Emax hi) given that they were estimated as having Emax lo (Emax hi) and being estimated as having Emax lo (Emax hi) given that they were simulated as having Emax lo (Emax hi). The false positive significance level was approximately 0.04 (using all 300 runs) or 0.078 (using only those runs with a successful covariance step), when there was no mixture. When simulating mixed data and for those characterizations with successful estimation and covariance steps, the median (range) percentage of 95% confidence intervals containing the true values for the parameters defining the mixture were 94% (89-96%), 89.5% (58-96%), and 95% (92-97%) for pr, Emax lo, and Emax hi, respectively. The median value of the estimated parameters pr, Emax lo (excluding the case when Emax lo was simulated to equal 0) and Emax hi within a scenario were within +/- 28% of the true values. The median proportion of subjects classified correctly ranged from 0.59 to 0.96. In conclusion, when no mixture was present the false positive probability was less than 0.078 and when mixtures were present they were characterized with varying degrees of success, depending on the nature of the mixture. When the difference between subpopulations was greater (as Emax lo approached zero or pr approached 0.5) the mixtures became easier to characterize.},
	Author = {Frame, Bill and Miller, Raymond and Lalonde, Richard L},
	Date-Added = {2012-07-27 14:19:23 +0100},
	Date-Modified = {2012-07-27 14:19:23 +0100},
	Journal = {J Pharmacokinet Pharmacodyn},
	Journal-Full = {Journal of pharmacokinetics and pharmacodynamics},
	Mesh = {Computer Simulation; Confidence Intervals; Controlled Clinical Trials as Topic; Humans; Models, Chemical; Poisson Distribution; Software},
	Month = {Jun},
	Number = {3},
	Pages = {167-83},
	Pmid = {14571690},
	Pst = {ppublish},
	Title = {Evaluation of mixture modeling with count data using NONMEM},
	Volume = {30},
	Year = {2003}}

@article{Plan:2009fk,
	Abstract = {There has been little evaluation of maximum likelihood approximation methods for non-linear mixed effects modelling of count data. The aim of this study was to explore the estimation accuracy of population parameters from six count models, using two different methods and programs. Simulations of 100 data sets were performed in NONMEM for each probability distribution with parameter values derived from a real case study on 551 epileptic patients. Models investigated were: Poisson (PS), Poisson with Markov elements (PMAK), Poisson with a mixture distribution for individual observations (PMIX), Zero Inflated Poisson (ZIP), Generalized Poisson (GP) and Negative Binomial (NB). Estimations of simulated datasets were completed with Laplacian approximation (LAPLACE) in NONMEM and LAPLACE/Gaussian Quadrature (GQ) in SAS. With LAPLACE, the average absolute value of the bias (AVB) in all models was 1.02% for fixed effects, and ranged 0.32-8.24% for the estimation of the random effect of the mean count (lambda). The random effect of the overdispersion parameter present in ZIP, GP and NB was underestimated (-25.87, -15.73 and -21.93% of relative bias, respectively). Analysis with GQ 9 points resulted in an improvement in these parameters (3.80% average AVB). Methods implemented in SAS had a lower fraction of successful minimizations, and GQ 9 points was considerably slower than 1 point. Simulations showed that parameter estimates, even when biased, resulted in data that were only marginally different from data simulated from the true model. Thus all methods investigated appear to provide useful results for the investigated count data models.},
	Author = {Plan, Elodie L and Maloney, Alan and Troc{\'o}niz, I{\~n}aki F and Karlsson, Mats O},
	Date-Added = {2012-07-27 14:15:49 +0100},
	Date-Modified = {2012-07-27 14:15:49 +0100},
	Doi = {10.1007/s10928-009-9126-8},
	Journal = {J Pharmacokinet Pharmacodyn},
	Journal-Full = {Journal of pharmacokinetics and pharmacodynamics},
	Mesh = {Bayes Theorem; Binomial Distribution; Biometry; Computer Simulation; Humans; Likelihood Functions; Markov Chains; Monte Carlo Method; Normal Distribution; Numerical Analysis, Computer-Assisted; Poisson Distribution; Software; Statistical Distributions},
	Month = {Aug},
	Number = {4},
	Pages = {353-66},
	Pmid = {19653080},
	Pst = {ppublish},
	Title = {Performance in population models for count data, part I: maximum likelihood approximations},
	Volume = {36},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10928-009-9126-8}}

@techreport{Lavielle:2011,
	Author = {Lavielle, Marc and Grevel, Joachim},
	Date-Added = {2012-04-13 18:12:00 +0100},
	Date-Modified = {2012-04-13 18:12:00 +0100},
	Institution = {{INRIA Saclay}},
	Title = {{WP}6.1 {Clinical Trial Simulator}: Prototype 01. {D}escription of Capabilities},
	Year = {September 1, 2011}}

@techreport{Lavielle:2012b,
	Author = {Lavielle, Marc},
	Date-Added = {2012-03-23 12:51:18 +0000},
	Date-Modified = {2013-01-15 15:46:56 +0000},
	Institution = {{INRIA Saclay}},
	Month = {June},
	Title = {Mathematical description of mixed effects models},
	Year = {June 25, 2012}}

@article{Goto:1984,
	Author = {Masashi Goto and Toshiaki Inoue and Yoshihide Tsuchiya},
	Date-Added = {2012-03-20 18:48:35 +0000},
	Date-Modified = {2012-03-20 18:50:54 +0000},
	Journal = {Bulletin of Informatics and Cybernetics},
	Number = {1-2},
	Pages = {41-53},
	Title = {ON ESTIMATION OF PARAMETERS IN POWER-NORMAL DISTRIBUTION},
	Volume = {21},
	Year = {1984}}

@manual{fitdistrplus:2010,
	Author = {Marie Laure Delignette-Muller and Regis Pouillot and Jean-Baptiste Denis and Christophe Dutang},
	Date-Added = {2012-03-20 16:08:42 +0000},
	Date-Modified = {2012-03-20 16:10:18 +0000},
	Keywords = {R package version 0.2-2},
	Title = {fitdistrplus: help to fit of a parametric distribution to non-censored or censored data},
	Year = {2011}}

@article{Freeman:2006fk,
	Abstract = {Box-Cox transformation system produces the power normal (PN) family, whose members include normal and lognormal distributions. We study the moments of PIN and obtain expressions for its mean and variance. The quantile functions and a quantile measure of skewness are discussed to show that the PN family is ordered with respect to the transformation parameter. Chebyshev-Hermite polynomials are used to show that the correlation coefficient is smaller in the PN scale than the original scale. We use the Frechet bounds to obtain expressions for the lower and upper bounds of the correlation coefficient. A numerical routine is used to compute the bounds. The transformation parameter of the PN family is used to investigate the effects of model uncertainty on the up per quantile estimates. (C) 2005 Elsevier B.V. All rights reserved.},
	Address = {PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS},
	Author = {Freeman, J and Modarres, R},
	Date-Added = {2012-03-14 13:13:19 +0000},
	Date-Modified = {2012-03-14 13:13:19 +0000},
	Doi = {DOI 10.1016/j.spl.2005.10.036},
	Isi = {000237368000002},
	Isi-Recid = {150077170},
	Isi-Ref-Recids = {75503401 123198625 44530543 2247010 103286504 50133285 105356619 150077171 100221763 42002014 95252580 520972 130508975 5343307 52516351 60692110 150077172 125369962 9524596 69966445 93126373 55776175 58491242 150077173 92573554 30166568},
	Journal = {Statistics \& Probability Letters},
	Keywords = {Box-Cox transformation; power normal; skewness; uncertainty analysis; quantiles; lognormal},
	Month = apr,
	Number = {8},
	Pages = {764--772},
	Publisher = {ELSEVIER SCIENCE BV},
	Times-Cited = {6},
	Title = {Inverse Box-Cox: The power-normal distribution},
	Volume = {76},
	Year = {2006},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000237368000002},
	Bdsk-Url-2 = {http://dx.doi.org/10.1016/j.spl.2005.10.036}}

@article{ROBERT:1995uq,
	Abstract = {We provide simulation algorithms for one-sided and two-sided truncated normal distributions. These algorithms are then used to simulate multivariate normal variables with convex restricted parameter space for any covariance structure.},
	Address = {2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN},
	Author = {ROBERT, CP},
	Date-Added = {2012-03-12 17:37:28 +0000},
	Date-Modified = {2012-03-12 17:37:28 +0000},
	Isi = {A1995RF65600010},
	Isi-Recid = {91921224},
	Isi-Ref-Recids = {91921225 91921226 46927176 72811647 79794498 83055748 84414839 91921227 9905497 851180 78176276 64261716 66305533 91075809 62972501 91921228},
	Journal = {Statistics and Computing},
	Keywords = {ACCEPT-REJECT; GIBBS SAMPLING; MARKOV CHAIN MONTE CARLO; CENSORED MODELS; ORDER-RESTRICTED MODELS},
	Month = jun,
	Number = {2},
	Pages = {121--125},
	Publisher = {CHAPMAN HALL LTD},
	Times-Cited = {127},
	Title = {SIMULATION OF TRUNCATED NORMAL VARIABLES},
	Volume = {5},
	Year = {1995},
	Bdsk-File-1 = {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}}

@article{BoxCox:1964,
	Author = {Box, GEP and Cox, DR},
	Date-Added = {2012-03-12 11:41:32 +0000},
	Date-Modified = {2012-03-12 11:44:50 +0000},
	Journal = {Journal of the Royal Statistical Society. Series B (Methodological)},
	Number = {2},
	Pages = {211--252},
	Title = {AN ANALYSIS OF TRANSFORMATIONS},
	Volume = {26},
	Year = {1964},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=A1982NG21400029}}

@techreport{Metrum:2012,
	Author = {Gastonguay, Marc R. and {Metrum Institute Faculty}},
	Date-Added = {2012-03-07 18:11:29 +0000},
	Date-Modified = {2013-09-10 19:25:23 +0100},
	Institution = {{Metrum Institute}},
	Title = {{MI-210: Essentials of Population PKPD - Modeling and Simulation}},
	Year = {2012}}

@book{Bonate:2011fk,
	Address = {New York},
	Annote = {LDR    00698nam  22002175a 4500
001    16798464
005    20110526113523.0
008    110526s2011    nyu           000 0 eng  
906    $a0$bibc$corignew$d2$eepcn$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $apc17 2011-05-26
010    $a  2011930671
020    $a9781441994844
040    $aDLC$cDLC
042    $apcc
100 1  $aBonate, Peter L.
245 10 $aPharmacokinetic-pharmacodynamic modeling and simulation /$cPeter L. Bonate.
260    $aNew York :$bSpringer,$c2011.
263    $a1106
300    $ap. cm.
963    $aS.Reka; phone: (413) 4213000; email: S.Reka@spi-global.com; bc: rhea.talbert@springer.com
},
	Author = {Bonate, Peter L},
	Date-Added = {2012-01-19 11:35:24 +0000},
	Date-Modified = {2012-01-19 11:35:24 +0000},
	Isbn = {9781441994844},
	Library-Id = {2011930671},
	Publisher = {Springer},
	Title = {Pharmacokinetic-pharmacodynamic modeling and simulation},
	Year = {2011}}

@article{Breda:2001aa,
	Abstract = {The simultaneous assessment of quantitative indexes of insulin secretion and action in a single individual is important when quantifying their relative role in the evolution of glucose tolerance in different physiopathological states. Available methods quantify these indexes in relatively nonphysiological conditions, e.g., during glucose clamps or intravenous glucose tolerance tests. Here, we present a method based on a physiological test applicable to large-scale genetic and epidemiologic studies-the oral glucose tolerance test (OGTT). Plasma C-peptide, insulin, and glucose data from a frequently sampled OGTT with 22 samples throughout 300 min (FSOGTT300-22) were analyzed in 11 subjects with various degrees of glucose tolerance. In each individual, two indexes of pancreatic sensitivity to glucose (phis [10(9) min(-1)] and phid [10(9)]) and the insulin sensitivity index (SI) (10(5) dl/kg per min per pmol/l) were estimated by using the minimal model of C-peptide secretion and kinetics originally proposed for intravenous graded glucose infusion and the minimal model approach recently proposed for meal/OGTTs. The indexes obtained from FSOGTT300-22 were used as a reference for internal validation of OGTT protocols with reduced sampling schedules. Our results show that 11 samples in a 300-min period (OGTT300-11) is the test of choice because the indexes it provides (phis = 36 +/- 3 [means +/- SE]; phid = 710 +/- 111; SI = 10.2 +/- 2.4) show excellent correlation and are not statistically different from those of FSOGTT300-22 (phis = 33 +/- 3; phid = 715 +/- 120; SI = 10.1 +/- 2.3). In conclusion, OGTT300-11, interpreted with C-peptide and glucose minimal models, provides a quantitative description of beta-cell function and insulin sensitivity in a single individual while preserving the important clinical classification of glucose tolerance provided by the standard 120-min OGTT.},
	Author = {Breda, E and Cavaghan, M K and Toffolo, G and Polonsky, K S and Cobelli, C},
	Date-Added = {2011-12-11 18:09:27 +0000},
	Date-Modified = {2011-12-11 18:09:27 +0000},
	Journal = {Diabetes},
	Journal-Full = {Diabetes},
	Mesh = {Adult; Blood Glucose; C-Peptide; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Models, Biological; Specimen Handling},
	Month = {Jan},
	Number = {1},
	Pages = {150-8},
	Pmid = {11147781},
	Pst = {ppublish},
	Title = {Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity},
	Volume = {50},
	Year = {2001}}

@article{Sunehag:2009aa,
	Abstract = {Given the increase in the incidence of insulin resistance, obesity, and type 2 diabetes in children and adolescents, it would be of paramount importance to assess quantitative indices of insulin secretion and action during a physiological perturbation, such as a meal or an oral glucose-tolerance test (OGTT). A minimal model method is proposed to measure quantitative indices of insulin secretion and action in adolescents from an oral test. A 7 h, 21-sample OGTT was performed in 11 adolescents. The C-peptide minimal model was identified on C-peptide and glucose data to quantify indices of beta-cell function: static phi(s) and dynamic phi(d) responsivity to glucose from which total responsivity phi was also measured. The glucose minimal model was identified on glucose and insulin data to estimate insulin sensitivity, S(I), which was compared to a reference measure, S(I)(ref), provided by a tracer method. Disposition indices, which adjust insulin secretion for insulin action, were then calculated. Indices of beta-cell function were phi(s) = 51.35 +/- 8.89 x 10(-9)min(-1), phi(d) = 1,392 +/- 258 x 10(-9), and phi = 82.09 +/- 17.70 x 10(-9)min(-1). Insulin sensitivity was S(I) = 14.19 +/- 2.73 x 10(-4), not significantly different from S(I)(ref) = 14.96 +/- 3.04 x 10(-4) dl/kg.min per microU/ml, and well correlated: r = 0.98, P < 0.0001, thus indicating that S(I) can be accurately measured from an oral test. Disposition indices were DI(s) = 1,040 +/- 201 x 10(-14) dl/kg/min(2) per pmol/l, DI(d) = 33,178 +/- 10,720 x 10(-14) dl/kg/min per pmol/l, DI = 1,844 +/- 522 x 10(-14) dl/kg/min(2) per pmol/l. Virtually the same minimal model assessment was obtained with a reduced 3 h, 9-sample protocol. OGTT interpreted with C-peptide and glucose minimal model has the potential to provide novel insight regarding the regulation of glucose metabolism in adolescents, and to evaluate the effect of obesity and interventions such as diet and exercise.},
	Author = {Sunehag, Agneta L and Man, Chiara Dalla and Toffolo, Gianna and Haymond, Morey W and Bier, Dennis M and Cobelli, Claudio},
	Date-Added = {2011-12-11 14:18:52 +0000},
	Date-Modified = {2011-12-11 14:18:52 +0000},
	Doi = {10.1038/oby.2008.496},
	Journal = {Obesity (Silver Spring)},
	Journal-Full = {Obesity (Silver Spring, Md.)},
	Mesh = {Adolescent; Blood Glucose; C-Peptide; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin-Secreting Cells; Male; Models, Biological; Time Factors},
	Month = {Feb},
	Number = {2},
	Pages = {233-9},
	Pmid = {19057529},
	Pst = {ppublish},
	Title = {beta-Cell function and insulin sensitivity in adolescents from an OGTT},
	Volume = {17},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/oby.2008.496}}

@article{Ozcelik:2010aa,
	Abstract = {To evaluate the protective effect of GnRH agonist for the prevention of ovarian reserve during treatment with paclitaxel and cisplatin.},
	Author = {Ozcelik, Bulent and Turkyilmaz, Cagdas and Ozgun, Mahmut Tuncay and Serin, Ibrahim Serdar and Batukan, Cem and Ozdamar, Saim and Ozturk, Ahmet},
	Date-Added = {2011-09-02 14:31:30 +0200},
	Date-Modified = {2011-09-02 14:31:30 +0200},
	Doi = {10.1016/j.fertnstert.2009.02.054},
	Journal = {Fertil Steril},
	Journal-Full = {Fertility and sterility},
	Mesh = {Animals; Anovulation; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Drug Administration Schedule; Female; Fertility; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Infertility, Female; Injections, Subcutaneous; Leuprolide; Ovarian Follicle; Paclitaxel; Rats; Rats, Wistar},
	Month = {Mar},
	Number = {5},
	Pages = {1609-14},
	Pmid = {19339002},
	Pst = {ppublish},
	Title = {Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist},
	Volume = {93},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.fertnstert.2009.02.054}}

@article{Ganguly:2011aa,
	Abstract = {Numerous studies have implicated mutations in tubulin or the overexpression of specific tubulin genes in resistance to microtubule-targeted drugs. Much less is known about the role of accessory proteins that modulate microtubule behavior in the genesis of drug resistance. Here, we examine mitotic centromere-associated kinesin (MCAK), a member of the kinesin family of microtubule motor proteins that has the ability to stimulate microtubule depolymerization, and show that overexpressing the protein confers resistance to paclitaxel and epothilone A, but increases sensitivity to colcemid. Cells transfected with FLAG-tagged MCAK cDNA using a tet-off-regulated expression system had a disrupted microtubule cytoskeleton and were able to survive a toxic concentration of paclitaxel in the absence, but not in the presence of tetracycline, showing that drug resistance was caused by ectopic MCAK production. Moreover, a population that was heterogeneous with respect to FLAG-MCAK expression became enriched with cells that produced the ectopic protein when it was placed under paclitaxel selection. Similar to previously isolated mutants with altered tubulin, paclitaxel resistant cells resulting from MCAK overexpression were found to have decreased microtubule polymer and a seven-fold increase in the frequency of microtubule detachment from centrosomes. These data are consistent with a model for paclitaxel resistance that is based on stability of the attachment of microtubules to their nucleating centers, and they implicate MCAK in the mechanism of microtubule detachment.},
	Author = {Ganguly, Anutosh and Yang, Hailing and Cabral, Fernando},
	Date-Added = {2011-09-02 14:24:23 +0200},
	Date-Modified = {2011-09-02 14:24:23 +0200},
	Doi = {10.1158/1535-7163.MCT-10-1109},
	Journal = {Mol Cancer Ther},
	Journal-Full = {Molecular cancer therapeutics},
	Month = {Jun},
	Number = {6},
	Pages = {929-37},
	Pmc = {PMC3112244},
	Pmid = {21471284},
	Pst = {ppublish},
	Title = {Overexpression of mitotic centromere-associated Kinesin stimulates microtubule detachment and confers resistance to paclitaxel},
	Volume = {10},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/1535-7163.MCT-10-1109}}

@book{Goodman:2001aa,
	Address = {Cambridge},
	Annote = {LDR    01449cam  22003254a 4500
001    11995117
005    20020821200632.0
008    000503s2001    enka     b    001 0 eng  
906    $a7$bcbc$corignew$d1$eocip$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $ato SSCD pc22 05-03-00; jc09 05-09-00; jc01 10-13-00; jc03 to Dewey 05-16-00;aa03 5-23-00; jc20 c. 2 to BCCD 06-27-01
010    $a   00034230 
020    $a052156123X (hbk.)
040    $aDLC$cDLC$dDLC
042    $apcc
043    $an-us---$an-usp--
050 00 $aRC271.P27$bG66 2001
082 00 $a616.99/406$221
100 1  $aGoodman, Jordan.
245 14 $aThe story of taxol :$bnature and politics in the pursuit of an anti-cancer drug /$cJordan Goodman, Vivien Walsh.
260    $aCambridge ;$aNew York :$bCambridge University Press,$c2001.
300    $axiii, 282 p. :$bill. ;$c24 cm.
504    $aIncludes bibliographical references (p. [251]-279) and index.
650  0 $aPaclitaxel$xResearch$xPolitical aspects$zUnited States.
650  0 $aPaclitaxel$xResearch$xEconomic aspects$zUnited States.
650  0 $aCancer$xTreatment$xResearch$xPolitical aspects$zUnited States.
650  0 $aPacific yew$xHarvesting$zNorthwest, Pacific.
700 1  $aWalsh, Vivien.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/description/cam021/00034230.html
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/cam026/00034230.html
},
	Author = {Goodman, Jordan and Walsh, Vivien},
	Call-Number = {RC271.P27},
	Date-Added = {2011-09-02 14:11:17 +0200},
	Date-Modified = {2011-09-02 14:11:17 +0200},
	Dewey-Call-Number = {616.99/406},
	Genre = {Paclitaxel},
	Isbn = {052156123X (hbk.)},
	Library-Id = {00034230},
	Publisher = {Cambridge University Press},
	Title = {The story of taxol: nature and politics in the pursuit of an anti-cancer drug},
	Url = {http://www.loc.gov/catdir/description/cam021/00034230.html},
	Year = {2001},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/description/cam021/00034230.html}}

@article{Lunn:2002aa,
	Abstract = {Markov chain Monte Carlo (MCMC) techniques have revolutionized the field of Bayesian statistics by enabling posterior inference for arbitrarily complex models. The now widely used WinBUGS software has, over the years, made the methodology accessible to a great many applied scientists, in all fields of research. Despite this, serious application of MCMC methods within the field of population PK/PD has been comparatively limited. We appreciate that for many applied pharmacokineticists the prospect of conducting a Bayesian analysis will require numerous alien concepts to be taken on board and it may be difficult to justify investing the time and effort required in order to understand them (especially since the approach is so computer-intensive). For this reason we provide here a thorough (but often informal) discussion of all aspects of Bayesian inference as they apply specifically to population PK/PD. We also acknowledge that while the WinBUGS software is general purpose, model specification for some types of problem, population PK/PD being a prime example, can be very difficult, to the extent that a specialized interface for describing the problem at hand is often a practical necessity. In the latter part of this paper we describe such an interface, namely PKBugs. A principal aim of the paper is to offer sufficient technical background, in an easy to follow format, that the reader may develop both the confidence and know-how to make appropriate use of the PKBugs/WinBUGS framework (or similar software) for their own data analysis needs, should they choose to adopt a Bayesian approach.},
	Author = {Lunn, David J and Best, Nicky and Thomas, Andrew and Wakefield, Jon and Spiegelhalter, David},
	Date-Added = {2011-08-25 11:22:38 +0100},
	Date-Modified = {2011-08-25 11:22:38 +0100},
	Journal = {J Pharmacokinet Pharmacodyn},
	Journal-Full = {Journal of pharmacokinetics and pharmacodynamics},
	Mesh = {Bayes Theorem; Models, Biological; Software},
	Month = {Jun},
	Number = {3},
	Pages = {271-307},
	Pmid = {12449499},
	Pst = {ppublish},
	Title = {Bayesian analysis of population PK/PD models: general concepts and software},
	Volume = {29},
	Year = {2002}}

@article{DBLP:journals/csda/KuhnL05,
	Author = {E. Kuhn and M. Lavielle},
	Bibsource = {DBLP, http://dblp.uni-trier.de},
	Date-Added = {2011-08-25 11:01:55 +0100},
	Date-Modified = {2011-08-25 11:01:55 +0100},
	Journal = {Computational Statistics {\&} Data Analysis},
	Number = {4},
	Pages = {1020-1038},
	Title = {Maximum likelihood estimation in nonlinear mixed effects models},
	Volume = {49},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.csda.2004.07.002}}

@techreport{DArgenio:2009aa,
	Author = {D'Argenio, D.Z., A. Schumitzky and X. Wang},
	Date-Added = {2011-08-25 10:56:57 +0100},
	Date-Modified = {2011-08-25 10:59:07 +0100},
	Institution = {Biomedical Simulations Resource, Los Angeles},
	Title = {ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software},
	Year = {2009}}

@article{Yagil:2007aa,
	Abstract = {We investigated the metabolic and genetic basis of diabetes in the Cohen Diabetic rat, a model of diet-induced diabetes, as a means to identify the molecular mechanisms involved. By altering individual components in the diabetogenic diet, we established that the dietary susceptibility that leads to the development of diabetes in this model is directly related to the high casein and low copper content in chow. The development of diabetes is accompanied by depletion of the acini from the exocrine pancreas and replacement with fat cells, while the appearance of the islets of Langerhans remains intact. With reversion back from diabetogenic to regular diet, the diabetic phenotype disappears but the histological changes in the exocrine pancreas prevail. Using positional cloning, we detected a major quantitative trait locus (QTL) on rat chromosome 4 with a chromosomal span of 4.9 cM, and two additional loci on chromosomes 7 and X. A screen for genes within that QTL in the rat and in the syntenic regions in mouse and man revealed only 23 candidate genes. Notable among these genes is Ica1, which has been causally associated with diabetes and bovine casein. We conclude that the development of diabetes in our model is dependent upon high casein and low copper in diet, that it is accompanied by histomorphological changes in the exocrine but not endocrine pancreas, that it is reversible, and that it is associated with a major QTL on chromosome 4 in which we detected Ica1, a high priority candidate gene.},
	Author = {Yagil, Chana and Barkalifa, Ronit and Sapojnikov, Marina and Wechsler, Alexander and Ben-Dor, David and Weksler-Zangen, Sarah and Kaiser, Nurit and Raz, Itamar and Yagil, Yoram},
	Date-Added = {2011-07-19 16:43:09 +0100},
	Date-Modified = {2011-07-19 16:43:09 +0100},
	Doi = {10.1152/physiolgenomics.00210.2006},
	Journal = {Physiol Genomics},
	Journal-Full = {Physiological genomics},
	Mesh = {Analysis of Variance; Animal Feed; Animals; Autoantigens; Caseins; Chromosome Mapping; Copper; Diabetes Mellitus, Experimental; Diet; Disease Models, Animal; Genetic Testing; Lod Score; Pancreas; Quantitative Trait Loci; Rats},
	Month = {Apr},
	Number = {2},
	Pages = {181-92},
	Pmid = {17213368},
	Pst = {ppublish},
	Title = {Metabolic and genomic dissection of diabetes in the Cohen rat},
	Volume = {29},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1152/physiolgenomics.00210.2006}}

@article{Efanov:2005aa,
	Abstract = {The glucose-sensing enzyme glucokinase (GK) plays a key role in glucose metabolism. We report here the effects of a novel glucokinase activator, LY2121260. The activator enhanced GK activity via binding to the allosteric site located in the hinge region of the enzyme. LY2121260 stimulated insulin secretion in a glucose-dependent manner in pancreatic beta-cells and increased glucose use in rat hepatocytes. In addition, incubation of beta-cells with the GK activator resulted in increased GK protein levels, suggesting that enhanced insulin secretion on chronic treatment with a GK activator may be due to not only changed enzyme kinetics but also elevated enzyme levels. Animals treated with LY2121260 showed an improved glucose tolerance after oral glucose challenge. These results support the concept that GK activators represent a new class of compounds that increase both insulin secretion and hepatic glucose use and in doing so may prove to be effective agents for the control of blood glucose levels in patients with type 2 diabetes.},
	Author = {Efanov, Alexander M and Barrett, David G and Brenner, Martin B and Briggs, Stephen L and Delaunois, Annie and Durbin, Jim D and Giese, Ulrich and Guo, Haihong and Radloff, Mark and Gil, Gema Sanz and Sewing, Sabine and Wang, Yong and Weichert, Andreas and Zaliani, Andrea and Gromada, Jesper},
	Date-Added = {2011-07-19 16:36:56 +0100},
	Date-Modified = {2011-07-19 16:36:56 +0100},
	Doi = {10.1210/en.2005-0377},
	Journal = {Endocrinology},
	Journal-Full = {Endocrinology},
	Mesh = {Animals; Blood Glucose; Cells, Cultured; Crystallography; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Enzyme Activators; Glucokinase; Hepatocytes; Humans; Insulin; Islets of Langerhans; Male; Protein Structure, Tertiary; Rats; Rats, Wistar; Sulfones; Thiazoles},
	Month = {Sep},
	Number = {9},
	Pages = {3696-701},
	Pmid = {15919746},
	Pst = {ppublish},
	Title = {A novel glucokinase activator modulates pancreatic islet and hepatocyte function},
	Volume = {146},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1210/en.2005-0377}}

@article{Andrikopoulos:2008aa,
	Abstract = {The objective of this study was to determine the optimal conditions under which to assess glucose tolerance in chow- and high-fat-fed C57BL/6J mice. Mice were fed either chow or high-fat diet for 8 wk. Variables tested were fasting duration (0-, 3-, 6-, and 24-h and overnight fasting), route of administration (intraperitoneal vs. oral) load of glucose given (2, 1, or 0.5 g/kg and fixed 50-mg dose), and state of consciousness. Basal glucose concentrations were increased in high-fat- compared with chow-fed mice following 6 h of fasting (9.1 +/- 0.3 vs. 7.9 +/- 0.4 mmol/l P = 0.01). Glucose tolerance was most different and therefore significant (P = 0.001) in high-fat-fed mice after 6 h of fasting (1,973 +/- 96 vs. 1,248 +/- 83 mmol.l(-1).120 min(-1)). The difference in glucose tolerance was greater following an OGTT (142\%), in contrast to an IPGTT, with a 127\% difference between high fat and chow. We also found that administering 2 g/kg of glucose resulted in a greater level of significance (P = 0.0008) in glucose intolerance in high-fat- compared with chow-fed mice. A fixed dose of 50 mg glucose regardless of body weight was enough to show glucose intolerance in high-fat- vs. chow-fed mice. Finally, high-fat-fed mice showed glucose intolerance compared with their chow-fed counterparts whether they were tested under conscious or anesthetized conditions. We conclude that 2 g/kg glucose administered orally following 6 h of fasting is best to assess glucose tolerance in mice under these conditions.},
	Author = {Andrikopoulos, Sofianos and Blair, Amy R and Deluca, Nadia and Fam, Barbara C and Proietto, Joseph},
	Date-Added = {2011-07-19 16:27:03 +0100},
	Date-Modified = {2011-07-19 16:27:03 +0100},
	Doi = {10.1152/ajpendo.90617.2008},
	Journal = {Am J Physiol Endocrinol Metab},
	Journal-Full = {American journal of physiology. Endocrinology and metabolism},
	Mesh = {Animals; Area Under Curve; Blood Glucose; Body Weight; Diet, Atherogenic; Eating; Energy Intake; Fasting; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Time Factors},
	Month = {Dec},
	Number = {6},
	Pages = {E1323-32},
	Pmid = {18812462},
	Pst = {ppublish},
	Title = {Evaluating the glucose tolerance test in mice},
	Volume = {295},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1152/ajpendo.90617.2008}}

@article{Sumiyoshi:2006aa,
	Abstract = {Intakes of some macronutrients can comprise risk factors for life-style-related diseases such as obesity, hyperlipidemia, diabetes, hypertension, and atherosclerosis. In this study, we examined the effects in C57BL/6J mice of consuming excess fat or sucrose for a long period of time (55 wk). Another group of mice consumed a low-fat, low-sucrose (LL) diet. Mice fed the high-fat (HF) diet gained weight and developed hyperlipidemia and hyperleptinemia. At 25 wk, but not at 55 wk, hepatic glucose-6-phosphatase (G6Pase) activity of the mice fed the high sucrose (HS) diet was greater than that of mice fed the LL or HF diet. Those fed the HS diet were not obese and had greater hepatic lipogenic and gluconeogenic enzyme activities. The HF and HS diets resulted in different types of glucose intolerance. In an oral glucose tolerance test, mice fed the HF diet had a delay in the clearance of glucose compared with those fed the LL diet, perhaps due to the peripheral insulin resistance that resulted from higher levels of circulating free fatty acids. Feeding the HS diet for 55 wk induced hyperglycemia 10 min after oral glucose administration, although blood glucose declined rapidly after i.p. insulin injection. This finding suggests that the effects of chronic HS diet intake may be due to the reduction in early insulin secretion from pancreatic islets and the increase in sucrase activity in the small intestine. It is important to consider the effects of macronutrients in lean as well as obese mice to clarify the pathogenesis of the metabolic disorders.},
	Author = {Sumiyoshi, Maho and Sakanaka, Masahiro and Kimura, Yoshiyuki},
	Date-Added = {2011-07-19 16:23:44 +0100},
	Date-Modified = {2011-07-19 16:23:44 +0100},
	Journal = {J Nutr},
	Journal-Full = {The Journal of nutrition},
	Mesh = {Adipocytes; Adiponectin; Animals; Blood Glucose; Chemokine CCL2; Dietary Fats; Dietary Sucrose; Disease Models, Animal; Glucose Intolerance; Hydroxymethylglutaryl CoA Reductases; Insulin; Lipids; Lipolysis; Lipoprotein Lipase; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Weight Gain},
	Month = {Mar},
	Number = {3},
	Pages = {582-7},
	Pmid = {16484528},
	Pst = {ppublish},
	Title = {Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice},
	Volume = {136},
	Year = {2006}}

@article{Desai:2001aa,
	Abstract = {Hyperglycemia of diabetes is caused in part by perturbation of hepatic glucose metabolism. Hepatic glucokinase (GK) is an important regulator of glucose storage and disposal in the liver. GK levels are lowered in patients with maturity-onset diabetes of the young and in some diabetic animal models. Here, we explored the adenoviral vector-mediated overexpression of GK in a diet-induced murine model of type 2 diabetes as a treatment for diabetes. Diabetic mice were treated by intravenous administration with an E1/E2a/E3-deleted adenoviral vector encoding human hepatic GK (Av3hGK). Two weeks posttreatment, the Av3hGK-treated diabetic mice displayed normalized fasting blood glucose levels (95 +/- 4.8 mg/dl; P < 0.001) when compared with Av3Null (135 +/- 5.9 mg/dl), an analogous vector lacking a transgene, and vehicle-treated diabetic mice (134 +/- 8 mg/dl). GK treatment also resulted in lowered insulin levels (632 +/- 399 pg/ml; P < 0.01) compared with the control groups (Av3Null, 1,803 +/- 291 pg/ml; vehicle, 1,861 +/- 392 pg/ml), and the glucose tolerance of the Av3hGK-treated diabetic mice was normalized. No significant increase in plasma or hepatic triglycerides, or plasma free fatty acids was observed in the Av3hGK-treated mice. These data suggest that overexpression of GK may have a therapeutic potential for the treatment of type 2 diabetes.},
	Author = {Desai, U J and Slosberg, E D and Boettcher, B R and Caplan, S L and Fanelli, B and Stephan, Z and Gunther, V J and Kaleko, M and Connelly, S},
	Date-Added = {2011-07-19 16:16:36 +0100},
	Date-Modified = {2011-07-19 16:16:36 +0100},
	Journal = {Diabetes},
	Journal-Full = {Diabetes},
	Mesh = {Adenoviridae; Animals; Blood Glucose; Diabetes Mellitus; Eating; Fasting; Gene Expression; Gene Transfer Techniques; Genetic Vectors; Glucokinase; Glycogen; Humans; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Phenotype; Triglycerides},
	Month = {Oct},
	Number = {10},
	Pages = {2287-95},
	Pmid = {11574410},
	Pst = {ppublish},
	Title = {Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression},
	Volume = {50},
	Year = {2001}}

@article{Lindstedt:2002aa,
	Abstract = {One challenge for veterinarians, animal facilities and research scientists is the making of physiological estimates appropriate to a variety of species for which data are often either completely lacking or are incomplete. Our intent in compiling the data in this paper is to provide the best possible database of normal physiological and anatomical values primarily (though not exclusively) for four common mammalian model species: mouse, rat, dog and man. In order to make those data as accessible and applicable as possible, we have presented the results of this study in the form of body-size dependent allometric equations in which some variable (Y) is expressed as a dependent function of body mass (M) in the power-law equation, Y = aM(b). By compiling these data, it is apparent that the resultant equations are quantitatively grouped (with similar slope or 'b' values). These emergent patterns provide insights into body-size dependent 'principles of design' that seem to dictate several aspects of design and function across species among all mammals. In general, the weights of most individual organs scale as a constant fraction of body mass (i.e. the body mass exponent, b approximately equal to 1.0). Biological rates (e.g. heart rate, respiratory rate) scale as b approximately equal to -1/4. Finally, volume-rates (the product of volume and rate) such as cardiac output, ventilation and oxygen uptake vary as b approximately equal to 3/4.},
	Author = {Lindstedt, S L and Schaeffer, P J},
	Date-Added = {2011-07-17 15:17:59 +0100},
	Date-Modified = {2011-07-17 15:17:59 +0100},
	Journal = {Lab Anim},
	Journal-Full = {Laboratory animals},
	Mesh = {Animals; Animals, Laboratory; Basal Metabolism; Biometry; Body Constitution; Body Weight; Dogs; Humans; Mice; Organ Size; Rats; Species Specificity},
	Month = {Jan},
	Number = {1},
	Pages = {1-19},
	Pmid = {11833526},
	Pst = {ppublish},
	Title = {Use of allometry in predicting anatomical and physiological parameters of mammals},
	Volume = {36},
	Year = {2002}}

@article{Rudenski:1991aa,
	Abstract = {A mathematical model of normal glucose/insulin homoeostasis has been based on the known, experimentally determined responses of the liver and periphery to different glucose/insulin concentrations. Different defects of glucose resistance and insulin resistance have been applied to the model to investigate the degree to which these abnormalities could successfully predict the range of fasting glucose and insulin values found in normal, obese, and diabetic subjects. Modeling glucose resistance or insulin resistance at the liver or the periphery alone did not increase the plasma glucose to levels observed in diabetes, even when associated with marked deficiency of beta-cell function. A defect of either glucose resistance or insulin resistance affecting both periphery and liver allowed a wider range of basal glucose and insulin concentration values, but resulted in unphysiologically low hepatic glucose output: with modeling insulin resistance, hyperglycemia suppressed glucose output, whereas with glucose resistance, raised insulin levels suppressed hepatic glucose output. A wide range of glucose and insulin values, with appropriate basal hepatic glucose output, could only be modeled by insulin resistance at both the liver and periphery with additional glucose resistance at the liver. The modeling results are in accord with investigative studies that suggest secondary hepatic and peripheral glucose resistance in response to hyperglycemia. Modeling provides a systematic means of examining the likely effect of different putative defects in a complex physiological system.},
	Author = {Rudenski, A S and Matthews, D R and Levy, J C and Turner, R C},
	Date-Added = {2011-06-09 14:02:51 +0200},
	Date-Modified = {2011-06-09 14:02:51 +0200},
	Journal = {Metabolism},
	Journal-Full = {Metabolism: clinical and experimental},
	Mesh = {Diabetes Mellitus; Drug Resistance; Feedback; Glucose; Humans; Insulin; Insulin Resistance; Liver; Models, Biological; Osmolar Concentration},
	Month = {Sep},
	Number = {9},
	Pages = {908-17},
	Pmid = {1895955},
	Pst = {ppublish},
	Title = {Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes},
	Volume = {40},
	Year = {1991}}

@article{Westerhoff:2009aa,
	Abstract = {Systems Biology is the science that aims to understand how biological function absent from macromolecules in isolation, arises when they are components of their system. Dedicated to the memory of Reinhart Heinrich, this paper discusses the origin and evolution of the new part of systems biology that relates to metabolic and signal-transduction pathways and extends mathematical biology so as to address postgenomic experimental reality. Various approaches to modeling the dynamics generated by metabolic and signal-transduction pathways are compared. The silicon cell approach aims to describe the intracellular network of interest precisely, by numerically integrating the precise rate equations that characterize the ways macromolecules' interact with each other. The non-equilibrium thermodynamic or 'lin-log' approach approximates the enzyme rate equations in terms of linear functions of the logarithms of the concentrations. Biochemical Systems Analysis approximates in terms of power laws. Importantly all these approaches link system behavior to molecular interaction properties. The latter two do this less precisely but enable analytical solutions. By limiting the questions asked, to optimal flux patterns, or to control of fluxes and concentrations around the (patho)physiological state, Flux Balance Analysis and Metabolic/Hierarchical Control Analysis again enable analytical solutions. Both the silicon cell approach and Metabolic/Hierarchical Control Analysis are able to highlight where and how system function derives from molecular interactions. The latter approach has also discovered a set of fundamental principles underlying the control of biological systems. The new law that relates concentration control to control by time is illustrated for an important signal transduction pathway, i.e. nuclear hormone receptor signaling such as relevant to bone formation. It is envisaged that there is much more Mathematical Biology to be discovered in the area between molecules and Life.},
	Author = {Westerhoff, Hans V and Kolodkin, Alexey and Conradie, Riaan and Wilkinson, Stephen J and Bruggeman, Frank J and Krab, Klaas and van Schuppen, Jan H and Hardin, Hanna and Bakker, Barbara M and Mon{\'e}, Martijn J and Rybakova, Katja N and Eijken, Marco and van Leeuwen, Hans J P and Snoep, Jacky L},
	Date-Added = {2011-05-25 17:59:44 +0200},
	Date-Modified = {2011-05-25 17:59:44 +0200},
	Doi = {10.1007/s00285-008-0160-8},
	Journal = {J Math Biol},
	Journal-Full = {Journal of mathematical biology},
	Mesh = {Kinetics; Metabolomics; Models, Biological; Signal Transduction; Systems Biology; Thermodynamics},
	Month = {Jan},
	Number = {1-2},
	Pages = {7-34},
	Pmid = {18278498},
	Pst = {ppublish},
	Title = {Systems biology towards life in silico: mathematics of the control of living cells},
	Volume = {58},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s00285-008-0160-8}}

@article{Li:2010aa,
	Abstract = {The behaviour of biological systems can be deduced from their mathematical models. However, multiple sources of data in diverse forms are required in the construction of a model in order to define its components and their biochemical reactions, and corresponding parameters. Automating the assembly and use of systems biology models is dependent upon data integration processes involving the interoperation of data and analytical resources.},
	Author = {Li, Peter and Dada, Joseph O and Jameson, Daniel and Spasic, Irena and Swainston, Neil and Carroll, Kathleen and Dunn, Warwick and Khan, Farid and Malys, Naglis and Messiha, Hanan L and Simeonidis, Evangelos and Weichart, Dieter and Winder, Catherine and Wishart, Jill and Broomhead, David S and Goble, Carole A and Gaskell, Simon J and Kell, Douglas B and Westerhoff, Hans V and Mendes, Pedro and Paton, Norman W},
	Date-Added = {2011-05-25 17:58:23 +0200},
	Date-Modified = {2011-05-25 17:58:23 +0200},
	Doi = {10.1186/1471-2105-11-582},
	Journal = {BMC Bioinformatics},
	Journal-Full = {BMC bioinformatics},
	Mesh = {Databases, Factual; Metabolic Networks and Pathways; Models, Biological; Systems Biology},
	Pages = {582},
	Pmc = {PMC3008707},
	Pmid = {21114840},
	Pst = {epublish},
	Title = {Systematic integration of experimental data and models in systems biology},
	Volume = {11},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1471-2105-11-582}}

@book{Alberghina:2008aa,
	Address = {Berlin},
	Annote = {LDR    00926cam  22002534a 4500
001    14948968
005    20080909101033.0
008    070801s2008    gw a     b    001 0 eng  
906    $a7$bcbc$corignew$d2$eepcn$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $apc17 2007-08-01$ijb04 2008-08-29$ejb04 2008-08-29 to Dewey$aaa07 2008-09-09
010    $a  2007934276
020    $a9783540742692 (softcover : alk. paper)
040    $aDLC$cDLC$dDLC
050 00 $aQH324.2$b.S973 2008
082 00 $a570$222
245 00 $aSystems biology :$bdefinitions and perspectives /$cLilia Alberghina, Hans V. Westerhoff (eds.).
260    $aBerlin :$bSpringer,$c[2008]
300    $axvii, 408 p. :$bill. ;$c24 cm.
490 0  $aTopics in current genetics
504    $aIncludes bibliographical references and index.
650  0 $aSystems biology.
700 1  $aAlberghina, L.$q(Lilia)
700 1  $aWesterhoff, Hans V.
},
	Author = {Alberghina, L and Westerhoff, Hans V},
	Call-Number = {QH324.2},
	Date-Added = {2011-05-25 17:55:41 +0200},
	Date-Modified = {2011-05-25 17:55:41 +0200},
	Dewey-Call-Number = {570},
	Genre = {Systems biology},
	Isbn = {9783540742692 (softcover : alk. paper)},
	Library-Id = {2007934276},
	Publisher = {Springer},
	Series = {Topics in current genetics},
	Title = {Systems biology: definitions and perspectives},
	Year = {2008}}

@book{Noble:2006aa,
	Address = {Oxford},
	Annote = {LDR    01486cam  22003254a 4500
001    14300665
005    20070515172404.0
008    060315s2006    enka     b    001 0 eng  
906    $a7$bcbc$corignew$d1$eecip$f20$gy-gencatlg
925 0  $aacquire$b2 shelf copies$xpolicy default
955    $ajb17 2006-03-15$cjb17 2006-03-15 to subject$djb08 2006-03-15$ejb08 2006-03-15 to Dewey$aaa07 2006-03-22$aps08 2006-09-23 1 copy rec'd., to CIP ver.$ajb00 2006-09-29$fjb17 2006-10-20 Z-CipVer$gjb17 2006-10-20 to BCCD$asp10 2007-01-26 copy 2 added
010    $a  2006008874
015    $aGBA627067$2bnb
016 7  $a013414310$2Uk
020    $a0199295735 (alk. paper)
020    $a9780199295739
035    $a(OCoLC)ocm64554661
040    $aDLC$cDLC$dUKM$dBAKER$dBWKUK$dYDXCP$dOCLCQ$dDLC
042    $apcc
050 00 $aQH501$b.N633 2006
082 00 $a570$222
100 1  $aNoble, Denis.
245 14 $aThe music of life :$bbiology beyond the genome /$cDenis Noble.
260    $aOxford ;$aNew York :$bOxford University Press,$c2006.
300    $axiii, 153 p. :$bill. ;$c21 cm.
504    $aIncludes bibliographical references (p. [144]-146) and index.
650  0 $aLife (Biology)
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0610/2006008874.html
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy0725/2006008874-b.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0725/2006008874-d.html
},
	Author = {Noble, Denis},
	Call-Number = {QH501},
	Date-Added = {2011-05-25 17:37:31 +0200},
	Date-Modified = {2011-05-25 17:37:31 +0200},
	Dewey-Call-Number = {570},
	Genre = {Life (Biology)},
	Isbn = {0199295735 (alk. paper)},
	Library-Id = {2006008874},
	Publisher = {Oxford University Press},
	Title = {The music of life: biology beyond the genome},
	Url = {http://www.loc.gov/catdir/toc/ecip0610/2006008874.html},
	Year = {2006},
	Bdsk-Url-1 = {http://www.loc.gov/catdir/toc/ecip0610/2006008874.html}}

@article{Geenen:2011aa,
	Abstract = {Ophthalmic acid (OA), an endogenous tripeptide analogue of glutathione, has been suggested as a potential biomarker for paracetamol/acetaminophen hepatotoxicity. Here HPLC-MS/MS methods have been developed for the precise, sensitive and specific detection and quantification of OA in in vitro cell culture medium and plasma. For the cell culture medium the LLOQ was found to be 1 ng/ml, with less than 1\% between sample carry over at all concentrations and precision below 15\% for within day and below 9\% for between day analyses. For rat plasma the presence of endogenous OA resulted in the LLOQ being 25 ng/ml (defined as the lowest concentration on the calibration curve where the base peak was less than 20\% of the LLOQ). For the plasma assay the percentage carry over was less than 1\% for all concentrations and within and between batch precision was below 21\%. The methods were linear for both sample types from the LLOQ up to 5 g/ml. The method was successfully applied to the determination of OA in samples obtained following the chronic administration of the rat hepatotoxin methapyrilene, where plasma OA concentrations were observed to show a weak negative correlation with those of established liver injury biomarkers such as aspartate aminotransferase (AST).},
	Author = {Geenen, Suzanne and Michopoulos, Filippos and Kenna, J Gerry and Kolaja, Kyle L and Westerhoff, Hans V and Wilson, Ian},
	Date-Added = {2011-05-25 16:55:18 +0200},
	Date-Modified = {2011-05-25 16:55:18 +0200},
	Doi = {10.1016/j.jpba.2010.11.038},
	Journal = {J Pharm Biomed Anal},
	Journal-Full = {Journal of pharmaceutical and biomedical analysis},
	Mesh = {Animals; Biological Markers; Cell Line; Chromatography, High Pressure Liquid; Culture Media; Drug-Induced Liver Injury; Epithelial Cells; Humans; Limit of Detection; Liver; Male; Methapyrilene; Oligopeptides; Rats; Reproducibility of Results; Tandem Mass Spectrometry},
	Month = {Apr},
	Number = {5},
	Pages = {1128-35},
	Pmid = {21176868},
	Pst = {ppublish},
	Title = {HPLC-MS/MS methods for the quantitative analysis of ophthalmic acid in rodent plasma and hepatic cell line culture medium},
	Volume = {54},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jpba.2010.11.038}}

@article{Hanahan:2000aa,
	Author = {Hanahan, D and Weinberg, R A},
	Date-Added = {2011-05-25 16:24:39 +0200},
	Date-Modified = {2011-05-25 16:24:39 +0200},
	Journal = {Cell},
	Journal-Full = {Cell},
	Mesh = {Animals; Apoptosis; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic},
	Month = {Jan},
	Number = {1},
	Pages = {57-70},
	Pmid = {10647931},
	Pst = {ppublish},
	Title = {The hallmarks of cancer},
	Volume = {100},
	Year = {2000}}

@article{Hornberg:2006aa,
	Abstract = {Cancer research has focused on the identification of molecular differences between cancerous and healthy cells. The emerging picture is overwhelmingly complex. Molecules out of many parallel signal transduction pathways are involved. Their activities appear to be controlled by multiple factors. The action of regulatory circuits, cross-talk between pathways and the non-linear reaction kinetics of biochemical processes complicate the understanding and prediction of the outcome of intracellular signaling. In addition, interactions between tumor and other cell types give rise to a complex supra-cellular communication network. If cancer is such a complex system, how can one ever predict the effect of a mutation in a particular gene on a functionality of the entire system? And, how should one go about identifying drug targets? Here, we argue that one aspect is to recognize, where the essence resides, i.e. recognize cancer as a Systems Biology disease. Then, more cancer biologists could become systems biologists aiming to provide answers to some of the above systemic questions. To this aim, they should integrate the available knowledge stemming from quantitative experimental results through mathematical models. Models that have contributed to the understanding of complex biological systems are discussed. We show that the architecture of a signaling network is important for determining the site at which an oncologist should intervene. Finally, we discuss the possibility of applying network-based drug design to cancer treatment and how rationalized therapies, such as the application of kinase inhibitors, may benefit from Systems Biology.},
	Author = {Hornberg, Jorrit J and Bruggeman, Frank J and Westerhoff, Hans V and Lankelma, Jan},
	Date = {2006 Feb-Mar},
	Date-Added = {2011-05-25 15:11:25 +0200},
	Date-Modified = {2011-05-25 15:11:25 +0200},
	Doi = {10.1016/j.biosystems.2005.05.014},
	Journal = {Biosystems},
	Journal-Full = {Bio Systems},
	Mesh = {Animals; Antineoplastic Agents; Drug Design; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Molecular Biology; Neoplasm Proteins; Neoplasms; Signal Transduction; Systems Biology; Systems Theory; Tumor Markers, Biological},
	Number = {2-3},
	Pages = {81-90},
	Pmid = {16426740},
	Pst = {ppublish},
	Title = {Cancer: a Systems Biology disease},
	Volume = {83},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.biosystems.2005.05.014}}

@article{Snoep:2006aa,
	Abstract = {Systems Biology aims to understand quantitatively how properties of biological systems can be understood as functions of the characteristics of, and interactions between their macromolecular components. Whereas, traditional biochemistry focused on isolation and characterization of cellular components, the challenge for Systems Biology lies in integration of this knowledge and the knowledge about molecular interactions. Computer models play an important role in this integration. We here discuss an approach with which we aim to link kinetic models on small parts of metabolism together, so as to form detailed kinetic models of larger chunks of metabolism, and ultimately of the entire living cell. Specifically, we will discuss techniques that can be used to model a sub-network in isolation of a larger network of which it is a part, while still maintaining the dynamics of the larger complete network. We will start by outlining the JWS online system, the silicon cell project, and the type of models we propose. JWS online is a model repository, which can be used for the storage, simulation and analysis of kinetic models. We advocate to integrate a top-down approach, where measurements on the complete system are used to derive fluxes in a detailed structural model, with a bottom-up approach, consisting of the integration of molecular mechanism-based detailed kinetic models into the structural model.},
	Author = {Snoep, Jacky L and Bruggeman, Frank and Olivier, Brett G and Westerhoff, Hans V},
	Date = {2006 Feb-Mar},
	Date-Added = {2011-05-25 15:06:30 +0200},
	Date-Modified = {2011-05-25 15:06:30 +0200},
	Doi = {10.1016/j.biosystems.2005.07.006},
	Journal = {Biosystems},
	Journal-Full = {Bio Systems},
	Mesh = {Animals; Cell Physiological Phenomena; Computer Simulation; Database Management Systems; Databases, Factual; Humans; Information Storage and Retrieval; Models, Biological; Online Systems; Proteome; Signal Transduction; Systems Biology; Systems Integration},
	Number = {2-3},
	Pages = {207-16},
	Pmid = {16242236},
	Pst = {ppublish},
	Title = {Towards building the silicon cell: a modular approach},
	Volume = {83},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.biosystems.2005.07.006}}

@article{Westerhoff:2004aa,
	Abstract = {Systems analysis has historically been performed in many areas of biology, including ecology, developmental biology and immunology. More recently, the genomics revolution has catapulted molecular biology into the realm of systems biology. In unicellular organisms and well-defined cell lines of higher organisms, systems approaches are making definitive strides toward scientific understanding and biotechnological applications. We argue here that two distinct lines of inquiry in molecular biology have converged to form contemporary systems biology.},
	Author = {Westerhoff, Hans V and Palsson, Bernhard O},
	Date-Added = {2011-05-25 15:01:38 +0200},
	Date-Modified = {2011-05-25 15:01:38 +0200},
	Doi = {10.1038/nbt1020},
	Journal = {Nat Biotechnol},
	Journal-Full = {Nature biotechnology},
	Mesh = {Biomedical Engineering; Genomics; History, 20th Century; History, 21st Century; Models, Biological; Molecular Biology; Systems Biology},
	Month = {Oct},
	Number = {10},
	Pages = {1249-52},
	Pmid = {15470464},
	Pst = {ppublish},
	Title = {The evolution of molecular biology into systems biology},
	Volume = {22},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nbt1020}}

@article{Venter:2001aa,
	Abstract = {A 2.91-billion base pair (bp) consensus sequence of the euchromatic portion of the human genome was generated by the whole-genome shotgun sequencing method. The 14.8-billion bp DNA sequence was generated over 9 months from 27,271,853 high-quality sequence reads (5.11-fold coverage of the genome) from both ends of plasmid clones made from the DNA of five individuals. Two assembly strategies-a whole-genome assembly and a regional chromosome assembly-were used, each combining sequence data from Celera and the publicly funded genome effort. The public data were shredded into 550-bp segments to create a 2.9-fold coverage of those genome regions that had been sequenced, without including biases inherent in the cloning and assembly procedure used by the publicly funded group. This brought the effective coverage in the assemblies to eightfold, reducing the number and size of gaps in the final assembly over what would be obtained with 5.11-fold coverage. The two assembly strategies yielded very similar results that largely agree with independent mapping data. The assemblies effectively cover the euchromatic regions of the human chromosomes. More than 90\% of the genome is in scaffold assemblies of 100,000 bp or more, and 25\% of the genome is in scaffolds of 10 million bp or larger. Analysis of the genome sequence revealed 26,588 protein-encoding transcripts for which there was strong corroborating evidence and an additional approximately 12,000 computationally derived genes with mouse matches or other weak supporting evidence. Although gene-dense clusters are obvious, almost half the genes are dispersed in low G+C sequence separated by large tracts of apparently noncoding sequence. Only 1.1\% of the genome is spanned by exons, whereas 24\% is in introns, with 75\% of the genome being intergenic DNA. Duplications of segmental blocks, ranging in size up to chromosomal lengths, are abundant throughout the genome and reveal a complex evolutionary history. Comparative genomic analysis indicates vertebrate expansions of genes associated with neuronal function, with tissue-specific developmental regulation, and with the hemostasis and immune systems. DNA sequence comparisons between the consensus sequence and publicly funded genome data provided locations of 2.1 million single-nucleotide polymorphisms (SNPs). A random pair of human haploid genomes differed at a rate of 1 bp per 1250 on average, but there was marked heterogeneity in the level of polymorphism across the genome. Less than 1\% of all SNPs resulted in variation in proteins, but the task of determining which SNPs have functional consequences remains an open challenge.},
	Author = {Venter, J C and Adams, M D and Myers, E W and Li, P W and Mural, R J and Sutton, G G and Smith, H O and Yandell, M and Evans, C A and Holt, R A and Gocayne, J D and Amanatides, P and Ballew, R M and Huson, D H and Wortman, J R and Zhang, Q and Kodira, C D and Zheng, X H and Chen, L and Skupski, M and Subramanian, G and Thomas, P D and Zhang, J and Gabor Miklos, G L and Nelson, C and Broder, S and Clark, A G and Nadeau, J and McKusick, V A and Zinder, N and Levine, A J and Roberts, R J and Simon, M and Slayman, C and Hunkapiller, M and Bolanos, R and Delcher, A and Dew, I and Fasulo, D and Flanigan, M and Florea, L and Halpern, A and Hannenhalli, S and Kravitz, S and Levy, S and Mobarry, C and Reinert, K and Remington, K and Abu-Threideh, J and Beasley, E and Biddick, K and Bonazzi, V and Brandon, R and Cargill, M and Chandramouliswaran, I and Charlab, R and Chaturvedi, K and Deng, Z and Di Francesco, V and Dunn, P and Eilbeck, K and Evangelista, C and Gabrielian, A E and Gan, W and Ge, W and Gong, F and Gu, Z and Guan, P and Heiman, T J and Higgins, M E and Ji, R R and Ke, Z and Ketchum, K A and Lai, Z and Lei, Y and Li, Z and Li, J and Liang, Y and Lin, X and Lu, F and Merkulov, G V and Milshina, N and Moore, H M and Naik, A K and Narayan, V A and Neelam, B and Nusskern, D and Rusch, D B and Salzberg, S and Shao, W and Shue, B and Sun, J and Wang, Z and Wang, A and Wang, X and Wang, J and Wei, M and Wides, R and Xiao, C and Yan, C and Yao, A and Ye, J and Zhan, M and Zhang, W and Zhang, H and Zhao, Q and Zheng, L and Zhong, F and Zhong, W and Zhu, S and Zhao, S and Gilbert, D and Baumhueter, S and Spier, G and Carter, C and Cravchik, A and Woodage, T and Ali, F and An, H and Awe, A and Baldwin, D and Baden, H and Barnstead, M and Barrow, I and Beeson, K and Busam, D and Carver, A and Center, A and Cheng, M L and Curry, L and Danaher, S and Davenport, L and Desilets, R and Dietz, S and Dodson, K and Doup, L and Ferriera, S and Garg, N and Gluecksmann, A and Hart, B and Haynes, J and Haynes, C and Heiner, C and Hladun, S and Hostin, D and Houck, J and Howland, T and Ibegwam, C and Johnson, J and Kalush, F and Kline, L and Koduru, S and Love, A and Mann, F and May, D and McCawley, S and McIntosh, T and McMullen, I and Moy, M and Moy, L and Murphy, B and Nelson, K and Pfannkoch, C and Pratts, E and Puri, V and Qureshi, H and Reardon, M and Rodriguez, R and Rogers, Y H and Romblad, D and Ruhfel, B and Scott, R and Sitter, C and Smallwood, M and Stewart, E and Strong, R and Suh, E and Thomas, R and Tint, N N and Tse, S and Vech, C and Wang, G and Wetter, J and Williams, S and Williams, M and Windsor, S and Winn-Deen, E and Wolfe, K and Zaveri, J and Zaveri, K and Abril, J F and Guig{\'o}, R and Campbell, M J and Sjolander, K V and Karlak, B and Kejariwal, A and Mi, H and Lazareva, B and Hatton, T and Narechania, A and Diemer, K and Muruganujan, A and Guo, N and Sato, S and Bafna, V and Istrail, S and Lippert, R and Schwartz, R and Walenz, B and Yooseph, S and Allen, D and Basu, A and Baxendale, J and Blick, L and Caminha, M and Carnes-Stine, J and Caulk, P and Chiang, Y H and Coyne, M and Dahlke, C and Mays, A and Dombroski, M and Donnelly, M and Ely, D and Esparham, S and Fosler, C and Gire, H and Glanowski, S and Glasser, K and Glodek, A and Gorokhov, M and Graham, K and Gropman, B and Harris, M and Heil, J and Henderson, S and Hoover, J and Jennings, D and Jordan, C and Jordan, J and Kasha, J and Kagan, L and Kraft, C and Levitsky, A and Lewis, M and Liu, X and Lopez, J and Ma, D and Majoros, W and McDaniel, J and Murphy, S and Newman, M and Nguyen, T and Nguyen, N and Nodell, M and Pan, S and Peck, J and Peterson, M and Rowe, W and Sanders, R and Scott, J and Simpson, M and Smith, T and Sprague, A and Stockwell, T and Turner, R and Venter, E and Wang, M and Wen, M and Wu, D and Wu, M and Xia, A and Zandieh, A and Zhu, X},
	Date-Added = {2011-05-25 14:01:29 +0200},
	Date-Modified = {2011-05-25 14:01:29 +0200},
	Doi = {10.1126/science.1058040},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {Algorithms; Animals; Chromosome Banding; Chromosome Mapping; Chromosomes, Artificial, Bacterial; Computational Biology; Consensus Sequence; CpG Islands; DNA, Intergenic; Databases, Factual; Evolution, Molecular; Exons; Female; Gene Duplication; Genes; Genetic Variation; Genome, Human; Human Genome Project; Humans; Introns; Male; Phenotype; Physical Chromosome Mapping; Polymorphism, Single Nucleotide; Proteins; Pseudogenes; Repetitive Sequences, Nucleic Acid; Retroelements; Sequence Analysis, DNA; Species Specificity},
	Month = {Feb},
	Number = {5507},
	Pages = {1304-51},
	Pmid = {11181995},
	Pst = {ppublish},
	Title = {The sequence of the human genome},
	Volume = {291},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1058040}}

@article{Sauro:2008aa,
	Abstract = {With the growing importance of computational models in systems biology there has been much interest in recent years to develop standard model interchange languages that permit biologists to easily exchange models between different software tools. In the present chapter two chief model exchange standards, SBML (Systems Biology Markup Language) and CellML are described. In addition, other related features including visual layout initiatives, ontologies and best practices for model annotation are discussed. Software tools such as developer libraries and basic editing tools are also introduced, together with a discussion on the future of modelling languages and visualization tools in systems biology.},
	Author = {Sauro, Herbert M and Bergmann, Frank T},
	Date-Added = {2011-05-19 18:04:09 +0200},
	Date-Modified = {2011-05-19 18:04:09 +0200},
	Doi = {10.1042/BSE0450211},
	Journal = {Essays Biochem},
	Journal-Full = {Essays in biochemistry},
	Mesh = {Algorithms; Computational Biology; Programming Languages; Systems Biology},
	Pages = {211-22},
	Pmc = {PMC2728449},
	Pmid = {18793134},
	Pst = {ppublish},
	Title = {Standards and ontologies in computational systems biology},
	Volume = {45},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1042/BSE0450211}}

@article{WHO:1987aa,
	Date-Added = {2011-05-19 12:34:29 +0200},
	Date-Modified = {2011-05-19 12:34:37 +0200},
	Journal = {World Health Organ Tech Rep Ser},
	Journal-Full = {World Health Organization technical report series},
	Mesh = {Biological Products; Reference Standards; World Health Organization},
	Pages = {1-203},
	Pmid = {3124356},
	Pst = {ppublish},
	Title = {WHO expert committee on biological standardization. Thirty-seventh report},
	Volume = {760},
	Year = {1987}}

@article{Manley:2007aa,
	Abstract = {The American Diabetes Association task force on standardization of insulin assays in 1996 showed wide variation in assay bias. Newer assays are specific for insulin, with several now available on automated immunoassay analyzers.},
	Author = {Manley, Susan E and Stratton, Irene M and Clark, Penelope M and Luzio, Stephen D},
	Date-Added = {2011-05-19 12:12:25 +0200},
	Date-Modified = {2011-05-19 12:12:25 +0200},
	Doi = {10.1373/clinchem.2006.077784},
	Journal = {Clin Chem},
	Journal-Full = {Clinical chemistry},
	Mesh = {Adolescent; Adult; Aged; Anticoagulants; Autoanalysis; Glucose Intolerance; Heparin; Humans; Immunoassay; Insulin; Linear Models; Middle Aged; Plasma; Proinsulin; Serum},
	Month = {May},
	Number = {5},
	Pages = {922-32},
	Pmid = {17363420},
	Pst = {ppublish},
	Title = {Comparison of 11 human insulin assays: implications for clinical investigation and research},
	Volume = {53},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1373/clinchem.2006.077784}}

@article{Belfiore:1998aa,
	Abstract = {Insulin Sensitivity Indices for glycemia [ISI(gly)] and blood FFA [ISI(ffa)] can be calculated with the formulas: ISI(gly) = 2/[(INSp x GLYp) + 1], and ISI(ffa) = 2/[(INSp x FFAp) + 1], where INSp, GLYp and FFAp = insulinemic, glycemic, and FFA areas during OGTT (75 g glucose) of the person under study, simplified by considering only data at 0 and 2 h (0-2 h areas), according to WHO criteria or, better, at 0, 1 and 2 h (0-1-2 h areas). Expressed as unit/ volume.h-1, 0-1-2 h area is equal to 1/2 value at 0 min + value at 1 h + 1/2 value at 2 h, while 0-2 h area is equal to value at 0 + value at 2 h. Instead of areas, basal levels can also be used. Basal levels and areas are expressed taking the mean normal value as unit, so that in normal subjects ISI(gly) and ISI(ffa) are always around 1, with maximal variations between 0 and 2. Each laboratory should have its normal reference values for basal levels and OGTT areas. However, reliable mean normal values were selected from literature. Based on meta-analysis of published data, ISI(gly) and ISI(ffa) were reduced in subjects who were overweight and/or IGT and in NIDDM patients and their relatives. Moreover, correlation of ISI(gly) with the euglycemic clamp data was significant. However, it should be stressed that the clamp procedure is performed under artificially induced steady-state whereas ISI(gly) and ISI(ffa) are obtained under rather physiological conditions, with hormonal and metabolic variables unmodified, thus being suitable to assess whole-body insulin sensitivity in the clinical setting.},
	Author = {Belfiore, F and Iannello, S and Volpicelli, G},
	Date-Added = {2011-05-18 20:59:51 +0200},
	Date-Modified = {2011-05-18 20:59:51 +0200},
	Doi = {10.1006/mgme.1997.2658},
	Journal = {Mol Genet Metab},
	Journal-Full = {Molecular genetics and metabolism},
	Mesh = {Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Models, Theoretical; Obesity},
	Month = {Feb},
	Number = {2},
	Pages = {134-41},
	Pmid = {9562967},
	Pst = {ppublish},
	Title = {Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels},
	Volume = {63},
	Year = {1998},
	Bdsk-Url-1 = {http://dx.doi.org/10.1006/mgme.1997.2658}}

@article{Bastard:2007aa,
	Abstract = {The purpose of this study was to compare assessment of insulin sensitivity from hyperinsulinemic euglycaemic (HIEG) clamp with indexes derived from fasting and oral glucose tolerance test (OGTT).},
	Author = {Bastard, J P and Vandernotte, J M and Faraj, M and Karelis, A D and Messier, L and Malita, F M and Garrel, D and Prud'homme, D and Rabasa-Lhoret, R},
	Date-Added = {2011-05-18 20:56:10 +0200},
	Date-Modified = {2011-05-18 20:56:10 +0200},
	Doi = {10.1016/j.diabet.2007.02.004},
	Journal = {Diabetes Metab},
	Journal-Full = {Diabetes \& metabolism},
	Mesh = {Adipose Tissue; Aged; Blood Glucose; Body Composition; Cross-Sectional Studies; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Middle Aged; Overweight; Postmenopause},
	Month = {Sep},
	Number = {4},
	Pages = {261-8},
	Pmid = {17499540},
	Pst = {ppublish},
	Title = {Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women},
	Volume = {33},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.diabet.2007.02.004}}

@article{Gutt:2000aa,
	Abstract = {The purpose of this study was to explore possible calculations using oral glucose tolerance test (OGTT) values in order to develop a simple measure of insulin sensitivity. We devised a formula for an insulin sensitivity index, ISI(0,120), that uses the fasting (0 min) and 120 min post-oral glucose (OGTT) insulin and glucose concentrations. It appears to be generalizable across a spectrum of glucose tolerance and obesity. Most importantly, our data show that ISI(0,120) correlates well, when applied prospectively in comparative studies, with the insulin sensitivity index obtained from the euglycemic hyperinsulinemic clamp (r = 0.63, P < 0.001). This correlation was demonstrably superior to other indices of insulin sensitivity such as the HOMA formula presented by Matthews, and performed comparably to the computerized HOMA index. Measurement of insulin sensitivity has traditionally been possible only in research settings because of the invasiveness and expense of the methods used. Clinical investigators have therefore sought more practical methods to obtain an index of insulin sensitivity. Such an index should approximate insulin sensitivity as measured by the euglycemic hyperinsulinemic clamp (M). We present ISI(0,120), a simple yet sensitive measure of insulin sensitivity which is adaptable for use in clinical settings as well as large epidemiologic studies.},
	Author = {Gutt, M and Davis, C L and Spitzer, S B and Llabre, M M and Kumar, M and Czarnecki, E M and Schneiderman, N and Skyler, J S and Marks, J B},
	Date-Added = {2011-05-18 20:31:15 +0200},
	Date-Modified = {2011-05-18 20:31:15 +0200},
	Journal = {Diabetes Res Clin Pract},
	Journal-Full = {Diabetes research and clinical practice},
	Mesh = {Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Obesity; Regression Analysis; Reproducibility of Results},
	Month = {Mar},
	Number = {3},
	Pages = {177-84},
	Pmid = {10741566},
	Pst = {ppublish},
	Title = {Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures},
	Volume = {47},
	Year = {2000}}

@article{Stumvoll:2001aa,
	Author = {Stumvoll, M and Van Haeften, T and Fritsche, A and Gerich, J},
	Date-Added = {2011-05-18 20:24:37 +0200},
	Date-Modified = {2011-05-18 20:24:37 +0200},
	Journal = {Diabetes Care},
	Journal-Full = {Diabetes care},
	Mesh = {Administration, Oral; Blood Glucose; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Islets of Langerhans; Metabolic Clearance Rate; Sensitivity and Specificity},
	Month = {Apr},
	Number = {4},
	Pages = {796-7},
	Pmid = {11315860},
	Pst = {ppublish},
	Title = {Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times},
	Volume = {24},
	Year = {2001}}

@article{Matsuda:1999aa,
	Abstract = {Several methods have been proposed to evaluate insulin sensitivity from the data obtained from the oral glucose tolerance test (OGTT). However, the validity of these indices has not been rigorously evaluated by comparing them with the direct measurement of insulin sensitivity obtained with the euglycemic insulin clamp technique. In this study, we compare various insulin sensitivity indices derived from the OGTT with whole-body insulin sensitivity measured by the euglycemic insulin clamp technique.},
	Author = {Matsuda, M and DeFronzo, R A},
	Date-Added = {2011-05-18 19:38:30 +0200},
	Date-Modified = {2011-05-18 19:38:30 +0200},
	Journal = {Diabetes Care},
	Journal-Full = {Diabetes care},
	Mesh = {Administration, Oral; Adult; Case-Control Studies; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin Resistance; Liver; Male; Middle Aged},
	Month = {Sep},
	Number = {9},
	Pages = {1462-70},
	Pmid = {10480510},
	Pst = {ppublish},
	Title = {Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp},
	Volume = {22},
	Year = {1999}}

@article{Volund:1993aa,
	Author = {V{\o}lund, A},
	Date-Added = {2011-05-13 20:33:40 +0200},
	Date-Modified = {2011-05-13 20:33:40 +0200},
	Journal = {Am J Clin Nutr},
	Journal-Full = {The American journal of clinical nutrition},
	Mesh = {Humans; Insulin; International System of Units},
	Month = {Nov},
	Number = {5},
	Pages = {714-5},
	Pmid = {8237884},
	Pst = {ppublish},
	Title = {Conversion of insulin units to SI units},
	Volume = {58},
	Year = {1993}}

@article{Heinemann:2010aa,
	Author = {Heinemann, Lutz},
	Date-Added = {2011-05-13 20:04:53 +0200},
	Date-Modified = {2011-05-13 20:04:53 +0200},
	Doi = {10.2337/dc10-0034},
	Journal = {Diabetes Care},
	Journal-Full = {Diabetes care},
	Mesh = {Biological Assay; Humans; Insulin},
	Month = {Jun},
	Number = {6},
	Pages = {e83; author reply e84},
	Pmid = {20508228},
	Pst = {ppublish},
	Title = {Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care: response to Staten et al},
	Volume = {33},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.2337/dc10-0034}}

@article{BIOCAT,
	Abstract = {The use of Web Services to enable programmatic access to on-line bioinformatics is becoming increasingly important in the Life Sciences. However, their number, distribution and the variable quality of their documentation can make their discovery and subsequent use difficult. A Web Services registry with information on available services will help to bring together service providers and their users. The BioCatalogue (http://www.biocatalogue.org/) provides a common interface for registering, browsing and annotating Web Services to the Life Science community. Services in the BioCatalogue can be described and searched in multiple ways based upon their technical types, bioinformatics categories, user tags, service providers or data inputs and outputs. They are also subject to constant monitoring, allowing the identification of service problems and changes and the filtering-out of unavailable or unreliable resources. The system is accessible via a human-readable {\^a}Web 2.0{\^a}{\texttrademark}-style interface and a programmatic Web Service interface. The BioCatalogue follows a community approach in which all services can be registered, browsed and incrementally documented with annotations by any member of the scientific community.},
	Author = {Bhagat, Jiten and Tanoh, Franck and Nzuobontane, Eric and Laurent, Thomas and Orlowski, Jerzy and Roos, Marco and Wolstencroft, Katy and Aleksejevs, Sergejs and Stevens, Robert and Pettifer, Steve and Lopez, Rodrigo and Goble, Carole A.},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Journal = {Nucleic Acids Research},
	Number = {suppl 2},
	Pages = {W689-W694},
	Title = {{BioCatalogue}: a universal catalogue of web services for the life sciences},
	Volume = {38},
	Year = {2010}}

@article{BIOPAX,
	Author = {Demir, Emek and Cary, Michael P. and Paley, Suzanne and Fukuda, Ken and Lemer, Christian and Vastrik, Imre and Wu, Guanming and D'Eustachio, Peter and Schaefer, Carl and Luciano, Joanne and Schacherer, Frank and Martinez-Flores, Irma and Hu, Zhenjun and Jimenez-Jacinto, Veronica and Joshi-Tope, Geeta and Kandasamy, Kumaran and Lopez-Fuentes, Alejandra C. and Mi, Huaiyu and Pichler, Elgar and Rodchenkov, Igor and Splendiani, Andrea and Tkachev, Sasha and Zucker, Jeremy and Gopinath, Gopal and Rajasimha, Harsha and Ramakrishnan, Ranjani and Shah, Imran and Syed, Mustafa and Anwar, Nadia and Babur, Ozgun and Blinov, Michael and Brauner, Erik and Corwin, Dan and Donaldson, Sylva and Gibbons, Frank and Goldberg, Robert and Hornbeck, Peter and Luna, Augustin and Murray-Rust, Peter and Neumann, Eric and Reubenacker, Oliver and Samwald, Matthias and van Iersel, Martijn and Wimalaratne, Sarala and Allen, Keith and Braun, Burk and Whirl-Carrillo, Michelle and Cheung, Kei-Hoi and Dahlquist, Kam and Finney, Andrew and Gillespie, Marc and Glass, Elizabeth and Gong, Li and Haw, Robin and Honig, Michael and Hubaut, Olivier and Kane, David and Krupa, Shiva and Kutmon, Martina and Leonard, Julie and Marks, Debbie and Merberg, David and Petri, Victoria and Pico, Alex and Ravenscroft, Dean and Ren, Liya and Shah, Nigam and Sunshine, Margot and Tang, Rebecca and Whaley, Ryan and Letovksy, Stan and Buetow, Kenneth H. and Rzhetsky, Andrey and Schachter, Vincent and Sobral, Bruno S. and Dogrusoz, Ugur and McWeeney, Shannon and Aladjem, Mirit and Birney, Ewan and Collado-Vides, Julio and Goto, Susumu and Hucka, Michael and Nov{\`e}re, Nicolas Le and Maltsev, Natalia and Pandey, Akhilesh and Thomas, Paul and Wingender, Edgar and Karp, Peter D. and Sander, Chris and Bader, Gary D.},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-09-02 14:35:17 +0200},
	Journal = {Nat Biotech},
	Number = {9},
	Pages = {935-942},
	Title = {The {BioPAX} community standard for pathway data sharing},
	Volume = {28},
	Year = {2010}}

@inproceedings{CELLML,
	Author = {Nielsen, P. F. and Halstead, M. D.},
	Booktitle = {Engineering in Medicine and Biology Society, 2004. IEMBS '04. 26th Annual International Conference of the IEEE},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Pages = {5411-5414},
	Title = {The evolution of {CellML}},
	Volume = {2},
	Year = {2004}}

@article{EMBRACE,
	Abstract = {Summary: The EMBRACE Registry is a web portal that collects and monitors web services according to test scripts provided by the their administrators. Users are able to search for, rank and annotate services, enabling them to select the most appropriate working service for inclusion in their bioinformatics analysis tasks.Availability and implementation: Web site implemented with PHP, Python, MySQL and Apache, with all major browsers supported. (www.embraceregistry.net)Contact: steve.pettifer@manchester.ac.uk},
	Author = {Pettifer, S. and Thorne, D. and McDermott, P. and Attwood, T. and Baran, J. and Bryne, J. C. and Hupponen, T. and Mowbray, D. and Vriend, G.},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Journal = {Bioinformatics},
	Number = {16},
	Pages = {2090-2091},
	Title = {An active registry for bioinformatics web services},
	Volume = {25},
	Year = {2009}}

@article{Kit02,
	Abstract = {{To understand complex biological systems requires the integration of experimental and computational research {\^a}'' in other words a systems biology approach. Computational biology, through pragmatic modelling and theoretical exploration, provides a powerful foundation from which to address critical scientific questions head-on. The reviews in this Insight cover many different aspects of this energetic field, although all, in one way or another, illuminate the functioning of modular circuits, including their robustness, design and manipulation. Computational systems biology addresses questions fundamental to our understanding of life, yet progress here will lead to practical innovations in medicine, drug discovery and engineering.}},
	Address = {Sony Computer Science Laboratories, Inc., Shinagwa, Tokyo, Japan. kitano@csl.sony.co.jp},
	Author = {Kitano, Hiroaki},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Day = {14},
	Doi = {10.1038/nature01254},
	Issn = {0028-0836},
	Journal = {Nature},
	Keywords = {biology, systems},
	Month = nov,
	Number = {6912},
	Pages = {206--210},
	Pmid = {12432404},
	Posted-At = {2011-05-11 23:54:07},
	Priority = {0},
	Publisher = {Nature Publishing Group},
	Title = {{Computational systems biology}},
	Url = {http://dx.doi.org/10.1038/nature01254},
	Volume = {420},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature01254}}

@article{MIASE,
	Author = {Waltemath, Dagmar and Adams, Richard and Beard, Daniel A. and Bergmann, Frank T. and Bhalla, Upinder S. and Britten, Randall and Chelliah, Vijayalakshmi and Cooling, Michael T. and Cooper, Jonathan and Crampin, Edmund J. and Garny, Alan and Hoops, Stefan and Hucka, Michael and Hunter, Peter and Klipp, Edda and Laibe, Camille and Miller, Andrew K. and Moraru, Ion and Nickerson, David and Nielsen, Poul and Nikolski, Macha and Sahle, Sven and Sauro, Herbert M. and Schmidt, Henning and Snoep, Jacky L. and Tolle, Dominic and Wolkenhauer, Olaf and Le Nov{\~A}re, Nicolas},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Journal = {PLoS Comput Biol},
	Number = {4},
	Pages = {e1001122},
	Title = {Minimum Information About a Simulation Experiment ({MIASE})},
	Volume = {7},
	Year = {2011}}

@article{MIRIAM,
	Author = {Nov{\`e}re, Nicolas Le and Finney, Andrew and Hucka, Michael and Bhalla, Upinder S. and Campagne, Fabien and Collado-Vides, Julio and Crampin, Edmund J. and Halstead, Matt and Klipp, Edda and Mendes, Pedro and Nielsen, Poul and Sauro, Herbert and Shapiro, Bruce and Snoep, Jacky L. and Spence, Hugh D. and Wanner, Barry L.},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-09-02 14:36:20 +0200},
	Journal = {Nat Biotech},
	Number = {12},
	Pages = {1509-1515},
	Title = {Minimum information requested in the annotation of biochemical models ({MIRIAM})},
	Volume = {23},
	Year = {2005}}

@article{PROCESSCURATION,
	Abstract = {In bioinformatics, we are familiar with the idea of curated data as a prerequisite for data integration. We neglect, often to our cost, the curation and cataloguing of the processes that we use to integrate and analyse our data. Programmatic access to services, for data and processes, means that compositions of services can be made that represent the in silico experiments or processes that bioinformaticians perform. Data integration through workflows depends on being able to know what services exist and where to find those services. The large number of services and the operations they perform, their arbitrary naming and lack of documentation, however, mean that they can be difficult to use. The workflows themselves are composite processes that could be pooled and reused but only if they too can be found and understood. Thus appropriate curation, including semantic mark-up, would enable processes to be found, maintained and consequently used more easily. This broader view on semantic annotation is vital for full data integration that is necessary for the modern scientific analyses in biology. This article will brief the community on the current state of the art and the current challenges for process curation, both within and without the Life Sciences.},
	Author = {Goble, Carole and Stevens, Robert and Hull, Duncan and Wolstencroft, Katy and Lopez, Rodrigo},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Journal = {Briefings in Bioinformatics},
	Number = {6},
	Pages = {506-517},
	Title = {Data curation + process curation=data integration + science},
	Volume = {9},
	Year = {2008}}

@article{SBGN,
	Author = {Nov{\`e}re, Nicolas Le and Hucka, Michael and Mi, Huaiyu and Moodie, Stuart and Schreiber, Falk and Sorokin, Anatoly and Demir, Emek and Wegner, Katja and Aladjem, Mirit I. and Wimalaratne, Sarala M. and Bergman, Frank T. and Gauges, Ralph and Ghazal, Peter and Kawaji, Hideya and Li, Lu and Matsuoka, Yukiko and Villeger, Alice and Boyd, Sarah E. and Calzone, Laurence and Courtot, Melanie and Dogrusoz, Ugur and Freeman, Tom C. and Funahashi, Akira and Ghosh, Samik and Jouraku, Akiya and Kim, Sohyoung and Kolpakov, Fedor and Luna, Augustin and Sahle, Sven and Schmidt, Esther and Watterson, Steven and Wu, Guanming and Goryanin, Igor and Kell, Douglas B. and Sander, Chris and Sauro, Herbert and Snoep, Jacky L. and Kohn, Kurt and Kitano, Hiroaki},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-09-02 14:36:30 +0200},
	Journal = {Nat Biotech},
	Number = {8},
	Pages = {735-741},
	Title = {The Systems Biology Graphical Notation},
	Volume = {27},
	Year = {2009}}

@article{NeuroMl,
	Added-At = {2012-03-06T00:00:00.000+0100},
	Author = {Gleeson, Padraig and Crook, Sharon and Cannon, Robert C. and Hines, Michael L. and Billings, Guy O. and Farinella, Matteo and Morse, Thomas M. and Davison, Andrew P. and Ray, Subhasis and Bhalla, Upinder S. and Barnes, Simon R. and Dimitrova, Yoana D. and Silver, Angus},
	Biburl = {http://www.bibsonomy.org/bibtex/29a53639fe76274a5adb08da5bd98d99c/dblp},
	Ee = {http://dx.doi.org/10.1371/journal.pcbi.1000815},
	Interhash = {7e58bfaff7320bf306c10766d4e71f2a},
	Intrahash = {9a53639fe76274a5adb08da5bd98d99c},
	Journal = {PLoS Computational Biology},
	Keywords = {dblp},
	Number = 6,
	Timestamp = {2012-03-06T00:00:00.000+0100},
	Title = {NeuroML: A Language for Describing Data Driven Models of Neurons and Networks with a High Degree of Biological Detail.},
	Url = {http://dblp.uni-trier.de/db/journals/ploscb/ploscb6.html#GleesonCCHBFMDRBBDS10},
	Volume = 6,
	Year = 2010,
	Bdsk-Url-1 = {http://dblp.uni-trier.de/db/journals/ploscb/ploscb6.html#GleesonCCHBFMDRBBDS10}}

@article{SBML,
	Abstract = {Motivation: Molecular biotechnology now makes it possible to build elaborate systems models, but the systems biology community needs information standards if models are to be shared, evaluated and developed cooperatively.Results: We summarize the Systems Biology Markup Language (SBML) Level 1, a free, open, XML-based format for representing biochemical reaction networks. SBML is a software-independent language for describing models common to research in many areas of computational biology, including cell signaling pathways, metabolic pathways, gene regulation, and others.Availability: The specification of SBML Level 1 is freely available from http://www.sbml.org/Contact: sysbio-team@caltech.edu},
	Author = {Hucka, M. and Finney, A. and Sauro, H. M. and Bolouri, H. and Doyle, J. C. and Kitano, H. and and the rest of the, Sbml Forum and Arkin, A. P. and Bornstein, B. J. and Bray, D. and Cornish-Bowden, A. and Cuellar, A. A. and Dronov, S. and Gilles, E. D. and Ginkel, M. and Gor, V. and Goryanin, I. I. and Hedley, W. J. and Hodgman, T. C. and Hofmeyr, J. H. and Hunter, P. J. and Juty, N. S. and Kasberger, J. L. and Kremling, A. and Kummer, U. and Le Nov\`{e}re, N. and Loew, L. M. and Lucio, D. and Mendes, P. and Minch, E. and Mjolsness, E. D. and Nakayama, Y. and Nelson, M. R. and Nielsen, P. F. and Sakurada, T. and Schaff, J. C. and Shapiro, B. E. and Shimizu, T. S. and Spence, H. D. and Stelling, J. and Takahashi, K. and Tomita, M. and Wagner, J. and Wang, J.},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Journal = {Bioinformatics},
	Number = {4},
	Pages = {524-531},
	Title = {The systems biology markup language ({SBML}): a medium for representation and exchange of biochemical network models},
	Volume = {19},
	Year = {2003}}

@article{SBRML,
	Abstract = {Motivation: Research in systems biology is carried out through a combination of experiments and models. Several data standards have been adopted for representing models (Systems Biology Markup Language) and various types of relevant experimental data (such as FuGE and those of the Proteomics Standards Initiative). However, until now, there has been no standard way to associate a model and its entities to the corresponding datasets, or vice versa. Such a standard would provide a means to represent computational simulation results as well as to frame experimental data in the context of a particular model. Target applications include model-driven data analysis, parameter estimation, and sharing and archiving model simulations.Results: We propose the Systems Biology Results Markup Language (SBRML), an XML-based language that associates a model with several datasets. Each dataset is represented as a series of values associated with model variables, and their corresponding parameter values. SBRML provides a flexible way of indexing the results to model parameter values, which supports both spreadsheet-like data and multidimensional data cubes. We present and discuss several examples of SBRML usage in applications such as enzyme kinetics, microarray gene expression and various types of simulation results.Availability and Implementation: The XML Schema file for SBRML is available at http://www.comp-sys-bio.org/SBRML under the Academic Free License (AFL) v3.0.Contact: pedro.mendes@manchester.ac.ukSupplementary information: Supplementary data are available at Bioinformatics online.},
	Author = {Dada, Joseph O. and Spasic, Irena and Paton, Norman W. and Mendes, Pedro},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-05-12 20:19:55 +0200},
	Journal = {Bioinformatics},
	Number = {7},
	Pages = {932-938},
	Title = {{SBRML}: a markup language for associating systems biology data with models},
	Volume = {26},
	Year = {2010}}

@incollection{SEDML,
	Affiliation = {University of Rostock Research Training School dIEM oSiRiS Germany},
	Author = {Kohn, Dagmar and Le Nov{\`e}re, Nicolas},
	Booktitle = {Computational Methods in Systems Biology},
	Date-Added = {2011-05-12 20:19:55 +0200},
	Date-Modified = {2011-09-02 14:35:53 +0200},
	Editor = {Heiner, Monika and Uhrmacher, Adelinde},
	Pages = {176-190},
	Publisher = {Springer Berlin / Heidelberg},
	Series = {Lecture Notes in Computer Science},
	Title = {{SED-ML} -- An {XML} Format for the Implementation of the {MIASE} Guidelines},
	Volume = {5307},
	Year = {2008}}

@webpage{pchip:2011,
	Author = {Mathworks},
	Date-Added = {2011-05-06 13:19:43 +0200},
	Date-Modified = {2012-03-12 12:59:20 +0000},
	Lastchecked = {6 May 2011},
	Month = {May},
	Title = {http://www.mathworks.com/help/techdoc/ref/pchip.html},
	Url = {http://www.mathworks.com/help/techdoc/ref/pchip.html},
	Year = {2011},
	Bdsk-Url-1 = {http://www.mathworks.com/help/techdoc/ref/pchip.html}}

@article{Muniyappa:2008aa,
	Abstract = {Insulin resistance contributes to the pathophysiology of diabetes and is a hallmark of obesity, metabolic syndrome, and many cardiovascular diseases. Therefore, quantifying insulin sensitivity/resistance in humans and animal models is of great importance for epidemiological studies, clinical and basic science investigations, and eventual use in clinical practice. Direct and indirect methods of varying complexity are currently employed for these purposes. Some methods rely on steady-state analysis of glucose and insulin, whereas others rely on dynamic testing. Each of these methods has distinct advantages and limitations. Thus, optimal choice and employment of a specific method depends on the nature of the studies being performed. Established direct methods for measuring insulin sensitivity in vivo are relatively complex. The hyperinsulinemic euglycemic glucose clamp and the insulin suppression test directly assess insulin-mediated glucose utilization under steady-state conditions that are both labor and time intensive. A slightly less complex indirect method relies on minimal model analysis of a frequently sampled intravenous glucose tolerance test. Finally, simple surrogate indexes for insulin sensitivity/resistance are available (e.g., QUICKI, HOMA, 1/insulin, Matusda index) that are derived from blood insulin and glucose concentrations under fasting conditions (steady state) or after an oral glucose load (dynamic). In particular, the quantitative insulin sensitivity check index (QUICKI) has been validated extensively against the reference standard glucose clamp method. QUICKI is a simple, robust, accurate, reproducible method that appropriately predicts changes in insulin sensitivity after therapeutic interventions as well as the onset of diabetes. In this Frontiers article, we highlight merits, limitations, and appropriate use of current in vivo measures of insulin sensitivity/resistance.},
	Author = {Muniyappa, R and Lee, S and Chen, H and Quon, MJ},
	Date-Added = {2011-05-02 14:31:28 +0200},
	Date-Modified = {2011-05-06 13:08:53 +0200},
	Doi = {10.1152/ajpendo.00645.2007},
	Journal = {Am J Physiol Endocrinol Metab},
	Journal-Full = {American journal of physiology. Endocrinology and metabolism},
	Mesh = {Animals; Blood Glucose; Glucose Clamp Technique; Glucose Intolerance; Homeostasis; Humans; Insulin Resistance; Models, Biological},
	Month = {Jan},
	Number = {1},
	Pages = {E15-26},
	Pmid = {17957034},
	Pst = {ppublish},
	Title = {Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage},
	Volume = {294},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1152/ajpendo.00645.2007}}

@article{Gizatullin:2006aa,
	Abstract = {VX-680 is a potent inhibitor of Aurora kinases that induces the accumulation of cells with > or =4N DNA content, followed by cell death. Here, we define the role of p53 and p21(Waf1/Cip1) in cell cycle perturbations following exposure to VX-680. Endoreduplication and apoptosis in response to VX-680 are limited in A549 and MCF-7 cells expressing wild-type p53, and markedly enhanced in cells lacking p53, including those engineered to express the HPV16-E6 oncoprotein or short interfering RNA pools targeting p53. In contrast, endoreduplication and apoptosis occur in the p53 wild-type cell lines, RKO and U2OS. The difference in response to VX-680 among these cell lines correlates with the timing of induction of p21(Waf1/Cip1) and its ability to inhibit cyclin E-cdk2 activity. In A549 cells, VX-680 induces the expression of p53 and p21(Waf1/Cip1) within 24 hours, with consequent inhibition of cyclin E-cdk2, and reduction of retinoblastoma protein phosphorylation, limiting endoreduplication. In RKO and U2OS cells, the induction of p21(Waf1/Cip1) is delayed and associated with higher residual cyclin E-cdk2 kinase activity and retinoblastoma protein phosphorylation, followed by progressive endoreduplication and apoptosis. Abrogation of p21(Waf1/Cip1) expression by short interfering RNA targeting in A549 cells results in a substantial increase in the degree of endoreduplication, whereas inducible expression of p21(Waf1/Cip1) in p53-negative NCI-H1299 cells inhibits VX-680-induced endoreduplication and cell death. These data suggest that the integrity of the p53-p21(Waf1/Cip1)-dependent postmitotic checkpoint governs the response to Aurora kinase inhibition. Although cells with intact checkpoint function arrest with 4N DNA content, those with compromised checkpoint function are more likely to undergo endoreduplication followed by eventual apoptosis.},
	Author = {Gizatullin, F and Yao, Y and Kung, V and Harding, MW and Loda, M and Shapiro, GI},
	Date-Added = {2011-04-29 16:38:08 +0200},
	Date-Modified = {2011-04-29 16:49:18 +0200},
	Doi = {10.1158/0008-5472.CAN-05-3353},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Gene Duplication; Humans; Mitosis; Neoplasms; Phosphorylation; Piperazines; Protein-Serine-Threonine Kinases; RNA, Small Interfering; Retinoblastoma Protein; Tumor Suppressor Protein p53},
	Month = {Aug},
	Number = {15},
	Pages = {7668-77},
	Pmid = {16885368},
	Pst = {ppublish},
	Title = {The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function},
	Volume = {66},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/0008-5472.CAN-05-3353}}

@article{Day:2004aa,
	Abstract = {A training workshop for cancer clinical trials was developed utilizing a computer simulation encompassing cancer biology, metabolism, adverse effects, and clinical trial design.},
	Author = {Day, RS and Manning, BK and Garrott, D and Brufsky, AM and Baar, J and Egorin, MJ and Shirey, WE and Friedman, C},
	Date-Added = {2011-04-21 17:41:29 +0200},
	Date-Modified = {2011-04-21 17:43:10 +0200},
	Doi = {10.1207/s15430154jce1903_8},
	Journal = {J Cancer Educ},
	Journal-Full = {Journal of cancer education : the official journal of the American Association for Cancer Education},
	Mesh = {Clinical Trials as Topic; Computer Simulation; Cross-Over Studies; Education; Education, Medical, Undergraduate; Educational Measurement; Humans; Neoplasms; Software; Teaching},
	Number = {3},
	Pages = {149-55},
	Pmid = {15458869},
	Pst = {ppublish},
	Title = {Evaluation of the OncoTCap (Oncology Thinking Cap) simulation in teaching medical students about clinical trials: some successes and some surprises},
	Volume = {19},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1207/s15430154jce1903_8}}

@article{ICRP:2002aa,
	Abstract = {This report presents detailed information on age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. These reference values provide needed input to prospective dosimetry calculations for radiation protection purposes for both workers and members of the general public. The purpose of this report is to consolidate and unify in one publication, important new information on reference anatomical and physiological values that has become available since Publication 23 was published by the ICRP in 1975. There are two aspects of this work. The first is to revise and extend the information in Publication 23 as appropriate. The second is to provide additional information on individual variation among grossly normal individuals resulting from differences in age, gender, race, or other factors. This publication collects, unifies, and expands the updated ICRP reference values for the purpose of providing a comprehensive and consistent set of age- and gender-specific reference values for anatomical and physiological features of the human body pertinent to radiation dosimetry. The reference values given in this report are based on: (a) anatomical and physiological information not published before by the ICRP; (b) recent ICRP publications containing reference value information; and (c) information in Publication 23 that is still considered valid and appropriate for radiation protection purposes. Moving from the past emphasis on 'Reference Man', the new report presents a series of reference values for both male and female subjects of six different ages: newborn, 1 year, 5 years, 10 years, 15 years, and adult. In selecting reference values, the Commission has used data on Western Europeans and North Americans because these populations have been well studied with respect to antomy, body composition, and physiology. When appropriate, comparisons are made between the chosen reference values and data from several Asian populations. The first section of the report provides summary tables of all the anatomical and physiological parameters given as reference values in this publication. These results give a comprehensive view of reference values for an individual as influenced by age and gender. The second section describes characteristics of dosimetric importance for the embryo and fetus. Information is provided on the development of the total body and the timing of appearance and development of the various organ systems. Reference values are provided on the mass of the total body and selected organs and tissues, as well as a number of physiological parameters. The third section deals with reference values of important anatomical and physiological characteristics of reference individuals from birth to adulthood. This section begins with details on the growth and composition of the total body in males and females. It then describes and quantifies anatomical and physiological characteristics of various organ systems and changes in these characteristics during growth, maturity, and pregnancy. Reference values are specified for characteristics of dosimetric importance. The final section gives a brief summary of the elemental composition of individuals. Focusing on the elements of dosimetric importance, information is presented on the body content of 13 elements: calcium, carbon, chloride, hydrogen, iodine, iron, magnesium, nitrogen, oxygen, potassium, sodium, sulphur, and phosphorus.},
	Author = {Valentin, J. edt.},
	Date-Added = {2011-04-19 18:45:10 +0200},
	Date-Modified = {2011-04-19 18:50:44 +0200},
	Journal = {Ann ICRP},
	Journal-Full = {Annals of the ICRP},
	Mesh = {Adolescent; Adult; Age Factors; Anthropometry; Body Weights and Measures; Child; Child, Preschool; Cross-Cultural Comparison; Embryonic and Fetal Development; Female; Fetal Weight; Gestational Age; Humans; Infant; Infant, Newborn; Male; Models, Anatomic; Models, Statistical; Physiology; Pregnancy; Radiation Protection; Radiometry; Reference Values; Sex Factors},
	Number = {3-4},
	Pages = {5-265},
	Pmid = {14506981},
	Pst = {ppublish},
	Title = {Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89},
	Volume = {32},
	Year = {2002}}

@article{Alfieri:2008aa,
	Abstract = {The cell cycle database is a biological resource that collects the most relevant information related to genes and proteins involved in human and yeast cell cycle processes. The database, which is accessible at the web site http://www.itb.cnr.it/cellcycle, has been developed in a systems biology context, since it also stores the cell cycle mathematical models published in the recent years, with the possibility to simulate them directly. The aim of our resource is to give an exhaustive view of the cell cycle process starting from its building-blocks, genes and proteins, toward the pathway they create, represented by the models.},
	Author = {Alfieri, R and Merelli, I and Mosca, E and Milanesi, L},
	Date-Added = {2011-04-18 22:02:59 +0200},
	Date-Modified = {2011-04-29 16:50:49 +0200},
	Doi = {10.1093/nar/gkm873},
	Journal = {Nucleic Acids Res},
	Journal-Full = {Nucleic acids research},
	Mesh = {Cell Cycle; Cell Cycle Proteins; Databases, Genetic; Genes, cdc; Humans; Internet; Models, Biological; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Systems Biology; User-Computer Interface},
	Month = {Jan},
	Number = {Database issue},
	Pages = {D641-5},
	Pmc = {PMC2238882},
	Pmid = {18160409},
	Pst = {ppublish},
	Title = {The cell cycle DB: a systems biology approach to cell cycle analysis},
	Volume = {36},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/nar/gkm873}}

@article{Shields:2007aa,
	Abstract = {CCR7 is implicated in lymph node metastasis of cancer, but its role is obscure. We report a mechanism explaining how interstitial flow caused by lymphatic drainage directs tumor cell migration by autocrine CCR7 signaling. Under static conditions, lymphatic endothelium induced CCR7-dependent chemotaxis of tumor cells through 3D matrices. However, interstitial flow induced strong increases in tumor cell migration that were also CCR7 dependent, but lymphatic independent. This autologous chemotaxis correlated with metastatic potential in four cell lines and was verified by visualizing directional polarization of cells in the flow direction. Computational modeling revealed that transcellular gradients of CCR7 ligand were created under flow to drive this response. This illustrates how tumor cells may be guided to lymphatics during metastasis.},
	Author = {Shields, JD and Fleury, ME and Yong, C and Tomei, AA and Randolph, GJ and Swartz, MA},
	Date-Added = {2011-04-18 21:28:40 +0200},
	Date-Modified = {2011-04-29 16:50:23 +0200},
	Doi = {10.1016/j.ccr.2007.04.020},
	Journal = {Cancer Cell},
	Journal-Full = {Cancer cell},
	Mesh = {Autocrine Communication; Cell Line, Tumor; Chemotaxis; Endothelial Cells; Humans; Lymphatic Metastasis; Lymphatic System; Models, Biological; Neoplasms; Receptors, CCR7; Receptors, Chemokine},
	Month = {Jun},
	Number = {6},
	Pages = {526-38},
	Pmid = {17560334},
	Pst = {ppublish},
	Title = {Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling},
	Volume = {11},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.ccr.2007.04.020}}

@article{Hostetter:2004aa,
	Author = {Hostetter, Thomas H},
	Date-Added = {2011-04-18 21:24:16 +0200},
	Date-Modified = {2011-04-18 21:24:16 +0200},
	Doi = {10.1056/NEJMe048236},
	Journal = {N Engl J Med},
	Journal-Full = {The New England journal of medicine},
	Mesh = {Cardiovascular Diseases; Chronic Disease; Creatinine; Glomerular Filtration Rate; Humans; Kidney Diseases; Risk Factors},
	Month = {Sep},
	Number = {13},
	Pages = {1344-6},
	Pmid = {15385664},
	Pst = {ppublish},
	Title = {Chronic kidney disease predicts cardiovascular disease},
	Volume = {351},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1056/NEJMe048236}}

@article{Ying:2005aa,
	Abstract = {Chronic inflammation contributes to tumorigenesis. The retinoblastoma protein (pRb), in its hyperphosphorylated form, releases E2 promoter binding factor-1 (E2F1), which drives cell proliferation. Here, we show that pRb is hyperphosphorylated in both mouse and human colitis. In turn, pRb hyperphosphorylation is associated with release of E2F1 from pRb, resulting in the activation of E2F1 target molecules involved in proliferation and apoptosis. These observations provide insight into the in vivo mechanisms associated with chronic colon inflammation and increased colon cancer risk.},
	Author = {Ying, L and Marino, J and Hussain, SP and Khan, MA and You, S and Hofseth, AB and Trivers, GE and Dixon, DA and Harris, CC and Hofseth, LJ},
	Date-Added = {2011-04-18 21:22:23 +0200},
	Date-Modified = {2011-04-29 16:51:55 +0200},
	Doi = {10.1158/0008-5472.CAN-05-1358},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Animals; Cell Growth Processes; Colitis, Ulcerative; E2F1 Transcription Factor; Gene Expression Regulation; Humans; Inflammation; Mice; Mice, Inbred C57BL; Phosphorylation; Retinoblastoma Protein},
	Month = {Oct},
	Number = {20},
	Pages = {9132-6},
	Pmid = {16230367},
	Pst = {ppublish},
	Title = {Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation},
	Volume = {65},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/0008-5472.CAN-05-1358}}

@article{Petersen:2002aa,
	Author = {Petersen, KF and Shulman, GI},
	Date-Added = {2011-04-18 20:59:55 +0200},
	Date-Modified = {2011-04-29 16:49:42 +0200},
	Journal = {J R Soc Med},
	Journal-Full = {Journal of the Royal Society of Medicine},
	Mesh = {Adipose Tissue; Biological Transport; Blood Glucose; Cell Communication; Hexokinase; Humans; Insulin Resistance; Muscle, Skeletal},
	Pages = {8-13},
	Pmc = {PMC1308947},
	Pmid = {12216329},
	Pst = {ppublish},
	Title = {Cellular mechanism of insulin resistance in skeletal muscle},
	Volume = {95 Suppl 42},
	Year = {2002}}

@article{Dickinson:2007aa,
	Abstract = {To assess the power of in vivo studies needed to discern the effect of genotype on pharmacokinetics (PK) and pharmacodynamics (PD) using CYP2C9 and (S)-warfarin as an example.},
	Author = {Dickinson, GL and Lennard, MS and Tucker, GT and Rostami-Hodjegan, A},
	Date-Added = {2011-04-18 15:50:43 +0200},
	Date-Modified = {2011-04-18 15:52:15 +0200},
	Doi = {10.1111/j.1365-2125.2007.02850.x},
	Journal = {Br J Clin Pharmacol},
	Journal-Full = {British journal of clinical pharmacology},
	Mesh = {Anticoagulants; Aryl Hydrocarbon Hydroxylases; Blood Coagulation; Genotype; Humans; Models, Biological; Polymorphism, Genetic; Warfarin},
	Month = {Jul},
	Number = {1},
	Pages = {14-26},
	Pmc = {PMC2000610},
	Pmid = {17298479},
	Pst = {ppublish},
	Title = {The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example},
	Volume = {64},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1111/j.1365-2125.2007.02850.x}}

@book{BetaSys:2011sb,
	Date-Added = {2011-04-18 14:35:54 +0200},
	Date-Modified = {2011-04-18 14:38:40 +0200},
	Editor = {Boo{\ss}-Bavnbek, B.; Kl{\"o}sgen, B.; Larsen, J.; Pociot, F.; Renstr{\"o}m, E.},
	Publisher = {Springer},
	Title = {Systems Biology of Regulated Exocytosis in Pancreatic beta-cells},
	Year = {2011}}

@article{Norton:1988aa,
	Abstract = {The pattern of growth of human breast cancer is important theoretically and clinically. Speer et al. (Cancer Res., 44: 4124-4130, 1984) have recently proposed that all individual tumors initially grow with identical Gompertzian parameters, but subsequently develop kinetic heterogeneity by a random time-dependent process. This concept has elicited interest because it fits clinical data for the survival of untreated patients, for the progression of shadows on serial paired mammograms, and for time-to-relapse following mastectomy. The success of these curve-fits is compelling, and the model has been applied to clinical trials. However, the assumption of uniform nascent growth is not supported by theory or data, and individual cancers have not been shown to follow the complex growth curves predicted by the Speer model. As an alternative, if kinetic heterogeneity is understood to be an intrinsic property of neoplasia, the same three historical data sets are fit well by an unadorned Gompertzian model which is parsimonious and has many other intuitive and empirical advantages. The two models differ significantly in such clinical projections as the estimated duration of silent growth prior to diagnosis and the anticipated optimal chemotherapy schedule postsurgery.},
	Author = {Norton, L},
	Date-Added = {2011-04-18 11:45:42 +0200},
	Date-Modified = {2011-04-18 11:45:42 +0200},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Mastectomy, Radical; Mathematics; Middle Aged; Models, Biological},
	Month = {Dec},
	Number = {24 Pt 1},
	Pages = {7067-71},
	Pmid = {3191483},
	Pst = {ppublish},
	Title = {A Gompertzian model of human breast cancer growth},
	Volume = {48},
	Year = {1988}}

@article{Dormann:2002aa,
	Abstract = {Pattern formation in multicellular spheroids is addressed with a hybrid lattice-gas cellular automaton model. Multicellular spheroids serve as experimental model system for the study of avascular tumor growth. Typically, multicellular spheroids consist of a necrotic core surrounded by rings of quiescent and proliferating tumor cells, respectively. Furthermore, after an initial exponential growth phase further spheroid growth is significantly slowed down even if further nutrient is supplied. The cellular automaton model explicitly takes into account mitosis, apoptosis and necrosis as well as nutrient consumption and a diffusible signal that is emitted by cells becoming necrotic. All cells follow identical interaction rules. The necrotic signal induces a chemotactic migration of tumor cells towards maximal signal concentrations. Starting from a small number of tumor cells automaton simulations exhibit the self-organized formation of a layered structure consisting of a necrotic core, a ring of quiescent tumor cells and a thin outer ring of proliferating tumor cells.},
	Author = {Dormann, S and Deutsch, A},
	Date-Added = {2011-04-15 20:57:40 +0200},
	Date-Modified = {2011-04-15 20:57:52 +0200},
	Journal = {In Silico Biol},
	Journal-Full = {In silico biology},
	Mesh = {Cell Division; Chemotaxis; Models, Biological; Neoplasms},
	Number = {3},
	Pages = {393-406},
	Pmid = {12542422},
	Pst = {ppublish},
	Title = {Modeling of self-organized avascular tumor growth with a hybrid cellular automaton},
	Volume = {2},
	Year = {2002}}

@article{Chen:2009aa,
	Abstract = {Mutations of the retinoblastoma tumour suppressor gene (RB1) or components regulating the RB pathway have been identified in almost every human malignancy. The E2F transcription factors function in cell cycle control and are intimately regulated by RB. Studies of model organisms have revealed conserved functions for E2Fs during development, suggesting that the cancer-related proliferative roles of E2F family members represent a recent evolutionary adaptation. However, given that some human tumours have concurrent RB1 inactivation and E2F amplification and overexpression, we propose that there are alternative tumour-promoting activities for the E2F family, which are independent of cell cycle regulation.},
	Author = {Chen, HZ and Tsai, SY and Leone, G},
	Date-Added = {2011-04-15 20:49:32 +0200},
	Date-Modified = {2011-04-15 20:49:59 +0200},
	Doi = {10.1038/nrc2696},
	Journal = {Nat Rev Cancer},
	Journal-Full = {Nature reviews. Cancer},
	Mesh = {Animals; Cell Cycle; E2F Transcription Factors; Humans; Multigene Family; Neoplasms; Retinoblastoma Protein},
	Month = {Nov},
	Number = {11},
	Pages = {785-97},
	Pmid = {19851314},
	Pst = {ppublish},
	Title = {Emerging roles of E2Fs in cancer: an exit from cell cycle control},
	Volume = {9},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrc2696}}

@article{Moreno-Sanchez:2010aa,
	Abstract = {Much of the search for the "magic cancer bullet" or "block buster" has followed the expectation of a single gene or protein as "the rate-limiting step" for tumor persistence. Examples continue to abound: EGFR, VEGFR, Akt/PI3K, HIF-1, PHD, PDK, or FAS continue to be targeted individually. However, many such attempts to block a metabolic or signal transduction pathway by targeting, specifically, a single rate-limiting molecule have proven to be unsuccessful. Metabolic control analysis (MCA) of cancer cells has generated a generic explanation for this phenomenon: several steps share the control of energy metabolism (for glycolysis: glucose transporter, hexokinase, glycogen synthesis and ATP demand; for oxidative phosphorylation: respiratory complex I and ATP demand), i.e., there is no single "rate-limiting step". Targeting a type of step that does not exist is unlikely to be a successful paradigm for continued research into drug targeting of cancer. MCA establishes how to determine, quantitatively, the degrees of control that the various enzymes in the intracellular network exert on vital flux (or function) and on the concentration of important metabolites, substituting for the intuitive, qualitative and most often erroneous concept of single rate-limiting step. Moreover, MCA helps to understand (i) the underlying mechanisms by which a given enzyme exerts high or low control, (ii) why the control of the pathway is shared by several pathway enzymes and transporters and (iii) what are the better sets of drug targets. Indeed, by applying MCA it should now be possible to identify the group of proteins (and genes) that should be modified to achieve a successful modulation of the intracellular networks of biotechnological or clinical relevance. The challenge is to move away from the design of drugs that specifically inhibit a single controlling step, towards unspecific drugs or towards drug mixtures, which may have multiple target sites in the most exacerbated, unique and controlling pathways in cancer cells. Successful nonspecific drugs should still be specific for the networks of cancer cells over those of normal cells and to establish such cell-type specificity within molecular non-specificity will continue to require sophisticated analyses. Clinical practice has anticipated the latter strategy of mixtures of drugs: combinations of anti-neoplastic drugs are already administered with encouraging results. Therefore, the most promising strategy for cancer treatment seems to be that of a multi-targeted, MCA-advised, therapy.},
	Author = {Moreno-S{\'a}nchez, R and Saavedra, E and Rodr{\'\i}guez-Enr{\'\i}quez, S and Gallardo-P{\'e}rez, JC and Quezada, H and Westerhoff, HV},
	Date-Added = {2011-04-15 20:10:50 +0200},
	Date-Modified = {2011-04-15 20:11:31 +0200},
	Doi = {10.1016/j.mito.2010.06.002},
	Journal = {Mitochondrion},
	Journal-Full = {Mitochondrion},
	Mesh = {Antineoplastic Agents; Energy Metabolism; Gene Expression Regulation; Homeostasis; Humans; Mitochondria; Neoplasms},
	Month = {Nov},
	Number = {6},
	Pages = {626-39},
	Pmid = {20599628},
	Pst = {ppublish},
	Title = {Metabolic control analysis indicates a change of strategy in the treatment of cancer},
	Volume = {10},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.mito.2010.06.002}}

@article{Marin-Hernandez:2010aa,
	Abstract = {Most cancer cells exhibit an accelerated glycolysis rate compared to normal cells. This metabolic change is associated with the over-expression of all the pathway enzymes and transporters (as induced by HIF-1 and other oncogenes), and with the expression of hexokinase (HK) and phosphofructokinase type 1 (PFK-1) isoenzymes with different regulatory properties. Hence, a control distribution of tumor glycolysis, modified from that observed in normal cells, can be expected. To define the control distribution and to understand the underlying control mechanisms, kinetic models of glycolysis of rodent AS-30D hepatoma and human cervix HeLa cells were constructed with experimental data obtained here for each pathway step (enzyme kinetics; steady-state pathway metabolite concentrations and fluxes). The models predicted with high accuracy the fluxes and metabolite concentrations found in living cancer cells under physiological O(2) and glucose concentrations as well as under hypoxic and hypoglycemic conditions prevailing during tumor progression. The results indicated that HKHPI>GLUT in AS-30D whereas glycogen degradationGLUT>HK in HeLa were the main flux- and ATP concentration-control steps. Modeling also revealed that, in order to diminish the glycolytic flux or the ATP concentration by 50\%, it was required to decrease GLUT or HK or HPI by 76\% (AS-30D), and GLUT or glycogen degradation by 87-99\% (HeLa), or decreasing simultaneously the mentioned steps by 47\%. Thus, these proteins are proposed to be the foremost therapeutic targets because their simultaneous inhibition will have greater antagonistic effects on tumor energy metabolism than inhibition of all other glycolytic, non-controlling, enzymes. This article is part of a Special Issue entitled Bioenergetics of Cancer.},
	Author = {Mar{\'\i}n-Hern{\'a}ndez, A and Gallardo-P{\'e}rez, JC and Rodr{\'\i}guez-Enr{\'\i}quez, S and Encalada, R and Moreno-S{\'a}nchez, R and Saavedra, E},
	Date-Added = {2011-04-15 20:08:56 +0200},
	Date-Modified = {2011-04-15 20:09:39 +0200},
	Doi = {10.1016/j.bbabio.2010.11.006},
	Journal = {Biochim Biophys Acta},
	Journal-Full = {Biochimica et biophysica acta},
	Month = {Nov},
	Pmid = {21110941},
	Pst = {aheadofprint},
	Title = {Modeling cancer glycolysis},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.bbabio.2010.11.006}}

@book{Masur:2008ma,
	Author = {K. Masur (Editor), F. Thevenod (Editor), K. S. Zanker},
	Date-Added = {2011-04-15 20:02:24 +0200},
	Date-Modified = {2011-04-15 20:03:35 +0200},
	Publisher = {S. Karger AG (Switzerland)},
	Title = {Diabetes and Cancer: Epidemiological Evidence and Molecular Links},
	Year = {2008}}

@article{Anderson:1998aa,
	Abstract = {Angiogenesis, the formation of blood vessels from a pre-existing vasculature, is a process whereby capillary sprouts are formed in response to externally supplied chemical stimuli. The sprouts then grow and develop, driven initially by endothelial-cell migration, and organize themselves into a dendritic structure. Subsequent cell proliferation near the sprout tip permits further extension of the capillary and ultimately completes the process. Angiogenesis occurs during embryogenesis, wound healing, arthritis and during the growth of solid tumors. In this paper we present both continuous and discrete mathematical models which describe the formation of the capillary sprout network in response to chemical stimuli (tumor angiogenic factors, TAF) supplied by a solid tumor. The models also take into account essential endothelial cell-extracellular matrix interactions via the inclusion of the matrix macromolecule fibronectin. The continuous model consists of a system of nonlinear partial differential equations describing the initial migratory response of endothelial cells to the TAF and the fibronectin. Numerical simulations of the system, using parameter values based on experimental data, are presented and compared qualitatively with in vivo experiments. We then use a discretized form of the partial differential equations to develop a biased random-walk model which enables us to track individual endothelial cells at the sprout tips and incorporate anastomosis, mitosis and branching explicitly into the model. The theoretical capillary networks generated by computer simulations of the discrete model are compared with the morphology of capillary networks observed in in vivo experiments.},
	Author = {Anderson, A R and Chaplain, M A},
	Date-Added = {2011-04-15 19:37:56 +0200},
	Date-Modified = {2011-04-15 19:37:56 +0200},
	Doi = {10.1006/bulm.1998.0042},
	Journal = {Bull Math Biol},
	Journal-Full = {Bulletin of mathematical biology},
	Mesh = {Angiogenesis Inducing Agents; Animals; Arteriovenous Anastomosis; Capillaries; Cell Communication; Cell Division; Computer Simulation; Endothelium, Vascular; Fibronectins; Humans; Mitosis; Models, Biological; Neoplasms, Experimental; Neovascularization, Pathologic; Numerical Analysis, Computer-Assisted; Stochastic Processes},
	Month = {Sep},
	Number = {5},
	Pages = {857-99},
	Pmid = {9739618},
	Pst = {ppublish},
	Title = {Continuous and discrete mathematical models of tumor-induced angiogenesis},
	Volume = {60},
	Year = {1998},
	Bdsk-Url-1 = {http://dx.doi.org/10.1006/bulm.1998.0042}}

@article{Drasdo:2005aa,
	Abstract = {To what extent the growth dynamics of tumors is controlled by nutrients, biomechanical forces and other factors at different stages and in different environments is still largely unknown. Here we present a biophysical model to study the spatio-temporal growth dynamics of two-dimensional tumor monolayers and three-dimensional tumor spheroids as a complementary tool to in vitro experiments. Within our model each cell is represented as an individual object and parametrized by cell-biophysical and cell-kinetic parameters that can all be experimentally determined. Hence our modeling strategy allows us to study which mechanisms on the microscopic level of individual cells may affect the macroscopic properties of a growing tumor. We find the qualitative growth kinetics and patterns at early growth stages to be remarkably robust. Quantitative comparisons between computer simulations using our model and published experimental observations on monolayer cultures suggest a biomechanically-mediated form of growth inhibition during the experimentally observed transition from exponential to sub-exponential growth at sufficiently large tumor sizes. Our simulations show that the same transition during the growth of avascular tumor spheroids can be explained largely by the same mechanism. Glucose (or oxygen) depletion seems to determine mainly the size of the necrotic core but not the size of the tumor. We explore the consequences of the suggested biomechanical form of contact inhibition, in order to permit an experimental test of our model. Based on our findings we propose a phenomenological growth law in early expansion phases in which specific biological small-scale processes are subsumed in a small number of effective parameters.},
	Author = {Drasdo, D and H{\"o}hme, S},
	Date-Added = {2011-04-15 19:36:17 +0200},
	Date-Modified = {2011-04-15 19:38:21 +0200},
	Doi = {10.1088/1478-3975/2/3/001},
	Journal = {Phys Biol},
	Journal-Full = {Physical biology},
	Mesh = {Biomechanics; Cell Proliferation; Computer Simulation; Contact Inhibition; Food; Humans; Kinetics; Models, Biological; Neoplasms; Spheroids, Cellular},
	Month = {Sep},
	Number = {3},
	Pages = {133-47},
	Pmid = {16224119},
	Pst = {epublish},
	Title = {A single-cell-based model of tumor growth in vitro: monolayers and spheroids},
	Volume = {2},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1088/1478-3975/2/3/001}}

@article{Lazarus:2009aa,
	Abstract = {Tamoxifen (TAM) is a selective estrogen receptor modulator that is widely used in the prevention and treatment of estrogen receptor-positive (ER(+)) breast cancer. Its use has significantly contributed to a decline in breast cancer mortality, since breast cancer patients treated with TAM for 5 years exhibit a 30-50\% reduction in both the rate of disease recurrence after 10 years of patient follow-up and occurrence of contralateral breast cancer. However, in patients treated with TAM there is substantial interindividual variability in the development of resistance to TAM therapy, and in the incidence of TAM-induced adverse events, including deep vein thrombosis, hot flashes, and the development of endometrial cancer. This article will focus on the UDP glucuronosyltransferases, a family of metabolizing enzymes that are responsible for the deactivation and clearance of TAM and TAM metabolites, and how interindividual differences in these enzymes may play a role in patient response to TAM.},
	Author = {Lazarus, P and Blevins-Primeau, AS and Zheng, Y and Sun, D},
	Date-Added = {2011-04-15 19:08:40 +0200},
	Date-Modified = {2011-04-15 19:09:18 +0200},
	Doi = {10.1111/j.1749-6632.2009.04114.x},
	Journal = {Ann N Y Acad Sci},
	Journal-Full = {Annals of the New York Academy of Sciences},
	Mesh = {Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Female; Glucuronosyltransferase; Humans; Pharmacogenetics; Selective Estrogen Receptor Modulators; Tamoxifen},
	Month = {Feb},
	Pages = {99-111},
	Pmc = {PMC2694135},
	Pmid = {19250197},
	Pst = {ppublish},
	Title = {Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen},
	Volume = {1155},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1111/j.1749-6632.2009.04114.x}}

@article{Rochat:2005aa,
	Abstract = {Although activity of cytochrome P450 isoenzymes (CYPs) plays a major role in the fate of anticancer agents in patients, there are relatively few clinical studies that evaluate drug metabolism with therapeutic outcome. Nevertheless, many clinical reports in various non-oncology fields have shown the dramatic importance of CYP activity in therapeutic efficacy, safety and interindividual variability of drug pharmacokinetics. Moreover, variability of drug metabolism in the liver as well as in cancer cells must also be considered as a potential factor mediating cancer resistance. This review underlines the role of drug metabolism mediated by CYPs in pharmacokinetic variability, drug resistance and safety. As examples, biotransformation pathways of tamoxifen, paclitaxel and imatinib are reviewed. This review emphasises the key role of therapeutic drug monitoring as a complementary tool of investigation to in vitro data. For instance, pharmacokinetic data of anticancer agents have not often been published within subpopulations of patients who show ultra-rapid, extensive or poor metabolism (e.g. due to CYP2D6 and CYP2C19 genotypes). Besides kinetic variability in the systemic circulation, induction of CYP activity may participate in creating drug resistance by speeding up the cancer agent degradation specifically in the target cells. For one cancer agent, various mechanisms of resistance are usually identified within different cell clones. This review also tries to emphasise that drug resistance mediated by CYP activity in cancer cells should be taken into consideration to a greater degree. The unequivocal identification of the metabolising enzymes involved in clinical conditions will eventually allow improvement and individualisation of anticancer agent therapy, i.e. drug dosage and selection. In addition, a more complete understanding of the metabolism of anticancer agents will assist in the prediction of drug-drug interactions, as anticancer agent combinations are becoming more prevalent.},
	Author = {Rochat, B},
	Date-Added = {2011-04-15 19:02:14 +0200},
	Date-Modified = {2011-04-15 19:02:28 +0200},
	Journal = {Clin Pharmacokinet},
	Journal-Full = {Clinical pharmacokinetics},
	Mesh = {Antineoplastic Agents; Biotransformation; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Drug Resistance, Neoplasm; Humans; Isoenzymes; Neoplasms; Paclitaxel; Piperazines; Polymorphism, Genetic; Pyrimidines; Tamoxifen},
	Number = {4},
	Pages = {349-66},
	Pmid = {15828850},
	Pst = {ppublish},
	Title = {Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism},
	Volume = {44},
	Year = {2005}}

@article{Lynch:2007aa,
	Abstract = {Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most significant enzymes being CYP3A4 and CYP2D6. Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes, including beta blockers and antidepressants. Cytochrome P450 enzymes can be inhibited or induced by drugs, resulting in clinically significant drug-drug interactions that can cause unanticipated adverse reactions or therapeutic failures. Interactions with warfarin, antidepressants, antiepileptic drugs, and statins often involve the cytochrome P450 enzymes. Knowledge of the most important drugs metabolized by cytochrome P450 enzymes, as well as the most potent inhibiting and inducing drugs, can help minimize the possibility of adverse drug reactions and interactions. Although genotype tests can determine if a patient has a specific enzyme polymorphism, it has not been determined if routine use of these tests will improve outcomes.},
	Author = {Lynch, T and Price, A},
	Date-Added = {2011-04-15 18:16:14 +0200},
	Date-Modified = {2011-04-15 18:16:26 +0200},
	Journal = {Am Fam Physician},
	Journal-Full = {American family physician},
	Mesh = {Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic},
	Month = {Aug},
	Number = {3},
	Pages = {391-6},
	Pmid = {17708140},
	Pst = {ppublish},
	Title = {The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects},
	Volume = {76},
	Year = {2007}}

@article{Sauro:2003vn,
	Abstract = {Researchers in quantitative systems biology make use of a large number of different software packages for modelling, analysis, visualization, and general data manipulation. In this paper, we describe the Systems Biology Workbench (SBW), a software framework that allows heterogeneous application components--written in diverse programming languages and running on different platforms--to communicate and use each others' capabilities via a fast binary encoded-message system. Our goal was to create a simple, high performance, opensource software infrastructure which is easy to implement and understand. SBW enables applications (potentially running on separate, distributed computers) to communicate via a simple network protocol. The interfaces to the system are encapsulated in client-side libraries that we provide for different programming languages. We describe in this paper the SBW architecture, a selection of current modules, including Jarnac, JDesigner, and SBWMeta-tool, and the close integration of SBW into BioSPICE, which enables both frameworks to share tools and compliment and strengthen each others capabilities.},
	Author = {Sauro, H M and Hucka, M and Finney, A and Wellock, C and Bolouri, H and Doyle, J and Kitano, H},
	Date-Added = {2011-04-15 15:48:22 +0200},
	Date-Modified = {2011-04-15 16:07:10 +0200},
	Doi = {10.1089/153623103322637670},
	Journal = {OMICS},
	Journal-Full = {Omics : a journal of integrative biology},
	Mesh = {Biochemical Phenomena; Biochemistry; Computer Simulation; Computer Systems; Models, Biological; Software; Systems Theory},
	Number = {4},
	Pages = {355-72},
	Pmid = {14683609},
	Pst = {ppublish},
	Title = {Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration},
	Volume = {7},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1089/153623103322637670}}

@article{Hoops:2006kx,
	Abstract = {Simulation and modeling is becoming a standard approach to understand complex biochemical processes. Therefore, there is a big need for software tools that allow access to diverse simulation and modeling methods as well as support for the usage of these methods.},
	Author = {Hoops, S and Sahle, S and Gauges, R and Lee, C and Pahle, J and Simus, N and Singhal, M and Xu, L and Mendes, P and Kummer, U},
	Date-Added = {2011-04-15 15:43:27 +0200},
	Date-Modified = {2011-04-15 16:11:22 +0200},
	Doi = {10.1093/bioinformatics/btl485},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Algorithms; Computer Graphics; Computer Simulation; Models, Biological; Programming Languages; Protein Interaction Mapping; Proteome; Signal Transduction; Software; User-Computer Interface},
	Month = {Dec},
	Number = {24},
	Pages = {3067-74},
	Pmid = {17032683},
	Pst = {ppublish},
	Title = {COPASI--a COmplex PAthway SImulator},
	Volume = {22},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/btl485}}

@article{Olivier:2005uq,
	Abstract = { The Python Simulator for Cellular Systems (PySCeS) is an extendable research tool for the numerical analysis and investigation of cellular systems. AVAILABILITY: PySCeS is distributed as Open Source Software under the GNU General Public Licence and is available for download from http://pysces.sourceforge.net CONTACT: bgoli@sun.ac.za.},
	Author = {Olivier, BG and Rohwer, JM and Hofmeyr, JHS},
	Date-Added = {2011-04-15 15:42:26 +0200},
	Date-Modified = {2011-04-15 16:12:57 +0200},
	Doi = {10.1093/bioinformatics/bti046},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Cell Physiological Phenomena; Computer Simulation; Models, Biological; Numerical Analysis, Computer-Assisted; Programming Languages; Software},
	Month = {Feb},
	Number = {4},
	Pages = {560-1},
	Pmid = {15454409},
	Pst = {ppublish},
	Title = {Modelling cellular systems with PySCeS},
	Volume = {21},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/bti046}}

@article{Lupi:2004fk,
	Abstract = {Topotecan (TPT) is a topoisomerase I inhibitor, and like the other drugs of this family, it is believed to act in a specific way on cells in S phase at the time of treatment. Exploiting a new method, coupling a particular experimental plan with computer simulation, a complete quantitative study of the time dependence and dose dependence of the activity of cell cycle controls has become feasible, and the overall scenario of events after treatment can be reconstructed in detail. We were able to demonstrate that the response of an ovarian cancer cell line to 1 h of treatment with TPT is not limited to inhibition of DNA synthesis, leading to cell death, but involves G(1) and G(2)-M checkpoints. G(1) and G(2)-M block, recycling, and death follow specific dose-dependent kinetics, lasting no less than 3 days after treatment. We also found that cells treated outside S phase contribute significantly to the overall activity. The utility of this analysis was demonstrated by reproducing more complex treatment schemes in which low TPT concentrations were applied for 1 h three times at 24-h intervals. In this case, the simulation clarified the origin of the auto-potentiation observed with repeated 0.2 micro M treatments, in which the cytotoxicity, particularly against S-phase cells, was higher than the cytotoxicity in cells treated with 10 micro M only once. We believe that this approach will help us to understand the complexity and heterogeneity of the response of a cell population to a drug challenge and could help us to establish the rationale for drug scheduling or drug combinations.},
	Author = {Lupi, M and Matera, G and Branduardi, D and D'Incalci, M and Ubezio, P},
	Date-Added = {2011-04-14 18:48:55 +0200},
	Date-Modified = {2011-04-15 16:05:09 +0200},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Antineoplastic Agents; Cell Division; Cell Line, Tumor; Computer Simulation; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Flow Cytometry; G1 Phase; Humans; Mitosis; Models, Biological; Ovarian Neoplasms; S Phase; Topotecan},
	Month = {Apr},
	Number = {8},
	Pages = {2825-32},
	Pmid = {15087399},
	Pst = {ppublish},
	Title = {Cytostatic and cytotoxic effects of topotecan decoded by a novel mathematical simulation approach},
	Volume = {64},
	Year = {2004}}

@article{Rostami-Hodjegan:2007qf,
	Abstract = {The perceived failure of new drug development has been blamed on deficiencies in in vivo studies of drug efficacy and safety. Prior simulation of the potential exposure of different individuals to a given dose might help to improve the design of such studies. This should also help researchers to focus on the characteristics of individuals who present with extreme reactions to therapy. An effort to build virtual populations using extensive demographic, physiological, genomic and in vitro biochemical data to simulate and predict drug disposition from routinely collected in vitro data is outlined.},
	Author = {Rostami-Hodjegan, A and Tucker, G},
	Date-Added = {2011-04-14 15:46:10 +0200},
	Date-Modified = {2011-04-15 16:02:46 +0200},
	Doi = {10.1038/nrd2173},
	Journal = {Nat Rev Drug Discov},
	Journal-Full = {Nature reviews. Drug discovery},
	Mesh = {Animals; Computer Simulation; Humans; Liver; Models, Biological; Pharmaceutical Preparations},
	Month = {Feb},
	Number = {2},
	Pages = {140-8},
	Pmid = {17268485},
	Pst = {ppublish},
	Title = {Simulation and prediction of in vivo drug metabolism in human populations from in vitro data},
	Volume = {6},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrd2173}}

@article{BioModels2010,
	Author = {Li, Chen and Donizelli, Marco and Rodriguez, Nicolas and Dharuri, Harish and Endler, Lukas and Chelliah, Vijayalakshmi and Li, Lu and He, Enuo and Henry, Arnaud and Stefan, Melanie I. and Snoep, Jacky L. and Hucka, Michael and Le Nov{\`e}re, Nicolas and Laibe, Camille},
	Journal = {BMC Systems Biology},
	Month = {Jun},
	Pages = {92},
	Pmid = {20587024},
	Title = {{BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models.}},
	Volume = {4},
	Year = {2010}}

@article{Le-Novere:2006ve,
	Abstract = {BioModels Database (http://www.ebi.ac.uk/biomodels/), part of the international initiative BioModels.net, provides access to published, peer-reviewed, quantitative models of biochemical and cellular systems. Each model is carefully curated to verify that it corresponds to the reference publication and gives the proper numerical results. Curators also annotate the components of the models with terms from controlled vocabularies and links to other relevant data resources. This allows the users to search accurately for the models they need. The models can currently be retrieved in the SBML format, and import/export facilities are being developed to extend the spectrum of formats supported by the resource.},
	Author = {Le Nov{\`e}re, N and Bornstein, B and Broicher, A and Courtot, M and Donizelli, M and Dharuri, H and Li, L and Sauro, H and Schilstra, M and Shapiro, B and Snoep, J L and Hucka, M},
	Date-Added = {2011-04-14 15:44:41 +0200},
	Date-Modified = {2011-04-15 16:01:30 +0200},
	Doi = {10.1093/nar/gkj092},
	Journal = {Nucleic Acids Res},
	Journal-Full = {Nucleic acids research},
	Mesh = {Biochemical Phenomena; Cell Physiological Phenomena; Databases, Factual; Genes; Internet; Kinetics; Models, Biological; User-Computer Interface; Vocabulary, Controlled},
	Month = {Jan},
	Number = {Database issue},
	Pages = {D689-91},
	Pmc = {PMC1347454},
	Pmid = {16381960},
	Pst = {ppublish},
	Title = {BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems},
	Volume = {34},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/nar/gkj092}}

@article{Olivier:2004ly,
	Abstract = {JWS Online is a repository of kinetic models, describing biological systems, which can be interactively run and interrogated over the Internet. It is implemented using a client-server strategy where the clients, in the form of web browser based Java applets, act as a graphical interface to the model servers, which perform the required numerical computations. AVAILABILITY: The JWS Online website is publicly accessible at http://jjj.biochem.sun.ac.za/ with mirrors at http://www.jjj.bio.vu.nl/ and http://jjj.vbi.vt.edu/},
	Author = {Olivier, BG and Snoep, JL},
	Date-Added = {2011-04-14 15:43:39 +0200},
	Date-Modified = {2011-04-15 16:18:31 +0200},
	Doi = {10.1093/bioinformatics/bth200},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Cell Physiological Phenomena; Computer Simulation; Databases, Factual; Information Storage and Retrieval; Internet; Kinetics; Metabolism; Models, Biological; Online Systems; Signal Transduction; User-Computer Interface},
	Month = {Sep},
	Number = {13},
	Pages = {2143-4},
	Pmid = {15072998},
	Pst = {ppublish},
	Title = {Web-based kinetic modelling using JWS Online},
	Volume = {20},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/bth200}}

@article{Dayneka:1993zr,
	Abstract = {Four basic models for characterizing indirect pharmacodynamic responses after drug administration have been developed and compared. The models are based on drug effects (inhibition or stimulation) on the factors controlling either the input or the dissipation of drug response. Pharmacokinetic parameters of methylprednisolone were used to generate plasma concentration and response-time profiles using computer simulations. It was found that the responses produced showed a slow onset and a slow return to baseline. The time of maximal response was dependent on the model and dose. In each case, hysteresis plots showed that drug concentrations preceded the response. When the responses were fitted with pharmacodynamic models based on distribution to a hypothetical effect compartment, the resulting parameters were dose-dependent and inferred biological implausibility. Indirect response models must be treated as distinct from conventional pharmacodynamic models which assume direct action of drugs. The assumptions, equations, and data patterns for the four basic indirect response models provide a starting point for evaluation of pharmacologic effects where the site of action precedes or follows the measured response variable.},
	Author = {Dayneka, N L and Garg, V and Jusko, W J},
	Date-Added = {2011-04-14 15:42:01 +0200},
	Date-Modified = {2011-04-14 15:42:01 +0200},
	Journal = {J Pharmacokinet Biopharm},
	Journal-Full = {Journal of pharmacokinetics and biopharmaceutics},
	Mesh = {Humans; Infusions, Intravenous; Methylprednisolone; Models, Theoretical},
	Month = {Aug},
	Number = {4},
	Pages = {457-78},
	Pmid = {8133465},
	Pst = {ppublish},
	Title = {Comparison of four basic models of indirect pharmacodynamic responses},
	Volume = {21},
	Year = {1993}}

@article{Beal:2001,
	Abstract = {Four basic models for characterizing indirect pharmacodynamic responses after drug administration have been developed and compared. The models are based on drug effects (inhibition or stimulation) on the factors controlling either the input or the dissipation of drug response. Pharmacokinetic parameters of methylprednisolone were used to generate plasma concentration and response-time profiles using computer simulations. It was found that the responses produced showed a slow onset and a slow return to baseline. The time of maximal response was dependent on the model and dose. In each case, hysteresis plots showed that drug concentrations preceded the response. When the responses were fitted with pharmacodynamic models based on distribution to a hypothetical effect compartment, the resulting parameters were dose-dependent and inferred biological implausibility. Indirect response models must be treated as distinct from conventional pharmacodynamic models which assume direct action of drugs. The assumptions, equations, and data patterns for the four basic indirect response models provide a starting point for evaluation of pharmacologic effects where the site of action precedes or follows the measured response variable.},
	Author = {Beal, Stuart L.},
	Date-Added = {2011-04-14 15:42:01 +0200},
	Date-Modified = {2013-08-05 16:55:43 +0100},
	Journal = {Journal of Pharmacokinetics and Pharmacodynamics},
	Journal-Full = {Journal of Pharmacokinetics and Pharmacodynamics},
	Month = {Oct},
	Number = {5},
	Pages = {481-504},
	Title = {Ways to Fit a PK Model with Some Data Below the Quantification Limit},
	Volume = {28},
	Year = {2001}}

@article{Gardner:2002ys,
	Abstract = {Predicting and tailoring optimal cancer treatments presents a major challenge.},
	Author = {Gardner, SN},
	Date-Added = {2011-04-14 15:12:07 +0200},
	Date-Modified = {2011-04-15 16:17:12 +0200},
	Doi = {10.1006/jtbi.2001.2459},
	Journal = {J Theor Biol},
	Journal-Full = {Journal of theoretical biology},
	Mesh = {Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Computational Biology; Computer Simulation; Decision Making, Computer-Assisted; Drug Administration Schedule; Humans; Neoplasms; Patient Care Planning},
	Month = {Jan},
	Number = {2},
	Pages = {181-207},
	Pmid = {11812172},
	Pst = {ppublish},
	Title = {Modeling multi-drug chemotherapy: tailoring treatment to individuals},
	Volume = {214},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1006/jtbi.2001.2459}}

@article{Gardner:2003vn,
	Abstract = {Computational models of cancer chemotherapy have the potential to streamline clinical trial design, contribute to the design of rational, tailored treatments, and facilitate our understanding of experimental results. Mechanistic models based on functional data from tumor biopsies will enable physicians to predict response to treatment for a specific patient, in contrast to statistical models in which the probability of response for a given patient may differ substantially from the population average. While microarray analyses of gene expression also show promise for guiding individualized treatments, it may be difficult to link statistical mining of microarray data with mechanistic, tailored treatments. Furthermore, gene expression does not identify how drugs should be scheduled. This review summarizes mechanistic mathematical models developed to improve the design of chemotherapy regimens. Mechanistic models that incorporate both genetic resistance and cell cycle-mediated resistance during treatment with multiple drugs will be most useful in designing treatment regimens tailored for individuals. Because there are already a number of papers that address the applications of microarray technology, we will limit our discussion to the contrasts between mechanistic computational models and microarray technology, and how these two approaches may complement one another.},
	Author = {Gardner, SN and Fernandes, M},
	Date-Added = {2011-04-14 15:11:41 +0200},
	Date-Modified = {2011-04-15 16:17:21 +0200},
	Journal = {Mol Cancer Ther},
	Journal-Full = {Molecular cancer therapeutics},
	Mesh = {Drug Resistance, Neoplasm; Humans; Kinetics; Neoplasm Metastasis; Neoplasms; Oligonucleotide Array Sequence Analysis; Software},
	Month = {Oct},
	Number = {10},
	Pages = {1079-84},
	Pmid = {14578473},
	Pst = {ppublish},
	Title = {New tools for cancer chemotherapy: computational assistance for tailoring treatments},
	Volume = {2},
	Year = {2003}}

@article{Ubezio:2008kx,
	Abstract = {Despite the recent development of technologies giving detailed images of tumours in vivo, direct or indirect ways to measure how many cells are actually killed by a treatment or are resistant to it are still beyond our reach.},
	Author = {Ubezio, P and Cameron, D},
	Date-Added = {2011-04-14 15:05:33 +0200},
	Date-Modified = {2011-04-15 16:12:37 +0200},
	Doi = {10.1186/1471-2407-8-201},
	Journal = {BMC Cancer},
	Journal-Full = {BMC cancer},
	Mesh = {Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Female; Humans; Ki-67 Antigen; Models, Biological; Neoplasm Regression, Spontaneous; Treatment Outcome},
	Pages = {201},
	Pmc = {PMC2496916},
	Pmid = {18644111},
	Pst = {epublish},
	Title = {Cell killing and resistance in pre-operative breast cancer chemotherapy},
	Volume = {8},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1471-2407-8-201}}

@article{Simeoni:2004uq,
	Abstract = {The available mathematical models describing tumor growth and the effect of anticancer treatments on tumors in animals are of limited use within the drug industry. A simple and effective model would allow applying quantitative thinking to the preclinical development of oncology drugs. In this article, a minimal pharmacokinetic-pharmacodynamic model is presented, based on a system of ordinary differential equations that link the dosing regimen of a compound to the tumor growth in animal models. The growth of tumors in nontreated animals is described by an exponential growth followed by a linear growth. In treated animals, the tumor growth rate is decreased by a factor proportional to both drug concentration and number of proliferating tumor cells. A transit compartmental system is used to model the process of cell death, which occurs at later times. The parameters of the pharmacodynamic model are related to the growth characteristics of the tumor, to the drug potency, and to the kinetics of the tumor cell death. Therefore, such parameters can be used for ranking compounds based on their potency and for evaluating potential differences in the tumor cell death process. The model was extensively tested on discovery candidates and known anticancer drugs. It fitted well the experimental data, providing reliable parameter estimates. On the basis of the parameters estimated in a first experiment, the model successfully predicted the response of tumors exposed to drugs given at different dose levels and/or schedules. It is, thus, possible to use the model prospectively, optimizing the design of new experiments.},
	Author = {Simeoni, M and Magni, P and Cammia, C and De Nicolao, G and Croci, V and Pesenti, E and Germani, M and Poggesi, I and Rocchetti, M},
	Date-Added = {2011-04-14 15:03:15 +0200},
	Date-Modified = {2011-04-15 16:00:22 +0200},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Antineoplastic Agents; Camptothecin; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Female; Fluorouracil; HCT116 Cells; Humans; Models, Biological; Ovarian Neoplasms; Paclitaxel},
	Month = {Feb},
	Number = {3},
	Pages = {1094-101},
	Pmid = {14871843},
	Pst = {ppublish},
	Title = {Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents},
	Volume = {64},
	Year = {2004}}

@article{Sparacino:2002fk,
	Abstract = {Deconvolution allows the reconstruction of non-accessible inputs (e.g. hormone secretion rate) from their causally-related measurable effects (e.g. hormone plasma concentration). Deconvolution is challenging under several aspects both general (e.g. determination of a suitable trade-off between data fit and solution smoothness in order to contrast ill-conditioning, assessment of the confidence intervals) as well as specific of physiological systems (e.g. non-uniform and infrequent data sampling). Recently, a stochastic regularization approach has been proposed and validated to handle these difficulties (De Nicolao et al., Automatica 33 (1997) 851-870). In this paper, an interactive program, WINSTODEC, is presented to allow the clinical investigator to easily obtain the solution of a deconvolution problem by this approach.},
	Author = {Sparacino, G and Pillonetto, G and Capello, M and De Nicolao, G and Cobelli, C},
	Date-Added = {2011-04-14 14:57:19 +0200},
	Date-Modified = {2011-04-15 16:03:29 +0200},
	Journal = {Comput Methods Programs Biomed},
	Journal-Full = {Computer methods and programs in biomedicine},
	Mesh = {Humans; Pharmacokinetics; Physiological Phenomena; Software; Stochastic Processes},
	Month = {Jan},
	Number = {1},
	Pages = {67-77},
	Pmid = {11750948},
	Pst = {ppublish},
	Title = {WINSTODEC: a stochastic deconvolution interactive program for physiological and pharmacokinetic systems},
	Volume = {67},
	Year = {2002}}

@article{Fowler:2007mj,
	Author = {Fowler, MJ},
	Date-Added = {2011-04-14 12:48:21 +0200},
	Date-Modified = {2011-04-14 12:49:24 +0200},
	Journal = {Clinical Diabetes},
	Pages = {105-109},
	Title = {Diabetes Treatment, Part 1: Diet and Exercise},
	Volume = {25},
	Year = {2007}}

@article{Lehmann:1992ff,
	Abstract = {A clinical model of glucose-insulin interaction in insulin-dependent diabetes mellitus has been developed for patient and medical staff education. The model attempts to reflect the underlying (patho)physiology of insulin action and carbohydrate absorption in quantitative terms such as insulin sensitivity, volume of glucose and insulin distribution and maximal rate of gastric emptying. The model's predictions also allow a 24 h simulation of patient blood glucose profiles to be generated. A description of the model is provided and its operation illustrated by clinical case studies of insulin-treated diabetic patients. The possible use of the model as a tool for automated insulin dosage adjustment is explored.},
	Author = {Lehmann, E D and Deutsch, T},
	Date-Added = {2011-04-14 12:47:37 +0200},
	Date-Modified = {2011-04-14 12:47:37 +0200},
	Journal = {J Biomed Eng},
	Journal-Full = {Journal of biomedical engineering},
	Mesh = {Blood Glucose; Computer Simulation; Diabetes Mellitus, Type 1; Dietary Carbohydrates; Humans; Insulin; Models, Biological},
	Month = {May},
	Number = {3},
	Pages = {235-42},
	Pmid = {1588781},
	Pst = {ppublish},
	Title = {A physiological model of glucose-insulin interaction in type 1 diabetes mellitus},
	Volume = {14},
	Year = {1992}}

@article{Dinesen:2006pi,
	Abstract = {We carried out a qualitative evaluation of the implementation of a computerized diabetes advisory system, DiasNet. Three patients with insulin-dependent diabetes used the system. The methodological frame of reference was the case study. Qualitative interviews were conducted with patients. In addition, 10 qualitative interviews were conducted with health-care professionals and one focus group interview was held. The study lasted for six months. The results showed that patients experienced greater confidence and a more personal rapport with the staff. DiasNet brought about changes in the tasks and duties performed by all professional groups in the diabetes team. From the perspective of the diabetes team, email facilitated a dialogue between the patient and the diabetes team which was independent of time and place.},
	Author = {Dinesen, B and Andersen, PER},
	Date-Added = {2011-04-14 12:47:15 +0200},
	Date-Modified = {2011-04-15 16:15:39 +0200},
	Doi = {10.1258/135763306776084329},
	Journal = {J Telemed Telecare},
	Journal-Full = {Journal of telemedicine and telecare},
	Mesh = {Attitude of Health Personnel; Attitude to Health; Diabetes Mellitus, Type 1; Electronic Mail; Evaluation Studies as Topic; Humans; Internet; Male; Middle Aged; Professional-Patient Relations; Remote Consultation},
	Number = {2},
	Pages = {71-4},
	Pmid = {16539752},
	Pst = {ppublish},
	Title = {Qualitative evaluation of a diabetes advisory system, DiasNet},
	Volume = {12},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1258/135763306776084329}}

@article{Swat:2011sb,
	Author = {Swat, M and Kie{\l}basa, SM and Polak, S and Olivier, B and Bruggeman, FJ and Tulloch, MQ and Snoep, JL and Verhoeven, AJ and Westerhoff, HV},
	Date-Added = {2011-04-14 12:42:23 +0200},
	Date-Modified = {2011-04-14 12:46:09 +0200},
	Journal = {Interface Focus},
	Number = {1},
	Pages = {16-23},
	Title = {What it takes to understand and cure a living system: computational systems biology and a systems biology-driven pharmacokinetics--pharmacodynamics platform},
	Volume = {1},
	Year = {2011}}

@phdthesis{Sorensen:1985,
	Author = {Sorensen, JT},
	Date-Added = {2011-04-14 12:40:47 +0200},
	Date-Modified = {2011-04-14 12:42:18 +0200},
	Rating = {5},
	School = {Massachusetts Institute of Technology},
	Title = {A Physiologic Model of Glucose Metabolism in Man and Its Use to Design and Assess Improved Insulin Therapies for Diabetes},
	Year = {1985}}

@article{Agar:2005mi,
	Abstract = {GLUCOSIM is an educational software package that simulates blood glucose and insulin dynamics in healthy individuals and patients with type 1 diabetes. It is being used to assist biomedical and chemical engineering students in visualizing the dynamic variations in blood glucose concentration in response to external variations such as food consumption and insulin administration. A nutritional database has been integrated to GLUCOSIM to provide meal inputs to the simulation. The simulator has been improved by the modification of mathematical models, and it has been adapted to include currently available commercial insulin brands.},
	Author = {Agar, B and Eren, M and Cinar, A},
	Date-Added = {2011-04-14 12:33:33 +0200},
	Date-Modified = {2011-04-15 16:04:21 +0200},
	Doi = {10.1109/IEMBS.2005.1616547},
	Journal = {Conf Proc IEEE Eng Med Biol Soc},
	Journal-Full = {Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference},
	Pages = {845-8},
	Pmid = {17282316},
	Pst = {ppublish},
	Title = {Glucosim: educational software for virtual experiments with patients with type 1 diabetes},
	Volume = {1},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1109/IEMBS.2005.1616547}}

@article{Dalla-Man:2007qa,
	Abstract = {A simulation model of the glucose-insulin system in the postprandial state can be useful in several circumstances, including testing of glucose sensors, insulin infusion algorithms and decision support systems for diabetes. Here, we present a new simulation model in normal humans that describes the physiological events that occur after a meal, by employing the quantitative knowledge that has become available in recent years. Model parameters were set to fit the mean data of a large normal subject database that underwent a triple tracer meal protocol which provided quasi-model-independent estimates of major glucose and insulin fluxes, e.g., meal rate of appearance, endogenous glucose production, utilization of glucose, insulin secretion. By decomposing the system into subsystems, we have developed parametric models of each subsystem by using a forcing function strategy. Model results are shown in describing both a single meal and normal daily life (breakfast, lunch, dinner) in normal. The same strategy is also applied on a smaller database for extending the model to type 2 diabetes.},
	Author = {Dalla Man, C and Rizza, RA and Cobelli, C},
	Date-Added = {2011-04-14 12:33:16 +0200},
	Date-Modified = {2011-04-15 16:09:32 +0200},
	Doi = {10.1109/TBME.2007.893506},
	Journal = {IEEE Trans Biomed Eng},
	Journal-Full = {IEEE transactions on bio-medical engineering},
	Mesh = {Computer Simulation; Diabetes Mellitus, Type 2; Female; Glucose; Homeostasis; Humans; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Postprandial Period},
	Month = {Oct},
	Number = {10},
	Pages = {1740-9},
	Pmid = {17926672},
	Pst = {ppublish},
	Title = {Meal simulation model of the glucose-insulin system},
	Volume = {54},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1109/TBME.2007.893506}}

@article{Dalla-Man:2007kl,
	Abstract = {A simulation model of the glucose-insulin system in normal life conditions can be very useful in diabetes research, e.g., testing insulin infusion algorithms and decision support systems and assessing glucose sensor performance and patient and student training. A new meal simulation model has been proposed that incorporates state-of-the-art quantitative knowledge on glucose metabolism and its control by insulin at both organ/tissue and whole-body levels. This article presents the interactive simulation software GIM (glucose insulin model), which implements this model.},
	Author = {Dalla Man, Ch and Raimondo, D M and Rizza, R A and Cobelli, C},
	Date-Added = {2011-04-14 12:32:50 +0200},
	Date-Modified = {2011-04-15 16:08:01 +0200},
	Journal = {J Diabetes Sci Technol},
	Journal-Full = {Journal of diabetes science and technology},
	Month = {May},
	Number = {3},
	Pages = {323-30},
	Pmc = {PMC2769591},
	Pmid = {19885087},
	Pst = {ppublish},
	Title = {GIM, simulation software of meal glucose-insulin model},
	Volume = {1},
	Year = {2007}}

@article{Charles:2001fu,
	Abstract = {Computer assisted learning has an important role in the teaching of pharmacokinetics to health sciences students because it transfers the emphasis from the purely mathematical domain to an 'experiential' domain in which graphical and symbolic representations of actions and their consequences form the major focus for learning. Basic pharmacokinetic concepts can be taught by experimenting with the interplay between dose and dosage interval with drug absorption (e.g. absorption rate, bioavailability), drug distribution (e.g. volume of distribution, protein binding) and drug elimination (e.g. clearance) on drug concentrations using library ('canned') pharmacokinetic models.

Such 'what if' approaches are found in calculator-simulators such as PharmaCalc, Practical Pharmacokinetics and PK Solutions. Others such as SAAM II, ModelMaker, and Stella represent the 'systems dynamics' genre, which requires the user to conceptualise a problem and formulate the model on-screen using symbols, icons, and directional arrows.

The choice of software should be determined by the aims of the subject/course, the experience and background of the students in pharmacokinetics, and institutional factors including price and networking capabilities of the package(s). Enhanced learning may result if the computer teaching of pharmacokinetics is supported by tutorials, especially where the techniques are applied to solving problems in which the link with healthcare practices is clearly established.},
	Address = {41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND},
	Author = {Charles, BG and Duffull, SB},
	Date-Added = {2011-04-14 12:32:28 +0200},
	Date-Modified = {2011-04-14 12:32:28 +0200},
	Isi = {000169996200001},
	Isi-Recid = {120828807},
	Isi-Ref-Recids = {66666871 62035553 84631139 28819387 68471638 70241278 88705569 120828808 103420339 113432054 120828809 83915508 84957405 120828810},
	Journal = {Clinical Pharmacokinetics},
	Number = {6},
	Pages = {395--403},
	Publisher = {ADIS INTERNATIONAL LTD},
	Times-Cited = {3},
	Title = {Pharmacokinetic software for the health sciences - Choosing the right package for teaching purposes},
	Volume = {40},
	Year = {2001},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000169996200001}}

@article{Hovorka:1996dz,
	Abstract = {ISEC (Insulin SECretion) is a computer program which calculates pre-hepatic insulin secretion from plasma C-peptide measurements. The program uses a regression (population) model to derive parameters of C-peptide kinetics from;subject's gender, type (normal, obese, non-insulin dependent diabetes mellitus), age, weight, and height. Insulin secretion is calculated as a piece-wise constant (step) function with flexible step length allowing for a fine resolution of the secretion profile between measurements. A constrained regularisation method of deconvolution is employed to carry out the calculations. The calculated profile satisfies three properties: (i) it fits the measurement within the given level of the measurement error, (ii) it is non-negative, and (iii) it has a minimum value of a regularisation criterion (norm of second differences) which quantifies the degree of deviation of the secretion profile from a straight line. Both theoretical aspects and specific features related to ISEC are considered. To exemplify the use of ISEC, pre-hepatic insulin secretion is calculated during meal tolerance test, frequently sampled intravenous glucose tolerance test, hyperinsulinaemic euglycaemic glucose clamp, and basal conditions with frequent sampling.},
	Address = {CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND},
	Author = {Hovorka, R and Soons, PA and Young, MA},
	Date-Added = {2011-04-14 12:32:14 +0200},
	Date-Modified = {2011-04-14 12:32:14 +0200},
	Isi = {A1996VJ35600006},
	Isi-Recid = {97525179},
	Isi-Ref-Recids = {84015892 64873609 51982582 36186506 93014248 84568399 97525180 40867908 65058606 97525181 84878401 88766962 97525182 92947565 48400303 58820367 81974090 83061667 42177285 38873161 10281927 79433849 85926521 63748417 70284041},
	Journal = {Computer Methods and Programs In Biomedicine},
	Keywords = {insulin secretion; deconvolution; regularisation},
	Month = aug,
	Number = {3},
	Pages = {253--264},
	Publisher = {ELSEVIER SCI IRELAND LTD},
	Times-Cited = {35},
	Title = {ISEC: A program to calculate insulin secretion},
	Type = {Proceedings Paper},
	Volume = {50},
	Year = {1996},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=A1996VJ35600006}}

@article{Toffolo:2001fv,
	Abstract = {Availability of quantitative indexes of insulin secretion is important for definition of the alterations in beta -cell responsivity to glucose associated with different physiopathological states. This is presently possible by using the intravenous glucose tolerance test (IVGTT) in conjunction with the C-peptide minimal model. However, the secretory response to a more physiological slowly increasing/decreasing glucose stimulus may uncover novel features of beta -cell function. Therefore, plasma C-peptide and glucose data from a graded glucose infusion protocol (seven 40-min periods of 0, 4, 8, 16, 8, 4, and 0 mg.kg(-1).min(-1)) in eight normal subjects were analyzed by use of a new model of insulin secretion and kinetics. The model assumes a two-compartment description of C-peptide kinetics and describes the stimulatory effect on insulin secretion of both glucose concentration and the rate at which glucose increases. It provides in each individual the insulin secretion profile and three indexes of pancreatic sensitivity to glucose: Phi (s), Phi (d), and Phi (b), related, respectively, to the control of insulin secretion by the glucose level (static control), the rate at which glucose increases (dynamic control), and basal glucose. Indexes (means +/- SE) were Phi (s) = 18.8 +/- 1.8 (10(9) min(-1)), Phi (d) = 222 +/- 30 (10(9)), and Phi (b) = 5.2 +/- 0.4 (10(9) min(-1)). The model also allows one to quantify the beta -cell times of response to increasing and decreasing glucose stimulus, equal to 5.7 +/- 2.2 (min) and 17.8 +/- 2.0 (min), respectively. In conclusion, the graded glucose infusion protocol, interpreted with a minimal model of C-peptide secretion and kinetics, provides a quantitative assessment of pancreatic function in an individual. Its application to various physiopathological states should provide novel insights into the role of insulin secretion in the development of glucose intolerance.},
	Address = {9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA},
	Author = {Toffolo, G and Breda, E and Cavaghan, MK and Ehrmann, DA and Polonsky, KS and Cobelli, C},
	Date-Added = {2011-04-14 12:31:57 +0200},
	Date-Modified = {2011-04-14 12:31:57 +0200},
	Isi = {000165908800002},
	Isi-Recid = {117862217},
	Isi-Ref-Recids = {95910849 97651648 26397419 104707556 91639523 97939216 50335509 101668629 117862218 40867908 33954940 21534748 23619583 99268013 92509178 111605003 79433849 94694584},
	Journal = {American Journal of Physiology-Endocrinology and Metabolism},
	Keywords = {insulin secretion; beta-cell sensitivity; mathematical model; kinetics},
	Month = jan,
	Number = {1},
	Pages = {E2--E10},
	Publisher = {AMER PHYSIOLOGICAL SOC},
	Times-Cited = {38},
	Title = {Quantitative indexes of beta-cell function during graded up\&down glucose infusion from C-peptide minimal models},
	Volume = {280},
	Year = {2001},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000165908800002}}

@article{Dalla-Man:2002bs,
	Abstract = {Recently, a new approach has been proposed to estimate insulin sensitivity (S-I) from an oral glucose tolerance test or a meal using an "integral equation". Here, we improve on the "integral equation" by resorting to a "differential equation" approach. The classic glucose kinetics minimal model was used with the addition of a parametric model for the rate of appearance into plasma of oral glucose (Ra). Three behavioral models of Ra were proposed: piecewise-linear (P), spline (S) and dynamic (D). All three models performed satisfactorily allowing a precise estimation of S, and a plausible reconstruction of Ra. Mean S, estimates were virtually identical: S-I(P) = 6.81 +/- 0.87 (SE); S-I(S) = 6.53 +/- 0.80; and S-I(D) = 6.62 +/- 0.79. S-I strongly correlated with the integral-equation index (1) S-I(I): r = 0.99, p < 0.01 for models D and S, and r = 0.97, p < 0.01 for P. Also, S-I compared well with insulin sensitivity estimated from intravenous glucose tolerance test in the same subjects (r = 0.75, p < 0.01; r = 0.71, p < 0.01; r = 0.73, p < 0.01, respectively, for P, S, and D models versus S-I(IVGTT)) I Finally, the novel approach allows estimation of S, from a shorter test (120 min): model P yielded S-I(R) = 7.16 +/- 1.0 (R for reduced) which correlated very well with S and (respectively, r = 0.94, p < 0.01; r = 0.95, p < 0.01) and still satisfactorily with SI-VGTT I (r = 0.77, p < 0.01).},
	Address = {345 E 47TH ST, NEW YORK, NY 10017-2394 USA},
	Author = {Dalla Man, C and Caumo, A and Cobelli, C},
	Date-Added = {2011-04-14 12:31:36 +0200},
	Date-Modified = {2011-04-14 12:31:36 +0200},
	Isi = {000174969600002},
	Isi-Recid = {124330834},
	Isi-Ref-Recids = {105333318 104707556 124330836 55702481 50335509 118029205 38745401 41625848 88232076 95777630},
	Journal = {Ieee Transactions On Biomedical Engineering},
	Keywords = {glucose kinetics; IVGTT; parameter estimation; physiological model; rate of appearance},
	Month = may,
	Number = {5},
	Pages = {419--429},
	Publisher = {IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC},
	Times-Cited = {41},
	Title = {The oral glucose minimal model: Estimation of insulin sensitivity from a meal test},
	Volume = {49},
	Year = {2002},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000174969600002}}

@article{Lorenzo:2010hc,
	Abstract = {Methods to directly measure insulin resistance are invasive, complex, and costly. Surrogate indexes derived from the oral glucose tolerance test (OGTT) have been developed, but few studies have systematically analyzed these indexes.},
	Author = {Lorenzo, C and Haffner, S M and Stanc{\'a}kov{\'a}, A and Laakso, M},
	Date-Added = {2011-04-14 12:27:37 +0200},
	Date-Modified = {2011-04-15 16:05:46 +0200},
	Doi = {10.1210/jc.2010-1144},
	Journal = {J Clin Endocrinol Metab},
	Journal-Full = {The Journal of clinical endocrinology and metabolism},
	Mesh = {Aged; Area Under Curve; Blood Glucose; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Finland; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Middle Aged; Risk Factors},
	Month = {Nov},
	Number = {11},
	Pages = {5082-90},
	Pmid = {20702522},
	Pst = {ppublish},
	Title = {Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals},
	Volume = {95},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1210/jc.2010-1144}}

@article{Kim:2007tg,
	Abstract = {A mathematical model of the whole-body metabolism is developed to predict fuel homeostasis during exercise by using hormonal control over cellular metabolic processes. The whole body model is composed of seven tissue compartments: brain, heart, liver, GI (gastrointestinal) tract, skeletal muscle, adipose tissue, and "other tissues". Each tissue compartment is described by dynamic mass balances and major cellular metabolic reactions. The glucagon-insulin controller is incorporated into the whole body model to predict hormonal changes during exercise. Moderate [150 W power output at 60\% of peak oxygen consumption (VO(2max))] exercise for 60 min was implemented by increasing ATP utilization rates in heart and skeletal muscle. Arterial epinephrine level was given as an input function, which directly affects heart and skeletal muscle metabolism and indirectly other tissues via glucagon-insulin controller. Model simulations were validated with experimental data from human exercise studies. The exercise induced changes in hormonal signals modulated metabolic flux rates of different tissues in a coordinated way to achieve glucose homeostasis, demonstrating the efficacy of hormonal control over cellular metabolic processes. From experimental measurements of whole body glucose balance and arterial substrate concentrations, this model could predict the dynamic changes of hepatic glycogenolysis and gluconeogenesis, which are not easy to measure experimentally, suggesting the higher contribution of glycogenolysis ( approximately 75\%). In addition, it could provide dynamic information on the relative contribution of carbohydrates and lipids for fuel oxidation in skeletal muscle. Model simulations indicate that external fuel supplies from other tissue/organ systems to skeletal muscle become important for prolonged exercise emphasizing the significance of interaction among tissues. In conclusion, this model can be used as a valuable complement to experimental studies due to its ability to predict what is difficult to measure directly, and usefulness to provide information about dynamic behaviors.},
	Author = {Kim, J and Saidel, GM and Cabrera, ME},
	Date-Added = {2011-04-14 12:27:16 +0200},
	Date-Modified = {2011-04-15 16:16:00 +0200},
	Doi = {10.1007/s10439-006-9201-x},
	Journal = {Ann Biomed Eng},
	Journal-Full = {Annals of biomedical engineering},
	Mesh = {Adaptation, Physiological; Computer Simulation; Energy Metabolism; Exercise; Feedback; Glucose; Homeostasis; Hormones; Humans; Models, Biological; Physical Exertion; Viscera},
	Month = {Jan},
	Number = {1},
	Pages = {69-90},
	Pmid = {17111212},
	Pst = {ppublish},
	Title = {Multi-scale computational model of fuel homeostasis during exercise: effect of hormonal control},
	Volume = {35},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10439-006-9201-x}}

@article{Eissing:2011kl,
	Abstract = {Today, in silico studies and trial simulations already complement experimental approaches in pharmaceutical R\&D and have become indispensable tools for decision making and communication with regulatory agencies. While biology is multiscale by nature, project work, and software tools usually focus on isolated aspects of drug action, such as pharmacokinetics at the organism scale or pharmacodynamic interaction on the molecular level. We present a modeling and simulation software platform consisting of PK-Sim({\textregistered}) and MoBi({\textregistered}) capable of building and simulating models that integrate across biological scales. A prototypical multiscale model for the progression of a pancreatic tumor and its response to pharmacotherapy is constructed and virtual patients are treated with a prodrug activated by hepatic metabolization. Tumor growth is driven by signal transduction leading to cell cycle transition and proliferation. Free tumor concentrations of the active metabolite inhibit Raf kinase in the signaling cascade and thereby cell cycle progression. In a virtual clinical study, the individual therapeutic outcome of the chemotherapeutic intervention is simulated for a large population with heterogeneous genomic background. Thereby, the platform allows efficient model building and integration of biological knowledge and prior data from all biological scales. Experimental in vitro model systems can be linked with observations in animal experiments and clinical trials. The interplay between patients, diseases, and drugs and topics with high clinical relevance such as the role of pharmacogenomics, drug-drug, or drug-metabolite interactions can be addressed using this mechanistic, insight driven multiscale modeling approach.},
	Author = {Eissing, T and Kuepfer, L and Becker, C and Block, M and Coboeken, K and Gaub, T and Goerlitz, L and Jaeger, J and Loosen, R and Ludewig, B and Meyer, M and Niederalt, C and Sevestre, M and Siegmund, H-U and Solodenko, J and Thelen, K and Telle, U and Weiss, W and Wendl, T and Willmann, S and Lippert, J},
	Date-Added = {2011-04-14 12:26:13 +0200},
	Date-Modified = {2011-04-15 15:59:04 +0200},
	Doi = {10.3389/fphys.2011.00004},
	Journal = {Front Physiol},
	Journal-Full = {Frontiers in physiology},
	Pages = {4},
	Pmid = {21483730},
	Pst = {epublish},
	Title = {A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks},
	Volume = {2},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.3389/fphys.2011.00004}}

@article{Farmer:2008nx,
	Abstract = {We have analysed several aspects of insulin-dependent diabetes mellitus, including the glucose metabolic system, diabetes complications, and previous and ongoing research aimed at controlling glucose in diabetic patients. An expert review of various models and control algorithms developed for the glucose homeostasis system is presented, along with an analysis of research towards the development of a polymeric insulin infusion system. Recommendations for future directions in creating a true closed-loop glucose control system are presented, including the development of multivariable models and control systems to more accurately describe and control the multi-metabolite, multi-hormonal system, as well as in-vivo assessments of implicit closed-loop control systems.},
	Address = {1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND},
	Author = {Farmer, Terry G., Jr. and Edgar, Thomas F. and Peppas, Nicholas A.},
	Date-Added = {2011-04-14 12:22:48 +0200},
	Date-Modified = {2011-04-14 12:22:48 +0200},
	Doi = {DOI 10.1211/jpp.60.1.0001},
	Isi = {000253152500001},
	Isi-Recid = {160583054},
	Isi-Ref-Recids = {160583055 160583056 11729559 160583057 71647843 24905450 150378016 44688363 44688362 55702481 72308801 18447634 146391273 118029205 111547922 25356099 37632408 45048930 111547923 117837957 160583058 90784013 147206390 126556953 160583059 118452119 160583060 93746565 160583061 66195963 76882275 75318363 35584805 113157673 24158960 57766772 153465940 160583062 35584802 150569326 94063244 82297954 67109633 37473062 160583063 120131989 44753912 136236722 124184461 27012595 160583064 48546426 143879030 132223809 118362634 110210950 66422209 136236726 160583065 154199247 152891472 54147909 71536730 118452116 120131965 108565899 160583066 117861657 148382977 135059564 114906743 137143429 160583067 142867100 136581022 115169077 114017900 108565904 87687570 127270854 154580312 153465825 56866951 103590155 121393347 24774699 78314742 67862758 72677458 133181349 151009138 27778194 38445528 160583068 36142079 142143442},
	Journal = {Journal of Pharmacy and Pharmacology},
	Month = jan,
	Number = {1},
	Pages = {1--13},
	Publisher = {PHARMACEUTICAL PRESS-ROYAL PHARMACEUTICAL SOC GREAT BRITIAN},
	Times-Cited = {5},
	Title = {The future of open- and closed-loop insulin delivery systems},
	Volume = {60},
	Year = {2008},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000253152500001},
	Bdsk-Url-2 = {http://dx.doi.org/10.1211/jpp.60.1.0001}}

@article{Calzone:2008cr,
	Abstract = {We present, here, a detailed and curated map of molecular interactions taking place in the regulation of the cell cycle by the retinoblastoma protein (RB/RB1). Deregulations and/or mutations in this pathway are observed in most human cancers. The map was created using Systems Biology Graphical Notation language with the help of CellDesigner 3.5 software and converted into BioPAX 2.0 pathway description format. In the current state the map contains 78 proteins, 176 genes, 99 protein complexes, 208 distinct chemical species and 165 chemical reactions. Overall, the map recapitulates biological facts from approximately 350 publications annotated in the diagram. The network contains more details about RB/E2F interaction network than existing large-scale pathway databases. Structural analysis of the interaction network revealed a modular organization of the network, which was used to elaborate a more summarized, higher-level representation of RB/E2F network. The simplification of complex networks opens the road for creating realistic computational models of this regulatory pathway.},
	Address = {75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA},
	Author = {Calzone, L and Gelay, A and Zinovyev, A and Radvanyi, F and Barillot, E},
	Date-Added = {2011-04-14 12:22:32 +0200},
	Date-Modified = {2011-04-15 16:12:12 +0200},
	Doi = {DOI 10.1038/msb.2008.7},
	Isi = {000254643000009},
	Isi-Recid = {161690089},
	Isi-Ref-Recids = {87995114 142426871 128009539 131651347 136122885 145135237 143937845 125780361 135065486 137480473 151904681 124065937 125394968 128610446 128610434 88362110 142159445 142855242 113441920 145723287 150091409 155750969 19722198 102206745 111416002 151472735 128392663 145875085 147759438 136695327 143360624 129230975 145513794 136092129 96729224 113776877 154200707 121372817 120371743 118545081 122481517 119524850 120875975 157096151 153973027 154312699 124658670 103034430 134696077 126077028 124429258 153543315 153354027 137523682 114284630 131901245 126624962 127023733 127064653 153413520 147016233 118684503 147475580 102905196 114708130 129761855 142159444 91180055 161690090 161690091},
	Journal = {Molecular Systems Biology},
	Keywords = {cell-cycle regulation; E2F; RB pathway; RB1; systems-biology standards},
	Month = mar,
	Pages = {173},
	Publisher = {NATURE PUBLISHING GROUP},
	Times-Cited = {13},
	Title = {A comprehensive modular map of molecular interactions in RB/E2F pathway},
	Volume = {4},
	Year = {2008},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000254643000009},
	Bdsk-Url-2 = {http://dx.doi.org/10.1038/msb.2008.7}}

@article{Christopher:2004dq,
	Abstract = {Using the Diagrammatic Cell Language(TM), Gene Network Sciences (GNS) has created a network model of interconnected signal transduction pathways and gene expression networks that control human cell proliferation and apoptosis. It includes receptor activation and mitogenic signaling, initiation of cell cycle, and passage of checkpoints and apoptosis. Time-course experiments measuring mRNA abundance and protein activity are conducted on Caco-2 and HCT 116 colon cell lines. These data were used to constrain unknown regulatory interactions and kinetic parameters via sensitivity analysis and parameter optimization methods contained in the DigitalCell(TM) computer simulation platform. FACS, RNA knockdown, cell growth, and apoptosis data are also used to constrain the model and to identify unknown pathways, and cross talk between known pathways will also be discussed. Using the cell simulation, GNS tested the efficacy of various drug targets and performed validation experiments to test computer simulation predictions. The simulation is a powerful tool that can in principle incorporate patient-specific data on the DNA, RNA, and protein levels for assessing efficacy of therapeutics in specific patient populations and can greatly impact success of a given therapeutic strategy.},
	Address = {2 EAST 63RD ST, NEW YORK, NY 10021 USA},
	Author = {Christopher, R and Dhiman, A and Fox, J and Gendelman, R and Haberitcher, T and Kagle, D and Spizz, G and Khalil, IG and Hill, C},
	Date-Added = {2011-04-14 12:22:13 +0200},
	Date-Modified = {2011-04-14 12:22:13 +0200},
	Doi = {DOI 10.1196/annals.1310.014},
	Isi = {000222177400013},
	Isi-Recid = {135235427},
	Isi-Ref-Recids = {135235428 123648593 120436166 100059558 128677782 121195633 118678102 128582650 120141916 109858444 135235429 131528522 116183012 113861760 112015536 121523709 127470902 123244310 121729277 92416188},
	Journal = {Applications of Bioinformatics In Cancer Detection},
	Keywords = {Gene Network Sciences (GNS); Diagrammatic Cell Language (DCL); DigitalCell; cancer; cell; computer; data; drug; model; simulation},
	Pages = {132--153},
	Publisher = {NEW YORK ACAD SCIENCES},
	Series = {ANNALS OF THE NEW YORK ACADEMY OF SCIENCES},
	Times-Cited = {41},
	Title = {Data-driven computer simulation of human cancer cell},
	Type = {Proceedings Paper},
	Volume = {1020},
	Year = {2004},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000222177400013},
	Bdsk-Url-2 = {http://dx.doi.org/10.1196/annals.1310.014}}

@article{Kohn:1999bh,
	Abstract = {Eventually to understand the integrated function of the cell cycle regulatory network, we must organize the known interactions in the form of a diagram, map, and/or database. A diagram convention was designed capable of unambiguous representation of networks containing multiprotein complexes, protein modifications, and enzymes that are substrates of other enzymes. To facilitate linkage to a database, each molecular species is symbolically represented only once in each diagram. Molecular species can be located on the map by means of indexed grid coordinates. Each interaction is referenced to an annotation list where pertinent information and references can be found. Parts of the network are grouped into functional subsystems. The map shows how multiprotein complexes could assemble and function at gene promoter sites and at sites of DNA damage. It also portrays the richness of connections between the p53-Mdm2 subsystem and other parts of the network.},
	Address = {PUBL OFFICE, 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA},
	Author = {Kohn, KW},
	Date-Added = {2011-04-14 12:21:52 +0200},
	Date-Modified = {2011-04-14 12:21:52 +0200},
	Isi = {000082057100019},
	Isi-Recid = {111416002},
	Isi-Ref-Recids = {101255838 101078146 96867338 106780762 85501245 101439032 100558844 106763258 105773112 80953172 102128163 109873366 97114506 82890390 98816551 101910093 102894788 101321604 103757404 106780769 102190811 108937756 106399979 95410338 94183997 98180613 102021146 107143243 86512249 93633324 101128919 97318105 96867341 104903278 92919804 92148317 106725518 106964954 89669504 69579283 100455119 77511910 84584059 79819466 90461525 100966434 106456431 109311073 109395107 100866427 99288027 102894232 106880242 88289810 107790867 108452275 107696282 102789805 91218949 96900570 102271124 106865603 106499425 91004819 97298269 99025250 111416003 108111569 95653578 104419740 107522177 101821924 86536608 111416004 111416005 98506755 100432061 90838371 108357574 104461836 92416145 94162604 86762230 97021542 103434496 97922897 82095191 103640877 108357462 92084657 104050874 109618138 92543460 104116207 102319380 85393561 85345105 106079153 111416006 95133776 81532375 93472610 99208627 100028720 96261687 102271983 102905183 104249248 94075560 100432062 98082414 100115774 109559837 105784970 104052479 106499469 103742164 103079655 105458825 87198074 106476748 99395724 100875871 95133777 96688434 98938845 105390671 102206783 100869368 103756720 104192176 95988788 91748778 105274941 95731854 86762195 94859872 105275160 102869560 92258262 104457516 101983560 99725832 90552244 84634212 86421617 95077367 80011165 111416008 90474096 94339370 98968804 99795766 90195173 95261467 100927862 105883166 99634167 102208707 109395165 104950157 106440904 103580130 100457685 98343806 104255228 87894916 84789286 96987698 101960584 104292332 99000632 88333530 104457388 107186158 71519967 103796108 105773200 105458906 98564979 101793223 107108258 101960585 99109641 101656543 86583560 87134074 104220796 96122564 109270197 100869365 107304664 109559821 102679220 93669670 103357422 105914046 81945754 109478288 107340566 89295980 97505765 107736192 104786383 85929857 106921669 106762049 102905111 90552193 104352487 109409075 88946453 92171119 99314030 106034769 106664324 101670521 108721324 89394952 104425734 105774886 109559820 102496220 108201835 105687013 91907615 91473936 107790923 105274828 104466318 91180055 89885390 96613897 106961739 105773231 98816554 97200310 83988987 96257564 91748779 108201659 89526399 108201834 101837403 104934316 104025105 97879456 108575965 106838466 104249253 92387995 102190796 104992529 89378582 86583564 88048223 104612643 85556835 104457392 111416009 92934240 98776587},
	Journal = {Molecular Biology of the Cell},
	Month = aug,
	Number = {8},
	Pages = {2703--2734},
	Publisher = {AMER SOC CELL BIOLOGY},
	Times-Cited = {256},
	Title = {Molecular interaction map of the mammalian cell cycle control and DNA repair systems},
	Volume = {10},
	Year = {1999},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000082057100019}}

@article{Giovannucci:2010qf,
	Abstract = {Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well as certain diabetes risk factors and treatments. This consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning 1) the association between diabetes and cancer incidence or prognosis; 2) risk factors common to both diabetes and cancer; 3) possible biologic links between diabetes and cancer risk; and 4) whether diabetes treatments influence the risk of cancer or cancer prognosis. In addition, key unanswered questions for future research are posed. CA Cancer J Clin 2010;60: 207-221. (C) 2010 by the American Diabetes Association and the American Cancer Society, Inc.},
	Address = {COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA},
	Author = {Giovannucci, E and Harlan, DM. and Archer, MC and Bergenstal, RM. and Gapstur, SM. and Habel, LA. and Pollak, M and Regensteiner, JG and Yee, D},
	Date-Added = {2011-04-14 12:21:24 +0200},
	Date-Modified = {2011-04-15 16:10:18 +0200},
	Doi = {DOI 10.3322/caac.20078},
	Isi = {000279870900003},
	Isi-Recid = {190014305},
	Isi-Ref-Recids = {190257440 190257441 174371171 186451486 176284945 159119594 144020019 173837358 178783631 146558059 184703079 161136362 174958531 190257442 148685699 181637472 177928574 129888922 184549133 135789491 129148714 177947528 127296854 121242926 157601682 182788265 175575168 182788266 183504231 178795040 156119215 159006959 151031764 144560533 146550643 127199556 163179094 176687617 186339122 122464469 155500816 112212608 152088714 182788267 20908695 108978593 183772866 144366596 133076628 162471205 182126027 182093630 182788268 5658543 174279977 179142670 190257443 123336360 156435269 159357843 115180555 152424534 187132443 175155650 132017268 171693673 152489622 162571755 181937542 150365372 174376797 151167690 182927182 102870308 151446649 184516038 171677701 186818076 158709634 175498295 119891255 180665628 175491764 81980541 121195734 149148486 74179057 186159795 146238602 151166127 156554875 174752413 180182395 187334029 77434705 157321940 152862272 182378462 108555485 182788326 157732371 151606287 184918713 147853824 182788269 182788264 157454727 190257444 119661323 176460323 182833124 183963129 175487133 185408454 99675972 176203319 159285037 175535321 184279902 184332059 183564343 152977271 154031365},
	Journal = {Ca-A Cancer Journal For Clinicians},
	Month = {Jul-Aug},
	Number = {4},
	Pages = {207--221},
	Publisher = {WILEY-BLACKWELL PUBLISHING, INC},
	Times-Cited = {10},
	Title = {Diabetes and Cancer: A Consensus Report},
	Volume = {60},
	Year = {2010},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000279870900003},
	Bdsk-Url-2 = {http://dx.doi.org/10.3322/caac.20078}}

@article{Sawyers:2008ve,
	Abstract = {Genomic technologies offer the promise of a comprehensive understanding of cancer. These technologies are being used to characterize tumours at the molecular level, and several clinical successes have shown that such information can guide the design of drugs targeted to a relevant molecule. One of the main barriers to further progress is identifying the biological indicators, or biomarkers, of cancer that predict who will benefit from a particular targeted therapy.},
	Address = {MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
	Author = {Sawyers, CL},
	Date-Added = {2011-04-14 12:20:54 +0200},
	Date-Modified = {2011-04-15 16:06:16 +0200},
	Doi = {DOI 10.1038/nature06913},
	Isi = {000254567200032},
	Isi-Recid = {161568794},
	Isi-Ref-Recids = {161568795 148282416 159827452 160945349 159194362 135790439 147406320 154188947 159690796 157213388 155523068 147100022 159498981 121357648 143309139 143852377 153192495 159367818 159878281 156130505 155386711 158012300 155699365 154860193 151175081 154860108 146301760},
	Journal = {Nature},
	Month = apr,
	Number = {7187},
	Pages = {548--552},
	Publisher = {NATURE PUBLISHING GROUP},
	Times-Cited = {119},
	Title = {The cancer biomarker problem},
	Volume = {452},
	Year = {2008},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000254567200032},
	Bdsk-Url-2 = {http://dx.doi.org/10.1038/nature06913}}

@article{Aarons:1999ly,
	Abstract = {Pharmacokinetic-pharmacodynamic modelling is being used increasingly as a tool in drug development because often in phase III clinical trials only sparse data are available for analysis and so a nonlinear mixed effects modelling approach has to be adopted. Specialist data analytical techniques and software are required to analyse such data. This article reviews some of the software currently available for performing nonlinear mixed effects modelling.

A questionnaire was devised and sent to a number of software producers and the findings are presented and discussed in this paper. The programs could be grouped into 3 main categories: parametric and nonparametric maximum likelihood and Bayesian.

It was apparent from the questionnaire that software development for population data analysis is a very active area of investigation. The implementation of methodologies varied widely between the packages: some were self-contained programs, whereas others were written within another application, usually a statistical package. They also varied with respect to their ease of use and level of support offered by the software producers. Although robustness and reliability are important concerns, they were not addressed in the present review. Most of the programs surveyed are in continual development.},
	Address = {41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND},
	Author = {Aarons, L},
	Date-Added = {2011-04-14 12:20:39 +0200},
	Date-Modified = {2011-04-14 12:20:39 +0200},
	Isi = {000080071700001},
	Isi-Recid = {109941703},
	Isi-Ref-Recids = {78011009 87815592 52587976 109941704 78250301 85758148 95146669 109941705 109941706 73673933 99924771 60932404 94830353 78011010 100810393 87815593 109941707 109941708 79632550 79519542 104784335 95146666 86082453 86589116},
	Journal = {Clinical Pharmacokinetics},
	Month = apr,
	Number = {4},
	Pages = {255--264},
	Publisher = {ADIS INTERNATIONAL LTD},
	Times-Cited = {41},
	Title = {Software for population pharmacokinetics and pharmacodynamics},
	Volume = {36},
	Year = {1999},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000080071700001}}

@article{Bois:2010zr,
	Abstract = {A major challenge for drug development and environmental or occupational health is the prediction of pharmacokinetic and pharmacodynamic interactions between drugs, natural chemicals or environmental contaminants. This article reviews briefly past developments in the area of physiologically based pharmacokinetic (PBPK) modelling of interactions. It also demonstrates a systems biology approach to the question, and the capabilities of new software tools to facilitate that development. Individual Systems Biology Markup Language models of metabolic pathways can now be automatically merged and coupled to a template PBPK pharmacokinetic model, using for example the GNU MCSim software. The global model generated is very efficient and able to simulate the interactions between a theoretically unlimited number of substances. Development time and the number of model parameter increase only linearly with the number of substances considered, even though the number of possible interactions increases exponentially.},
	Address = {COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA},
	Author = {Bois, FY},
	Date-Added = {2011-04-14 12:20:24 +0200},
	Date-Modified = {2011-04-15 16:17:42 +0200},
	Doi = {DOI 10.1111/j.1742-7843.2009.00488.x},
	Isi = {000274454300003},
	Isi-Recid = {186654961},
	Isi-Ref-Recids = {63016991 144884124 158501209 183787704 186654962 71526597 180660347 67818245 121764919 178051641 154944823 176048635 131622643 186654963 120138317 160147941 159522336 148916577 94329536 96559027 113750218 121368585 108462817 128610434 136130616 176708290 178244984 143726073 146743246 89970662 130005654 123068685 162660449 39107718 63730052 179424995 143018546 173520338 143018526 73118265 186654964 144327951 151970990 99729773 91899281 83782126 95800320 151826818 121289144 108189028},
	Journal = {Basic \& Clinical Pharmacology \& Toxicology},
	Month = mar,
	Number = {3},
	Pages = {154--161},
	Publisher = {WILEY-BLACKWELL PUBLISHING, INC},
	Times-Cited = {1},
	Title = {Physiologically Based Modelling and Prediction of Drug Interactions},
	Volume = {106},
	Year = {2010},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000274454300003},
	Bdsk-Url-2 = {http://dx.doi.org/10.1111/j.1742-7843.2009.00488.x}}

@inproceedings{Raymond:2003ys,
	Author = {Raymond, GM and Butterworth, E and Bassingthwaighte, JB},
	Booktitle = {Faseb Journal},
	Date-Added = {2011-04-14 12:19:58 +0200},
	Date-Modified = {2011-04-14 15:57:39 +0200},
	Isi = {000181733101852},
	Isi-Recid = {129649441},
	Month = mar,
	Number = {4},
	Pages = {A390--A390},
	Times-Cited = {0},
	Title = {JSIM: free software package for teaching physiological modeling and research},
	Volume = {17},
	Year = {2003},
	Bdsk-Url-1 = {http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS&DestLinkType=FullRecord;KeyUT=000181733101852}}

@article{Astanin:2009vn,
	Abstract = {The model proposed here links together two approaches to describe tumours: a continuous medium to describe the movement and the mechanical properties of the tissue, and a population dynamics approach to represent internal genetic inhomogeneity and instability of the tumour. In this way one can build models which cover several stages of tumour progression. In this paper we focus on describing transition from aerobic to purely glycolytic metabolism (the Warburg effect) in tumour cords. From the mathematical point of view this model leads to a free boundary problem where domains in contact are characterized by different sets of equations. Accurate stitching of the solution was possible with a modified ghost fluid method. Growth and death of the cells and uptake of the nutrients are related through ATP production and energy costs of the cellular processes. In the framework of the bi-population model this allowed to keep the number of model parameters relatively small.},
	Author = {Astanin, Sergey and Preziosi, Luigi},
	Date-Added = {2011-04-14 12:18:26 +0200},
	Date-Modified = {2011-04-14 12:18:26 +0200},
	Doi = {10.1016/j.jtbi.2009.01.034},
	Journal = {J Theor Biol},
	Journal-Full = {Journal of theoretical biology},
	Mesh = {Cell Count; Cell Line, Tumor; Cell Survival; Computer Simulation; Disease Progression; Glycolysis; Humans; Models, Biological; Neoplasms},
	Month = {Jun},
	Number = {4},
	Pages = {578-90},
	Pmid = {19232360},
	Pst = {ppublish},
	Title = {Mathematical modelling of the Warburg effect in tumour cords},
	Volume = {258},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jtbi.2009.01.034}}

@article{Hejlesen:2000kx,
	Abstract = {Although studies have shown that intensive diabetes treatment with the goal of maintaining blood glucose concentrations close to the normal range lead to a substantial reduction of the rate of the complications (e.g. blindness, kidney failure, amputations and circulatory diseases), this can be difficult to achieve using conventional means. It is recognised that a number of patients may have poor control despite specialist care, and this along with devolution of care to non-specialists suggests that alternative interventions should be developed. DiasNet, which is used by patients as a tool for education and communication, is based on a well documented decision support system used by clinicians to give advise on insulin dose. In DiasNet the patients can experiment with their own data, adjusting insulin doses or meals sizes, and thereby learning how to cope with various situations. The system can run both as an ordinary application on a standard PC, and as an Internet application using a standard web browser. The latter enables a new way of communication between patient and clinician. DiasNet is currently being tested on a small group of diabetes patients.},
	Author = {Hejlesen, OK and Plougmann, S and Cavan, DA},
	Date-Added = {2011-04-14 12:18:01 +0200},
	Date-Modified = {2011-04-15 16:10:41 +0200},
	Journal = {Stud Health Technol Inform},
	Journal-Full = {Studies in health technology and informatics},
	Mesh = {Blood Glucose; Communication; Diabetes Mellitus, Type 1; Humans; Insulin; Internet; Patient Education as Topic; Patient Participation; Self Administration; User-Computer Interface},
	Pages = {563-7},
	Pmid = {11187615},
	Pst = {ppublish},
	Title = {DiasNet--an Internet tool for communication and education in diabetes},
	Volume = {77},
	Year = {2000}}

@article{Vander-Heiden:2009uq,
	Abstract = {In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect." Aerobic glycolysis is an inefficient way to generate adenosine 5'-triphosphate (ATP), however, and the advantage it confers to cancer cells has been unclear. Here we propose that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell. Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-associated mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP production. A better understanding of the mechanistic links between cellular metabolism and growth control may ultimately lead to better treatments for human cancer.},
	Author = {Vander Heiden, MG and Cantley, LC and Thompson, CB},
	Date-Added = {2011-04-14 12:10:41 +0200},
	Date-Modified = {2011-04-15 16:16:44 +0200},
	Doi = {10.1126/science.1160809},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {Adenosine Triphosphate; Aerobiosis; Amino Acids; Animals; Cell Proliferation; Glucose; Glycolysis; Humans; Lipids; Metabolic Networks and Pathways; Mutation; Neoplasms; Nucleotides; Oxidative Phosphorylation; Signal Transduction},
	Month = {May},
	Number = {5930},
	Pages = {1029-33},
	Pmc = {PMC2849637},
	Pmid = {19460998},
	Pst = {ppublish},
	Title = {Understanding the Warburg effect: the metabolic requirements of cell proliferation},
	Volume = {324},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1160809}}

@article{Lehmann:2000fk,
	Abstract = {The user experience with the AIDA simulator demonstrates one of the advantages of making such diabetes software readily available for free via the Internet. The comments collectively provide a picture of some of the many and varied ways in which the simulator has been applied by different users. These comments also demonstrate the potential for empowerment that some people feel can result from the use of the software. The experience with this approach is sufficiently encouraging to warrant formal evaluation studies to quantify the clinical utility of such an interactive educational diabetes simulation program. For this reason, a formal survey of 200 AIDA users (patients, relatives, and healthcare professionals) from at least 15 different countries is currently ongoing, and further formal evaluation studies in the clinic setting are planned.},
	Author = {Lehmann, E D},
	Date = {2000 Jul-Aug},
	Date-Added = {2011-04-14 12:07:44 +0200},
	Date-Modified = {2011-04-14 12:07:44 +0200},
	Journal = {Diabetes Educ},
	Journal-Full = {The Diabetes educator},
	Mesh = {Attitude of Health Personnel; Attitude to Health; Computer-Assisted Instruction; Diabetes Mellitus; Family; Humans; Patient Education as Topic; Software Validation; User-Computer Interface},
	Number = {4},
	Pages = {633-8, 641-3},
	Pmid = {11140072},
	Pst = {ppublish},
	Title = {Spontaneous comments from users of the AIDA interactive educational diabetes simulator},
	Volume = {26},
	Year = {2000},
	Bdsk-File-1 = {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}}

@article{Lehmann:2003fk,
	Abstract = {AIDA is a diabetes-computing program freely available from www.2aida.org on the Web. The software is intended to serve as an educational support tool, and can be used by anyone who has an interest in diabetes, whether they be patients, relatives, health-care professionals, or students. In previous "Diabetes Information Technology \& WebWatch" columns various indicators of usage of the AIDA program have been reviewed, and various comments from users of the software have been documented. One aspect of AIDA, though, that has been of considerable interest has been to investigate its Web-based distribution as a wider paradigm for more general medically related usage of the Internet. In this respect we have been keen to understand in general terms: (1) why people are turning to the Web for health-care/diabetes information; (2) more specifically, what sort of people are making use of the AIDA software; and (3) what benefits they feel might accrue from using the program. To answer these types of questions we have been conducting a series of audits/surveys via the AIDA Website, and via the software program itself, to learn as much as possible about who the AIDA end users really are. The rationale for this work is that, in this way, it should be possible to improve the program as well as tailor future versions of the software to the interests and needs of its users. However, a recurring observation is that data collection is easiest if it is as unobtrusive and innocuous as possible. One aspect of learning as much as possible about diabetes Website visitors and users may be to apply techniques that do not necessitate any visitor or user interaction. There are various programs that can monitor what pages visitors are viewing at a site. As these programs do not require visitors to do anything special, over time some interesting insights into Website usage may be obtained. For the current study we have reviewed anonymous logstats data, which are automatically collected at many Websites, to try and establish a baseline level of usage for the AIDA site. For the initial pilot study the analysis was performed from October 1, 2000 to November 1, 2001. The study has yielded an interesting insight into how the AIDA Website is being used. The results also confirm those of previous audits based on different self-reported methodologies, confirming, amongst other things, what countries people are visiting from and what operating systems/computers they are using. These analyses have been informative and useful. Given this, it is proposed to repeat the current pilot survey approach on a routine basis, in the future, as a way of monitoring on-going usage of the AIDA Website.},
	Author = {Lehmann, Eldon D},
	Date-Added = {2011-04-14 11:56:28 +0200},
	Date-Modified = {2011-04-14 11:56:28 +0200},
	Doi = {10.1089/152091503763816490},
	Journal = {Diabetes Technol Ther},
	Journal-Full = {Diabetes technology \& therapeutics},
	Mesh = {Diabetes Mellitus; Education, Medical, Continuing; Education, Nursing, Continuing; Humans; Internet; Patient Education as Topic; Reproducibility of Results; Software},
	Number = {1},
	Pages = {75-89},
	Pmid = {12725710},
	Pst = {ppublish},
	Title = {Usage of the www.2aida.org AIDA diabetes software Website: a pilot study},
	Volume = {5},
	Year = {2003},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1089/152091503763816490}}

@article{Katz:2000fk,
	Abstract = {Insulin resistance plays an important role in the pathophysiology of diabetes and is associated with obesity and other cardiovascular risk factors. The "gold standard" glucose clamp and minimal model analysis are two established methods for determining insulin sensitivity in vivo, but neither is easily implemented in large studies. Thus, it is of interest to develop a simple, accurate method for assessing insulin sensitivity that is useful for clinical investigations. We performed both hyperinsulinemic isoglycemic glucose clamp and insulin-modified frequently sampled iv glucose tolerance tests on 28 nonobese, 13 obese, and 15 type 2 diabetic subjects. We obtained correlations between indexes of insulin sensitivity from glucose clamp studies (SI(Clamp)) and minimal model analysis (SI(MM)) that were comparable to previous reports (r = 0.57). We performed a sensitivity analysis on our data and discovered that physiological steady state values [i.e. fasting insulin (I(0)) and glucose (G(0))] contain critical information about insulin sensitivity. We defined a quantitative insulin sensitivity check index (QUICKI = 1/[log(I(0)) + log(G(0))]) that has substantially better correlation with SI(Clamp) (r = 0.78) than the correlation we observed between SI(MM) and SI(Clamp). Moreover, we observed a comparable overall correlation between QUICKI and SI(Clamp) in a totally independent group of 21 obese and 14 nonobese subjects from another institution. We conclude that QUICKI is an index of insulin sensitivity obtained from a fasting blood sample that may be useful for clinical research.},
	Author = {Katz, A and Nambi, S S and Mather, K and Baron, A D and Follmann, D A and Sullivan, G and Quon, M J},
	Date-Added = {2010-06-17 14:57:53 +0200},
	Date-Modified = {2010-06-17 14:57:53 +0200},
	Journal = {J Clin Endocrinol Metab},
	Journal-Full = {The Journal of clinical endocrinology and metabolism},
	Mesh = {Adult; Blood Glucose; Diabetes Mellitus; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Obesity},
	Month = {Jul},
	Number = {7},
	Pages = {2402-10},
	Pmid = {10902785},
	Pst = {ppublish},
	Title = {Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans},
	Volume = {85},
	Year = {2000}}

@article{Saad:1994fk,
	Abstract = {An insulin-modified frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis was compared with the glucose clamp in 11 subjects with normal glucose tolerance (NGT), 20 with impaired glucose tolerance (IGT), and 24 with non-insulin-dependent diabetes mellitus (NIDDM). The insulin sensitivity index (SI) was calculated from FSIGTT using 22- and 12-sample protocols (SI(22) and SI(12), respectively). Insulin sensitivity from the clamp was expressed as SI(clamp) and SIP(clamp). Minimal model parameters were similar when calculated with SI(22) and SI(12). SI could not be distinguished from 0 in approximately 50\% of diabetic patients with either protocol. SI(22) correlated significantly with SI(clamp) in the whole group (r = 0.62), and in the NGT (r = 0.53), IGT (r = 0.48), and NIDDM (r = 0.41) groups (P < 0.05 for each). SI(12) correlated significantly with SI(clamp) in the whole group (r = 0.55, P < 0.001) and in the NGT (r = 0.53, P = 0.046) and IGT (r = 0.58, P = 0.008) but not NIDDM (r = 0.30, P = 0.085) groups. When SI(22), SI(clamp), and SIP(clamp) were expressed in the same units, SI(22) was 66 +/- 5\% (mean +/- SE) and 50 +/- 8\% lower than SI(clamp) and SIP(clamp), respectively. Thus, minimal model analysis of the insulin-modified FSIGTT provides estimates of insulin sensitivity that correlate significantly with those from the glucose clamp. The correlation was weaker, however, in NIDDM. The insulin-modified FSIGTT can be used as a simple test for assessment of insulin sensitivity in population studies involving nondiabetic subjects. Additional studies are needed before using this test routinely in patients with NIDDM.},
	Author = {Saad, M F and Anderson, R L and Laws, A and Watanabe, R M and Kades, W W and Chen, Y D and Sands, R E and Pei, D and Savage, P J and Bergman, R N},
	Date-Added = {2010-06-17 12:47:14 +0200},
	Date-Modified = {2010-06-17 12:47:14 +0200},
	Journal = {Diabetes},
	Journal-Full = {Diabetes},
	Mesh = {Analysis of Variance; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Kinetics; Male; Middle Aged; Models, Biological; Reference Values; Regression Analysis; Sensitivity and Specificity},
	Month = {Sep},
	Number = {9},
	Pages = {1114-21},
	Pmid = {8070611},
	Pst = {ppublish},
	Title = {A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study},
	Volume = {43},
	Year = {1994}}

@article{Cobelli:1986kx,
	Abstract = {The "minimal model" of glucose disappearance provides noninvasive estimates of insulin sensitivity and glucose effectiveness from an intravenous glucose tolerance test (IVGTT). However, this model does not allow the separation of glucose production from utilization. To overcome this limitation, labeled glucose was injected along with cold glucose in six normal dogs, and both cold and labeled glucose time courses were monitored along with insulin concentration. A revised minimal model was fitted to tracer data to obtain new measures of insulin sensitivity (SI* = 6.41 +/- 0.91 10(-4) min-1 X microU-1 X ml-1) and fractional glucose clearance (SG* = 0.0092 +/- 0.0009 min-1). SG* was compared with a direct measure obtained by a hepatic arterial-venous difference technique, which yielded a value of 0.0097 +/- 0.0002, virtually identical to SG*, thereby validating the model estimate. When the original minimal model was identified from cold data, we obtained S1 = 4.52 +/- 1.39 and SG = 0.042 +/- 0.009. SI* and SG* were different from SI and SG, respectively. In particular SG overestimates fractional glucose clearance by approximately five times. The revised minimal model yields glucose disposal parameters SI* and SG* that are not affected by the confounding effect of insulin and glucose inhibition of glucose production. Limitations inherent in cold IVGTT and original minimal model are overcome by labeled IVGTT and the revised minimal model, while test simplicity remains.},
	Author = {Cobelli, Claudio and Pacini, G and Toffolo, G and Sacc{\`a}, L},
	Date-Added = {2010-05-26 14:10:14 +0200},
	Date-Modified = {2011-05-17 11:11:00 +0200},
	Journal = {Am J Physiol},
	Journal-Full = {The American journal of physiology},
	Mesh = {Animals; Blood Glucose; Dogs; Female; Glucose; Glucose Tolerance Test; Insulin; Kinetics; Liver; Male; Mathematics; Metabolic Clearance Rate; Models, Biological; Tritium},
	Month = {May},
	Number = {5 Pt 1},
	Pages = {E591-8},
	Pmid = {3518490},
	Pst = {ppublish},
	Title = {Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT},
	Volume = {250},
	Year = {1986},
	Bdsk-File-1 = {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}}

@article{Yokoyama:2004uq,
	Abstract = {The purpose of the study was to investigate whether quantitative insulin sensitivity check index (QUICKI) and the reciprocal index of homeostasis model assessment (1/HOMA-IR) are excellent surrogate indexes of insulin resistance in type 2 diabetic patients with various ranges of fasting plasma glucose. One hundred eight type 2 diabetic patients were divided into tertiles according to fasting levels of plasma glucose (FPG) [T1: 4.2 < or = FPG (mmol/liter) < 6.5, n = 36; T2: 6.5 < or = FPG < 8.1, n = 36; T3: 8.1 < or = FPG < or = 11.1, n = 36]. The association between QUICKI or 1/HOMA-IR and insulin resistance index assessed by euglycemic hyperinsulinemic clamp (Clamp-IR) was investigated in each group. QUICKI was strongly correlated with Clamp-IR in all groups (r = 0.615 in T1, r = 0.659 in T2, and r = 0.788 in T3; all subjects, r = 0.691; all P < 0.001). Reciprocal of HOMA-IR also highly correlated with Clamp-IR in all groups (r = 0.600, r = 0.721, and r = 0.730, respectively; all subjects, r = 0.685; all P < 0.001). In conclusion, QUICKI and the reciprocal index of HOMA were highly correlated with Clamp-IR in type 2 diabetic patients with relatively wide ranges of fasting plasma glucose.},
	Author = {Yokoyama, Hisayo and Emoto, Masanori and Fujiwara, Shigehiko and Motoyama, Koka and Morioka, Tomoaki and Komatsu, Miyoko and Tahara, Hideki and Koyama, Hidenori and Shoji, Tetsuo and Inaba, Masaaki and Nishizawa, Yoshiki},
	Date-Added = {2010-05-26 12:11:13 +0200},
	Date-Modified = {2010-05-26 12:11:13 +0200},
	Journal = {J Clin Endocrinol Metab},
	Journal-Full = {The Journal of clinical endocrinology and metabolism},
	Mesh = {Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glucose Clamp Technique; Homeostasis; Humans; Insulin Resistance; Male; Middle Aged},
	Month = {Mar},
	Number = {3},
	Pages = {1481-4},
	Pmid = {15001651},
	Pst = {ppublish},
	Title = {Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose},
	Volume = {89},
	Year = {2004},
	Bdsk-File-1 = {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}}

@article{Bucolo:1974uq,
	Author = {Bucolo, R J and Bergman, R N and Marsh, D J and Yates, F E},
	Date-Added = {2010-05-25 18:57:22 +0200},
	Date-Modified = {2010-05-25 18:57:22 +0200},
	Journal = {Am J Physiol},
	Journal-Full = {The American journal of physiology},
	Mesh = {Animals; Blood Glucose; Dogs; Glucose; Liver; Liver Glycogen; Perfusion; Portal Vein; Time Factors},
	Month = {Jul},
	Number = {1},
	Pages = {209-17},
	Pmid = {4843372},
	Pst = {ppublish},
	Title = {Dynamics of glucose autoregulation in the isolated, blood-perfused canine liver},
	Volume = {227},
	Year = {1974},
	Bdsk-File-1 = {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}}

@article{Bergman:1974fk,
	Author = {Bergman, R N and Bucolo, R J},
	Date-Added = {2010-05-25 12:52:18 +0200},
	Date-Modified = {2010-05-25 12:52:18 +0200},
	Journal = {Am J Physiol},
	Journal-Full = {The American journal of physiology},
	Mesh = {Animals; Blood Flow Velocity; Blood Glucose; Dogs; Female; Glucose; Homeostasis; Insulin; Liver; Liver Circulation; Male; Perfusion; Portal Vein; Regression Analysis; Time Factors},
	Month = {Dec},
	Number = {6},
	Pages = {1314-22},
	Pmid = {4440776},
	Pst = {ppublish},
	Title = {Interaction of insulin and glucose in the control of hepatic glucose balance},
	Volume = {227},
	Year = {1974},
	Bdsk-File-1 = {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}}

@article{Metzler:1971,
	Abstract = {Compartment models are widely used in pharmaceutical research to quantitate the kinetics of absorption, distribution, metabolism and excretion of a drug. In this article two applications of the two compartment open model are discussed. This discussion shows that, in spite of the extreme simplification and obvious weaknesses of this model, it has properties that make it a useful tool in drug research when properly used.},
	Author = {Metzler, Carl M.},
	Date-Added = {2010-02-06 16:28:51 +0100},
	Date-Modified = {2010-02-06 16:36:46 +0100},
	Journal = {Journal of the American Statistical Association},
	Month = {Mar},
	Number = {333},
	Pages = {49--53},
	Title = {Usefulness of the Two-Compartment Open Model in Pharmacokinetics},
	Volume = {66},
	Year = {1971},
	Bdsk-File-1 = {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}}

@article{Eaton:1980fk,
	Abstract = {The prehepatic production of insulin in normal man was evaluated by kinetic analysis of connecting peptide (C-peptide) behavior in the plasma in men and women. Studies were performed during suppression of endogenous insulin secretion (induced by both fasting and exogenous insulin injection) as well as during stimulation of secretion (induced by oral glucose ingestion) and iv glucose injection. Least squares spline fitting of the C-peptide data by interactive computer analysis permitted evaluation of the precursor production of insulin using a two-compartment model for C-peptide removal. Basal prehepatic insulin production averaged 15-4 mU/70 kg.min in 20 subjects and was reduced to 0.9 +/- 2.2 mU/70 kg.min after 84 h of fasting. The injection of exogenous iv insulin resulted in suppression of endogenous production to 0 +/- 2.5 mU/70 kg.min. Maximum prehepatic insulin production induced by a 100-g oral glucose tolerance test was 91 +/- 1.2 mU/70 kg.min, with a cumulative hormone secretion of 11.4 +/- 2.0 U over the 5 h of observation. After the acute iv injection of 25 g glucose, production rose to 465 +/- 108 mU/70 kg.min at 2 min post injection and rapidly returned toward basal. Levels of insulin in the portal vein calculated from this analysis were markedly elevated relative to simultaneous peripheral venous levels. These results quantitate prehepatic insulin production and portal venous insulin concentration from an analysis of the behavior of C-peptide within the plasma in both the steady state and the nonsteady state in man.},
	Author = {Eaton, R P and Allen, R C and Schade, D S and Erickson, K M and Standefer, J},
	Date-Added = {2010-01-25 13:38:45 +0100},
	Date-Modified = {2010-01-25 13:38:45 +0100},
	Journal = {J Clin Endocrinol Metab},
	Journal-Full = {The Journal of clinical endocrinology and metabolism},
	Mesh = {Adult; C-Peptide; Fasting; Female; Glucose Tolerance Test; Humans; Infusions, Parenteral; Insulin; Kinetics; Male; Pancreas; Peptides},
	Month = {Sep},
	Number = {3},
	Pages = {520-8},
	Pmid = {6997329},
	Title = {Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior},
	Volume = {51},
	Year = {1980},
	Bdsk-File-1 = {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}}

@article{Van-Cauter:1992fk,
	Abstract = {Insulin secretion rates can be accurately estimated from plasma C-peptide levels with a two-compartment model for C-peptide distribution and degradation. In previous studies, the kinetic parameters of C-peptide clearance were derived in each subject from the decay curve observed after bolus intravenous injection of biosynthetic human C-peptide. To determine whether standard parameters for C-peptide clearance could be defined and used to calculate insulin secretion without obtaining a decay curve in each subject, we analyzed 200 decay curves of biosynthetic human C-peptide obtained in normal, obese, and non-insulin-dependent diabetes mellitus subjects studied in our laboratory. This analysis showed that the volume of distribution and kinetic parameters of C-peptide distribution and metabolism vary by less than 30\% in a population highly heterogeneous in terms of age, sex, degree of obesity, and degree of glucose tolerance. The volume of distribution correlated with the degree of obesity as quantified by body surface area (BSA). This dependence of C-peptide distribution volume on BSA was more marked in men than in women. The long half-life was slightly longer in elderly subjects than in younger adults. When effects of BSA, sex, and age were taken into account, the parameters of C-peptide kinetics were very similar in normal, obese, and diabetic subjects. Based on these findings, a simple procedure to derive standard parameters for C-peptide clearance taking into account degree of obesity, sex, and age was defined. These standard parameters resulted in estimations of mean insulin secretion rates, which differed in each subject by only 10-12\% from those obtained with individual parameters. The approach of using standard rather than individual parameters did not systematically underestimate or overestimate insulin secretion so that group values for the fasting secretion rate, the mean 24-h secretion rate, and the number and the amplitude of secretory pulses obtained with standard parameters differed by only 1-2\% from the values obtained with individual parameters. Furthermore, the accuracy of measurements based on standard parameters was not different from that associated with replicate determinations of the parameters of C-peptide clearance in the same subject. We conclude that it is possible to estimate insulin secretion rates from plasma C-peptide levels with standard parameters for C-peptide clearance rather than individually derived parameters without significant loss of accuracy.},
	Author = {Van Cauter, E and Mestrez, F and Sturis, J and Polonsky, K S},
	Date-Added = {2010-01-21 18:33:18 +0100},
	Date-Modified = {2010-01-21 18:33:18 +0100},
	Journal = {Diabetes},
	Journal-Full = {Diabetes},
	Mesh = {Adult; Body Mass Index; Body Surface Area; C-Peptide; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Kinetics; Male; Mathematics; Metabolic Clearance Rate; Models, Biological; Obesity; Reference Values},
	Month = {Mar},
	Number = {3},
	Pages = {368-77},
	Pmid = {1551497},
	Title = {Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance},
	Volume = {41},
	Year = {1992},
	Bdsk-File-1 = {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}}

@article{Hovorka:1996fk,
	Abstract = {ISEC (Insulin SECretion) is a computer program which calculates pre-hepatic insulin secretion from plasma C-peptide measurements. The program uses a regression (population) model to derive parameters of C-peptide kinetics from subject's gender, type (normal, obese, non-insulin dependent diabetes mellitus), age, weight, and height. Insulin secretion is calculated as a piece-wise constant (step) function with flexible step length allowing for a fine resolution of the secretion profile between measurements. A constrained regularisation method of deconvolution is employed to carry out the calculations. The calculated profile satisfies three properties: (i) it fits the measurement within the given level of the measurement error, (ii) it is non-negative, and (iii) it has a minimum value of a regularisation criterion (norm of second differences) which quantifies the degree of deviation of the secretion profile from a straight line. Both theoretical aspects and specific features related to ISEC are considered. To exemplify the use of ISEC, pre-hepatic insulin secretion is calculated during meal tolerance test, frequently sampled intravenous glucose tolerance test, hyperinsulinaemic euglycaemic glucose clamp, and basal conditions with frequent sampling.},
	Author = {Hovorka, R and Soons, P A and Young, M A},
	Date-Added = {2010-01-20 18:36:39 +0100},
	Date-Modified = {2010-01-20 18:36:39 +0100},
	Journal = {Comput Methods Programs Biomed},
	Journal-Full = {Computer methods and programs in biomedicine},
	Mesh = {Adult; C-Peptide; Eating; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Male; Models, Biological; Software},
	Month = {Aug},
	Number = {3},
	Pages = {253-64},
	Pmid = {8894385},
	Title = {ISEC: a program to calculate insulin secretion},
	Volume = {50},
	Year = {1996},
	Bdsk-File-1 = {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}}

@article{Dalla-Man:2005zl,
	Abstract = {Highly informative yet simple protocols to assess insulin secretion and action would considerably enhance the quality of epidemiological and large-scale clinical trials. In an effort to develop such protocols, a 5-h, 11-sample oral glucose tolerance test (OGTT) was performed in 100 individuals and a 7-h, 21-sample meal in another 100. Plasma glucose, insulin, and C-peptide concentrations were measured. We show that virtually the same minimal model assessment of beta-cell responsivity (dynamic [Phi(d)] and static [Phi(s)]), insulin sensitivity (Si), and disposition index (DI) can be obtained with a reduced seven-sample 2-h protocol: Phi(d), reduced versus full: 871.50 vs. 873.32, r = 0.98 in OGTT and 494.88 vs. 477.99 10(-9), r = 0.91 in meal; Phi(s): 42.36 vs. 44.35, r = 0.88 in OGTT and 35.31 vs. 35.37 10(-9) min(-1), r = 0.90 in meal; Si: 24.33 vs. 22.77 10(-5) dl x kg(-1) x min(-1) per pmol/l, r = 0.89 in OGTT and 19.03 vs. 19.77 10(-5) dl x kg(-1) x min(-1) per pmol/l, r = 0.85 in meal; and DI: 1,282.26 vs. 1,273.23, r = 0.84 in OGTT and 726.92 vs. 776.97 10(-14) dl . kg(-1) x min(-2) per pmol/l, r = 0.84 in meal. This reduced protocol will facilitate the study of insulin secretion and action under physiological conditions in nondiabetic humans.},
	Author = {Dalla Man, Chiara and Campioni, Marco and Polonsky, Kenneth S and Basu, Rita and Rizza, Robert A and Toffolo, Gianna and Cobelli, Claudio},
	Date-Added = {2009-09-21 12:04:45 +0200},
	Date-Modified = {2009-09-21 12:04:45 +0200},
	Journal = {Diabetes},
	Journal-Full = {Diabetes},
	Mesh = {Adult; Aged, 80 and over; Blood Glucose; C-Peptide; Diet; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Middle Aged; Models, Biological; Time Factors},
	Month = {Nov},
	Number = {11},
	Pages = {3265-73},
	Pmid = {16249454},
	Title = {Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals},
	Volume = {54},
	Year = {2005},
	Bdsk-File-1 = {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}}

@article{Leggett:2003fv,
	Abstract = {A physiologically descriptive model of the biological behavior of cesium in the human body has been constructed around a detailed blood flow model. The rate of transfer from plasma into a tissue is determined by the blood perfusion rate and the tissue-specific extraction fraction of Cs during passage from arterial to venous plasma. Information on tissue-specific extraction of Cs is supplemented with information on the Cs analogues, K and Rb, and known patterns of discrimination between these metals by tissues. The rate of return from a tissue to plasma is estimated from the relative contents of Cs in plasma and the tissue at equilibrium as estimated from environmental studies. Transfers of Cs other than exchange between plasma and tissues (e.g. secretions into the gastrointestinal tract) are based on a combination of physiological considerations and empirical data on Cs or related elements. Model predictions are consistent with the sizable database on the time-dependent distribution and retention of radiocesium in the human body.},
	Author = {Leggett, R W and Williams, L R and Melo, D R and Lipsztein, J L},
	Date-Added = {2009-06-26 13:57:32 +0200},
	Date-Modified = {2009-06-26 13:57:32 +0200},
	Doi = {10.1016/S0048-9697(03)00333-4},
	Journal = {Sci Total Environ},
	Journal-Full = {The Science of the total environment},
	Mesh = {Cesium; Databases, Factual; Humans; Kinetics; Models, Theoretical; Potassium; Regional Blood Flow; Tissue Distribution},
	Month = {Dec},
	Number = {1-3},
	Pages = {235-55},
	Pmid = {14630424},
	Title = {A physiologically based biokinetic model for cesium in the human body},
	Volume = {317},
	Year = {2003},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0048-9697(03)00333-4}}

@article{Leggett:1993yg,
	Abstract = {Recent efforts to incorporate greater anatomical and physiological realism into biokinetic models have resulted in many cases in mathematically complex formulations that limit routine application of the models. This paper describes an elementary, computer-efficient technique for implementing complex compartmental models, with attention focused primarily on biokinetic models involving time-dependent transfer rates and recycling. The technique applies, in particular, to the physiologically based, age-specific biokinetic models recommended in Publication No. 56 of the International Commission on Radiological Protection, Age-Dependent Doses to Members of the Public from Intake of Radionuclides.},
	Author = {Leggett, R W and Eckerman, K F and Williams, L R},
	Date-Added = {2009-06-26 13:57:22 +0200},
	Date-Modified = {2009-06-26 13:57:22 +0200},
	Journal = {Health Phys},
	Journal-Full = {Health physics},
	Mesh = {Age Factors; Americium; Humans; Infant; Models, Biological; Radiation Dosage; Radioisotopes; Software},
	Month = {Mar},
	Number = {3},
	Pages = {260-71},
	Pmid = {8432645},
	Title = {An elementary method for implementing complex biokinetic models},
	Volume = {64},
	Year = {1993}}

@article{Leggett:1995zl,
	Abstract = {As part of the revision of the Reference Man model of the International Commission on Radiological Protection (ICRP), we have reviewed and reanalyzed available data on blood flow and in previous publications have proposed reference values for total and regional blood volumes, total cardiac output, and the distribution of cardiac output. In this paper we unify these proposed features of the revised Reference Man within the framework of a dynamic blood circulation model and show how the model can be used to predict the distribution of decays of short-lived radionuclides after injection or absorption into blood. The total blood volume is partitioned into the blood contents of 24 separate organs or tissues, right heart chambers, left heart chambers, pulmonary circulation, arterial outflow to the systemic tissues (aorta and large arteries), and venous return from the systemic tissues (large veins). As a compromise between physical reality and computational simplicity, the circulation of blood is viewed as a system of first-order transfers between blood pools, but outflow from any given pool is delayed during the first pass of material through the circulation with the delay time depending on the mean transit time across the pool. The model can be used to predict the movement and gradual dispersal of a bolus of material in the circulation after intravascular injection. In contrast to the treatment of the circulation in ICRP Publication 53, Radiation Dose to Patients from Radiopharmaceuticals, the present model allows consideration of incomplete, tissue-dependent extraction of material during passage through the circulation and return of material from tissues to plasma.},
	Author = {Leggett, R W and Williams, L R},
	Date-Added = {2009-06-26 13:57:06 +0200},
	Date-Modified = {2009-06-26 13:57:06 +0200},
	Journal = {Health Phys},
	Journal-Full = {Health physics},
	Mesh = {Adult; Blood Circulation; Blood Circulation Time; Computer Simulation; Half-Life; Health Physics; Humans; Kinetics; Male; Middle Aged; Models, Cardiovascular; Radioisotopes; Reference Values},
	Month = {Aug},
	Number = {2},
	Pages = {187-201},
	Pmid = {7622365},
	Title = {A proposed blood circulation model for Reference Man},
	Volume = {69},
	Year = {1995},
	Bdsk-File-1 = {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}}

@article{Kalhan:1997zm,
	Abstract = {The rate of appearance (Ra) of glucose in plasma and the contribution of gluconeogenesis were quantified in normal pregnant women early ( approximately 10 wk) and late ( approximately 34 wk) in gestation. Their data were compared with those of normal nonpregnant women. Glucose Ra was measured using the [U-13C]glucose tracer dilution method. Gluconeogenesis was quantified by the appearance of 2H on carbon 5 and 6 of glucose after deuterium labeling of body water pool. Weight-specific glucose Ra was unchanged during pregnancy (nonpregnant, 1.89+/-0.24; first trimester, 2.05+/-0.21; and third trimester 2.17+/-0.28 mg/kg.min, mean+/-SD), while total glucose Ra was significantly increased (early, 133.5+/-7.2; late, 162.6+/-16.4 mg/min; P = 0.005). The fractional contribution of gluconeogenesis via pyruvate measured by 2H enrichment on C-6 of glucose (45-61%), and of total gluconeogenesis quantified from 2H enrichment on C-5 of glucose (i.e. , including glycerol [68-85%]) was not significantly different between pregnant and nonpregnant women. Inasmuch as total glucose Ra was significantly increased, total gluconeogenesis was also increased in pregnancy (early pregnancy, 94.7+/-15.9 mg/min; late pregnancy, 122.7+/-9.3 mg/min; P = 0.003). These data demonstrate the ability of the mother to adapt to the increasing fetal demands for glucose with advancing gestation. The mechanism for this unique quantitative adjustment to the fetal demands remains undefined.},
	Address = {Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA. sck@po.cwru.edu},
	Author = {Kalhan, S and Rossi, K and Gruca, L and Burkett, E and O'Brien, A},
	Crdt = {1997/10/06 00:00},
	Da = {19971029},
	Date = {1997 Oct 1},
	Date-Added = {2009-06-23 18:05:03 +0200},
	Date-Modified = {2009-06-23 18:05:03 +0200},
	Dcom = {19971029},
	Doi = {10.1172/JCI119704},
	Edat = {1997/10/06},
	Gr = {HD11089/HD/NICHD NIH HHS/United States; MO1 RR00080/RR/NCRR NIH HHS/United States},
	Issn = {0021-9738 (Print)},
	Jid = {7802877},
	Journal = {J Clin Invest},
	Jt = {The Journal of clinical investigation},
	Language = {eng},
	Lr = {20081120},
	Mh = {3-Hydroxybutyric Acid; Blood Glucose/*metabolism; Carbon Isotopes; Deuterium; Fatty Acids, Nonesterified/blood; Female; *Gluconeogenesis; Humans; Hydroxybutyrates/blood; Linear Models; Physiology/methods; Pregnancy/*physiology; Pregnancy Trimester, First/physiology; Pregnancy Trimester, Third/physiology},
	Mhda = {1997/10/06 00:01},
	Month = {Oct},
	Number = {7},
	Oid = {NLM: PMC508362},
	Own = {NLM},
	Pages = {1775--1781},
	Pl = {UNITED STATES},
	Pmc = {PMC508362},
	Pmid = {9312177},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (Blood Glucose); 0 (Carbon Isotopes); 0 (Fatty Acids, Nonesterified); 0 (Hydroxybutyrates); 300-85-6 (3-Hydroxybutyric Acid); 7782-39-0 (Deuterium)},
	Sb = {AIM; IM},
	Source = {J Clin Invest. 1997 Oct 1;100(7):1775-81.},
	Status = {MEDLINE},
	Title = {Glucose turnover and gluconeogenesis in human pregnancy.},
	Volume = {100},
	Year = {1997},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1172/JCI119704}}

@article{Stagsted:1993zl,
	Abstract = {In rat adipocytes, insulin dose-response curves were determined for the following effects in the same cells under the same conditions: glucose uptake, binding to insulin receptors (IR), IR autophosphorylation in vivo and in vitro, IR tyrosine kinase activity and insulin-stimulated phosphatidylinositol (PI) kinase. All the EC50 values were essentially the same (mean +/- S.E.M. was 7 +/- 1 nM), except for glucose uptake, which was 170 pM. Using an improved method, we were able to measure PI kinase activity at picomolar concentrations of insulin (> 30 pM) corresponding to the EC50 for glucose uptake. These experiments showed that insulin-stimulated increase in glucose uptake was associated with an increase in antiphosphotyrosine antibody precipitable PI kinase activity, consistent with the view that IR tyrosine kinase activity may be involved in insulin-mediated signaling of glucose uptake. Small peptides (17-25 residues long) derived from major histocompatibility complex class I have previously been shown to inhibit IR internalization without any effect on the affinity of insulin to the receptor. It is now shown that the peptide-mediated inhibition of internalization, which doubles the number of insulin-occupied receptors at an insulin concentration of 70 pM, also results in a corresponding enhancement of PI kinase activity and glucose uptake. Thus, the receptors arrested on the cell surface by the peptide are biologically active.},
	Address = {Reception, Inc., Concord, California.},
	Author = {Stagsted, J and Hansen, T and Roth, R A and Goldstein, A and Olsson, L},
	Crdt = {1993/11/01 00:00},
	Da = {19940106},
	Date = {1993 Nov},
	Date-Added = {2009-03-23 13:12:39 +0100},
	Date-Modified = {2009-03-23 13:12:39 +0100},
	Dcom = {19940106},
	Edat = {1993/11/01},
	Issn = {0022-3565 (Print)},
	Jid = {0376362},
	Journal = {J Pharmacol Exp Ther},
	Jt = {The Journal of pharmacology and experimental therapeutics},
	Language = {eng},
	Lr = {20061115},
	Mh = {1-Phosphatidylinositol 4-Kinase; Adipocytes/drug effects/metabolism; Amino Acid Sequence; Animals; Glucose/pharmacokinetics; Histocompatibility Antigens Class I/*pharmacology; Insulin/*metabolism/*pharmacology; Kinetics; Macromolecular Substances; Major Histocompatibility Complex/genetics/immunology; Molecular Sequence Data; Peptide Fragments/*pharmacology; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor)/metabolism; Protein-Tyrosine Kinases/antagonists \& inhibitors/*metabolism; Rats; Rats, Wistar; Receptor, Insulin/*metabolism; Stimulation, Chemical},
	Mhda = {1993/11/01 00:01},
	Month = {Nov},
	Number = {2},
	Own = {NLM},
	Pages = {997--1001},
	Pl = {UNITED STATES},
	Pmid = {8246175},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Histocompatibility Antigens Class I); 0 (Macromolecular Substances); 0 (Peptide Fragments); 11061-68-0 (Insulin); 50-99-7 (Glucose); EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor)); EC 2.7.1.112 (Protein-Tyrosine Kinases); EC 2.7.1.112 (Receptor, Insulin); EC 2.7.1.67 (1-Phosphatidylinositol 4-Kinase)},
	Sb = {IM},
	Source = {J Pharmacol Exp Ther. 1993 Nov;267(2):997-1001.},
	Status = {MEDLINE},
	Title = {Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.},
	Volume = {267},
	Year = {1993},
	Bdsk-File-1 = {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}}

@article{Biewald:1978hl,
	Abstract = {Methods are described for estimation of blood volume and extracellular space (ECS) in the whole body and in some organs with 51Cr, 14C-thiocyanate and 3H-inulin. A mean blood volume of 47 ml/kg, a thiocyanate space of 350 ml/kg and a inulin space of 288 ml/kg were determined in the rat. The corresponding values of organs are shown in figures 1--3.},
	Author = {Biewald, N and Billmeier, J},
	Crdt = {1978/03/15 00:00},
	Da = {19780508},
	Date = {1978 Mar 15},
	Date-Added = {2009-03-20 21:05:03 +0100},
	Date-Modified = {2009-03-20 21:05:03 +0100},
	Dcom = {19780508},
	Edat = {1978/03/15},
	Issn = {0014-4754 (Print)},
	Jid = {0376547},
	Journal = {Experientia},
	Jt = {Experientia},
	Language = {eng},
	Lr = {20031114},
	Mh = {Animals; Blood Volume Determination/*methods; Extracellular Space/*analysis; Inulin/diagnostic use; Male; Rats; Thiocyanates/diagnostic use},
	Mhda = {1978/03/15 00:01},
	Month = {Mar},
	Number = {3},
	Own = {NLM},
	Pages = {412--413},
	Pl = {SWITZERLAND},
	Pmid = {631287},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Thiocyanates); 9005-80-5 (Inulin)},
	Sb = {IM},
	Source = {Experientia. 1978 Mar 15;34(3):412-3.},
	Status = {MEDLINE},
	Title = {Blood volume and extracellular space (ECS) of the whole body and some organs of the rat.},
	Volume = {34},
	Year = {1978},
	Bdsk-File-1 = {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}}

@article{Pattaranit:2008mb,
	Abstract = {Diabetes and obesity present a mounting global challenge. Clinicians are increasingly turning to mechanism-based mathematical models for a quantitative definition of physiological defects such as insulin resistance, glucose intolerance and elevated obesity set points, and for predictions of the likely outcomes of therapeutic interventions. However, a very large range of such models is available, making a judicious choice difficult. To better inform this choice, here we present the most important models published to date in a uniform format, discussing similarities and differences in terms of the decisions faced by modellers. We review models for glucostasis, based on the glucose-insulin feedback control loop, and consider extensions to long-term energy balance, dislipidaemia and obesity.},
	Address = {Warwick Systems Biology Centre, University of Warwick, Coventry CV4 7AL, UK.},
	Author = {Pattaranit, Ratchada and van den Berg, Hugo Antonius},
	Crdt = {2008/07/10 09:00},
	Da = {20080818},
	Date = {2008 Oct 6},
	Date-Added = {2009-03-04 15:13:32 +0100},
	Date-Modified = {2009-03-04 15:13:32 +0100},
	Dcom = {20081107},
	Doi = {10.1098/rsif.2008.0216},
	Edat = {2008/07/10 09:00},
	Issn = {1742-5689 (Print)},
	Jid = {101217269},
	Journal = {J R Soc Interface},
	Jt = {Journal of the Royal Society, Interface / the Royal Society},
	Language = {eng},
	Mh = {Blood Glucose/*metabolism; Diabetes Mellitus/metabolism; Energy Metabolism/*physiology; Feedback; Humans; Insulin/*metabolism; *Models, Biological; Obesity/metabolism},
	Mhda = {2008/11/08 09:00},
	Month = {Oct},
	Number = {27},
	Oid = {NLM: PMC2516324},
	Own = {NLM},
	Pages = {1119--1135},
	Pii = {FQ131X1J61082526},
	Pl = {England},
	Pmc = {PMC2516324},
	Pmid = {18611843},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Review},
	Rf = {97},
	Rn = {0 (Blood Glucose); 11061-68-0 (Insulin)},
	Sb = {IM},
	Status = {MEDLINE},
	Title = {Mathematical models of energy homeostasis.},
	Volume = {5},
	Year = {2008},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1098/rsif.2008.0216}}

@article{Giri:2004fu,
	Abstract = {BACKGROUND: The phenomenon of switch-like response to graded input signal is the theme involved in various signaling pathways in living systems. Positive feedback loops or double negative feedback loops embedded with nonlinearity exhibit these switch-like bistable responses. Such feedback regulations exist in insulin signaling pathway as well. METHODS: In the current manuscript, a steady state analysis of the metabolic insulin-signaling pathway is presented. The threshold concentration of insulin required for glucose transporter GLUT4 translocation was studied with variation in system parameters and component concentrations. The dose response curves of GLUT4 translocation at various concentration of insulin obtained by steady state analysis were quantified in-terms of half saturation constant. RESULTS: We show that, insulin-stimulated GLUT4 translocation can operate as a bistable switch, which ensures that GLUT4 settles between two discrete, but mutually exclusive stable steady states. The threshold concentration of insulin required for GLUT4 translocation changes with variation in system parameters and component concentrations, thus providing insights into possible pathological conditions. CONCLUSION: A steady state analysis indicates that negative feedback regulation of phosphatase PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation. The threshold concentration of insulin required for GLUT4 translocation and the corresponding bistable response at different system parameters and component concentrations was compared with reported experimental observations on specific defects in regulation of the system.},
	Address = {Department of Chemical Engineering and School of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai-400076, India. lopa@che.iitb.ac.in},
	Author = {Giri, L and Mutalik, VK and Venkatesh, KV},
	Crdt = {2004/08/05 05:00},
	Da = {20060801},
	Date = {2004},
	Date-Added = {2009-02-26 14:01:29 +0100},
	Date-Modified = {2011-04-15 16:10:32 +0200},
	Dcom = {20060908},
	Dep = {20040803},
	Doi = {10.1186/1742-4682-1-2},
	Edat = {2004/08/05 05:00},
	Issn = {1742-4682 (Electronic)},
	Jid = {101224383},
	Journal = {Theor Biol Med Model},
	Jt = {Theoretical biology \& medical modelling},
	Language = {eng},
	Lr = {20081120},
	Mh = {Animals; Biological Transport/drug effects/physiology; Cell Membrane/metabolism; Dose-Response Relationship, Drug; Feedback, Biochemical/*physiology; Glucose Transporter Type 4/*metabolism; *Homeostasis; Humans; Insulin/administration \& dosage/pharmacology/*physiology; Models, Biological; Osmolar Concentration; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases/*metabolism; Proto-Oncogene Proteins c-akt/*physiology; Signal Transduction/*physiology},
	Mhda = {2006/09/09 09:00},
	Oid = {NLM: PMC516236},
	Own = {NLM},
	Pages = {2},
	Phst = {2004/06/22 {$[$}received{$]$}; 2004/08/03 {$[$}accepted{$]$}; 2004/08/03 {$[$}aheadofprint{$]$}},
	Pii = {1742-4682-1-2},
	Pl = {England},
	Pmc = {PMC516236},
	Pmid = {15291972},
	Pst = {epublish},
	Pt = {Journal Article},
	Rn = {0 (Glucose Transporter Type 4); 11061-68-0 (Insulin); EC 2.7.1.37 (Proto-Oncogene Proteins c-akt); EC 3.1.3.48 (PTPN1 protein, human); EC 3.1.3.48 (Protein Tyrosine Phosphatase, Non-Receptor Type 1); EC 3.1.3.48 (Protein Tyrosine Phosphatases)},
	Sb = {IM},
	Source = {Theor Biol Med Model. 2004 Aug 3;1:2.},
	Status = {MEDLINE},
	Title = {A steady state analysis indicates that negative feedback regulation of PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation.},
	Volume = {1},
	Year = {2004},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1742-4682-1-2}}

@article{Yarmush:2003bh,
	Abstract = {The field of metabolic engineering encompasses a powerful set of tools that can be divided into (a) methods to model complex metabolic pathways and (b) techniques to manipulate these pathways for a desired metabolic outcome. These tools have recently seen increased utility in the medical arena, and this paper aims to review significant accomplishments made using these approaches. The modeling of metabolic pathways has been applied to better understand disease-state physiology in a variety of cellar, subcellular, and organ systems, including the liver, heart, mitochondria, and cancerous cells. Metabolic pathway engineering has been used to generate cells with novel biochemical functions for therapeutic use, and specific examples are provided in the areas of glycosylation engineering and dopamine-replacement therapy. In order to document the potential of applying both metabolic modeling and pathway manipulation, we describe pertinent advances in the field of diabetes research. Undoubtedly, as the field of metabolic engineering matures and is applied to a wider array of problems, new advances and therapeutic strategies will follow.},
	Address = {Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Shriners Burns Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. ireis@sbi.org},
	Au = {Yarmush, ML and Banta, S},
	Author = {Yarmush, Martin L and Banta, Scott},
	Crdt = {2003/10/07 05:00},
	Da = {20031006},
	Date-Added = {2009-02-25 12:24:43 +0100},
	Date-Modified = {2009-02-25 12:24:43 +0100},
	Dcom = {20040106},
	Doi = {10.1146/annurev.bioeng.5.031003.163247},
	Edat = {2003/10/07 05:00},
	Gr = {DK 59766-A01A1/DK/NIDDK NIH HHS/United States; DK43371-09A1/DK/NIDDK NIH HHS/United States; GM058125-04/GM/NIGMS NIH HHS/United States},
	Issn = {1523-9829 (Print)},
	Jid = {100883581},
	Journal = {Annu Rev Biomed Eng},
	Jt = {Annual review of biomedical engineering},
	Language = {eng},
	Lr = {20071114},
	Mh = {Computer Simulation; Diabetes Mellitus/genetics/metabolism/*therapy; Gene Expression Regulation/*genetics; Gene Therapy/*methods; Genetic Engineering/*methods; Glycolysis/genetics; Humans; Metabolism/*genetics/physiology; *Models, Biological; Parkinson Disease/genetics/metabolism/*therapy},
	Mhda = {2004/01/07 05:00},
	Own = {NLM},
	Pages = {349--381},
	Pl = {United States},
	Pmid = {14527316},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review},
	Rf = {211},
	Sb = {IM},
	So = {Annu Rev Biomed Eng. 2003;5:349-81.},
	Stat = {MEDLINE},
	Title = {Metabolic engineering: advances in modeling and intervention in health and disease.},
	Volume = {5},
	Year = {2003},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1146/annurev.bioeng.5.031003.163247}}

@article{Qutub:2005hl,
	Abstract = {Glucose transport to the brain involves sophisticated interactions of solutes, transporters, enzymes, and cell signaling processes, within an intricate spatial architecture. The dynamics of the transport are influenced by the adaptive nature of the blood-brain barrier (BBB), the semi-impermeable membranes of brain capillaries. As both the gate and the gatekeeper between blood-borne nutrients and brain tissue, the BBB helps govern brain homeostasis. Glucose in the blood must cross the BBB's luminal and abluminal membranes to reach neural tissue. A robust representation of the glucose transport mechanism can highlight a target for brain therapeutic intervention, help characterize mechanisms behind several disease phenotypes, or suggest a new delivery route for drugs. The challenge for researchers is understanding the relationships between influential physiological variables in vivo, and using that knowledge to predict how alterations or interventions affect glucose transport. This paper reviews factors influencing glucose transport and approaches to representing blood-to-brain glucose transport including in vitro, in vivo, and kinetic models. Applications for different models are highlighted, while their limitations in answering arising questions about the human in vivo BBB lead to a discussion of an alternate approach. A developing complex systems simulation is introduced, initiating a single platform to represent the dynamics of glucose transport across the adapting human blood-brain barrier.},
	Address = {Joint Graduate Group in Bioengineering, University of California, Berkeley and San Francisco, USA. aminaq@jhu.edu},
	Au = {Qutub, AA and Hunt, CA},
	Author = {Qutub, Amina A and Hunt, C Anthony},
	Crdt = {2005/11/05 09:00},
	Da = {20051104},
	Date-Added = {2009-02-24 21:09:39 +0100},
	Date-Modified = {2009-02-24 21:09:39 +0100},
	Dcom = {20051222},
	Dep = {20050420},
	Doi = {10.1016/j.brainresrev.2005.03.002},
	Edat = {2005/11/05 09:00},
	Jid = {8908638},
	Journal = {Brain Res Brain Res Rev},
	Jt = {Brain research. Brain research reviews},
	Language = {eng},
	Lr = {20070226},
	Mh = {Animals; Biological Transport, Active/physiology; Blood-Brain Barrier/physiology; Brain Chemistry/*physiology; Glucose/*metabolism; Humans; Kinetics; Models, Biological},
	Mhda = {2005/12/24 09:00},
	Number = {3},
	Own = {NLM},
	Pages = {595--617},
	Phst = {2004/08/24 {$[$}received{$]$}; 2005/03/02 {$[$}revised{$]$}; 2005/03/09 {$[$}accepted{$]$}; 2005/04/20 {$[$}aheadofprint{$]$}},
	Pii = {S0165-0173(05)00042-1},
	Pl = {Netherlands},
	Pmid = {16269321},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Review},
	Rf = {220},
	Rn = {50-99-7 (Glucose)},
	Sb = {IM},
	So = {Brain Res Brain Res Rev. 2005 Nov;49(3):595-617. Epub 2005 Apr 20.},
	Stat = {MEDLINE},
	Title = {Glucose transport to the brain: a systems model.},
	Volume = {49},
	Year = {2005 Nov},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.brainresrev.2005.03.002}}

@article{Choi:2001ph,
	Abstract = {Glucose is the major substrate that sustains normal brain function. When the brain glucose concentration approaches zero, glucose transport across the blood-brain barrier becomes rate limiting for metabolism during, for example, increased metabolic activity and hypoglycemia. Steady-state brain glucose concentrations in alpha-chloralose anesthetized rats were measured noninvasively as a function of plasma glucose. The relation between brain and plasma glucose was linear at 4.5 to 30 mmol/L plasma glucose, which is consistent with the reversible Michaelis-Menten model. When the model was fitted to the brain glucose measurements, the apparent Michaelis-Menten constant, Kt, was 3.3 +/- 1.0 mmol/L, and the ratio of the maximal transport rate relative to CMRglc, Tmax/CMRglc, was 2.7 +/- 0.1. This Kt is comparable to the authors' previous human data, suggesting that glucose transport kinetics in humans and rats are similar. Cerebral blood flow (CBF) was simultaneously assessed and constant above 2 mmol/L plasma glucose at 73 +/- 6 mL 100 g(-1) min(-1). Extrapolation of the reversible Michaelis-Menten model to hypoglycemia correctly predicted the plasma glucose concentration (2.1 +/- 0.6 mmol/L) at which brain glucose concentrations approached zero. At this point, CBF increased sharply by 57% +/- 22%, suggesting that brain glucose concentration is the signal that triggers defense mechanisms aimed at improving glucose delivery to the brain during hypoglycemia.},
	Address = {Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis 55455, USA.},
	Au = {Choi, IY and Lee, SP and Kim, SG and Gruetter, R},
	Author = {Choi, I Y and Lee, S P and Kim, S G and Gruetter, R},
	Crdt = {2001/08/08 10:00},
	Da = {20010807},
	Date-Added = {2009-02-24 20:26:01 +0100},
	Date-Modified = {2009-02-24 20:26:01 +0100},
	Dcom = {20010816},
	Doi = {10.1097/00004647-200106000-00003},
	Edat = {2001/08/08 10:00},
	Gr = {P41RR08079/RR/NCRR NIH HHS/United States; R01NS38672/NS/NINDS NIH HHS/United States; R21DK58001/DK/NIDDK NIH HHS/United States},
	Issn = {0271-678X (Print)},
	Jid = {8112566},
	Journal = {J Cereb Blood Flow Metab},
	Jt = {Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism},
	Language = {eng},
	Lr = {20071114},
	Mh = {Animals; Biological Transport; Blood Flow Velocity; Blood Glucose/analysis; Blood-Brain Barrier; Brain/*blood supply/*metabolism; Brain Chemistry; Glucose/analysis/*metabolism; Hypoglycemia/*physiopathology; Kinetics; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Sprague-Dawley},
	Mhda = {2001/08/17 10:01},
	Number = {6},
	Own = {NLM},
	Pages = {653--663},
	Pl = {United States},
	Pmid = {11488534},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (Blood Glucose); 50-99-7 (Glucose)},
	Sb = {IM},
	So = {J Cereb Blood Flow Metab. 2001 Jun;21(6):653-63.},
	Stat = {MEDLINE},
	Title = {In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia.},
	Volume = {21},
	Year = {2001 Jun},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1097/00004647-200106000-00003}}

@article{Shepherd:1999wo,
	Address = {Department of Biochemistry and Molecular Biology, University College London.},
	Annote = {http://content.nejm.org/cgi/content/full/341/4/248},
	Au = {Shepherd, PR and Kahn, BB},
	Author = {Shepherd, P R and Kahn, B B},
	Con = {N Engl J Med. 1999 Jul 22;341(4):240-6. PMID: 10413736},
	Crdt = {1999/07/22 00:00},
	Da = {19990722},
	Date-Added = {2009-02-24 19:44:55 +0100},
	Date-Modified = {2009-02-24 19:55:16 +0100},
	Dcom = {19990722},
	Edat = {1999/07/22},
	Gr = {DK43051/DK/NIDDK NIH HHS/United States},
	Issn = {0028-4793 (Print)},
	Jid = {0255562},
	Journal = {N Engl J Med},
	Jt = {The New England journal of medicine},
	Language = {eng},
	Lr = {20071114},
	Mh = {Adipocytes/metabolism; Animals; Biological Transport; Diabetes Mellitus/*metabolism; Glucose/*metabolism; Glucose Transporter Type 4; Hemostasis; Humans; Insulin/*metabolism/physiology; Insulin Resistance; Intracellular Membranes; Monosaccharide Transport Proteins/*metabolism; *Muscle Proteins; Muscle, Skeletal/metabolism; Signal Transduction},
	Mhda = {1999/07/22 00:01},
	Number = {4},
	Own = {NLM},
	Pages = {248--257},
	Pl = {UNITED STATES},
	Pmid = {10413738},
	Pst = {ppublish},
	Pt = {Comment; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review},
	Rf = {103},
	Rn = {0 (Glucose Transporter Type 4); 0 (Monosaccharide Transport Proteins); 0 (Muscle Proteins); 0 (SLC2A4 protein, human); 11061-68-0 (Insulin); 50-99-7 (Glucose)},
	Sb = {AIM; IM},
	So = {N Engl J Med. 1999 Jul 22;341(4):248-57.},
	Stat = {MEDLINE},
	Title = {Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.},
	Volume = {341},
	Year = {1999 Jul 22},
	Bdsk-File-1 = {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}}

@article{Freetly:1996et,
	Abstract = {The objective of the study was to determine whether exogenous glucose infusion affects endogenous glucose production in ewes. Mature ewes with catheters placed in the abdominal aorta, two mesenteric veins, the hepatic portal vein and the hepatic vein were used to determine the effect of exogenous glucose infusion on net glucose, insulin, lactate and oxygen flux by the portal-drained viscera (PDV) and liver of conscious sheep. Net hepatic glucose release was determined, and glucose was subsequently infused into either a mesenteric vein or an abdominal vena cava at an equal rate (mmol/L) for 240 min, and net fluxes were determined every 30 min. Arterial concentrations of glucose and insulin increased over time, whereas lactate concentration decreased over time (P < 0.05). Hepatic glucose release decreased linearly over time when glucose was infused into the mesenteric vein (P = 0.03) and tended to decrease linearly when glucose was infused into the abdominal vena cava (P = 0.06). Net PDV and splanchnic plasma insulin release during the vena cava infusion increased linearly over time (P < 0.02). Net PDV blood lactate release did not differ between infusion sites (P = 0.75), nor did the release rate change over time (P > 0.10). Net splanchnic lactate release in the abdominal vena++ cava infusion, however, did decrease over time (P = 0.05). Net hepatic oxygen consumption decreased quadratically over time (P = 0.004) when glucose was infused into the mesenteric vein. In conclusion, infusion of glucose results in a decrease in hepatic glucose production.},
	Address = {U.S. Department of Agriculture, Agricultural Research Service, Roman L. Hruska U.S. Meat Animal Research Center, Clay Center, NE 68933, USA.},
	Au = {Freetly, HC and Klindt, J},
	Author = {Freetly, H C and Klindt, J},
	Crdt = {1996/04/01 00:00},
	Da = {19960603},
	Date-Added = {2009-02-12 17:08:02 +0100},
	Date-Modified = {2009-02-12 17:08:02 +0100},
	Dcom = {19960603},
	Edat = {1996/04/01},
	Issn = {0022-3166 (Print)},
	Jid = {0404243},
	Journal = {J Nutr},
	Jt = {The Journal of nutrition},
	Language = {eng},
	Lr = {20031114},
	Mh = {Animals; Arteries; Blood Flow Velocity; Blood Glucose/*metabolism; Female; Glucose/*administration \& dosage; Insulin/blood; Intestines/*blood supply/metabolism; Lactates/blood; Lactic Acid; Liver/*blood supply/metabolism; Mesenteric Veins; Oxygen/blood; Oxygen Consumption; Sheep/*metabolism; *Venae Cavae},
	Mhda = {1996/04/01 00:01},
	Number = {4},
	Own = {NLM},
	Pages = {924--932},
	Pl = {UNITED STATES},
	Pmid = {8613896},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Blood Glucose); 0 (Lactates); 11061-68-0 (Insulin); 50-21-5 (Lactic Acid); 50-99-7 (Glucose); 7782-44-7 (Oxygen)},
	Sb = {IM},
	So = {J Nutr. 1996 Apr;126(4):924-32.},
	Stat = {MEDLINE},
	Title = {Changes in gut and liver glucose, lactate, insulin, and oxygen flux in mature ewes during mesenteric or abdominal vena cava glucose infusion.},
	Volume = {126},
	Year = {1996 Apr},
	Bdsk-File-1 = {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}}

@article{Daly:1998lt,
	Abstract = {Decreased insulin sensitivity is associated with diabetes mellitus, ischemic heart disease, and hypertension, both independently and in association as what is called the metabolic syndrome. Although the negative effects of obesity, sedentary lifestyles, and high-fat diets on insulin sensitivity are well established, the influence of type and quantity of dietary carbohydrate is more controversial. This study aimed to assess the acute (24 h) effects of a high-sucrose compared with a high-starch diet on insulin sensitivity and to identify changes in blood metabolites that might lead to altered insulin sensitivity. Eight healthy adults consumed high-sucrose or high-starch diets (50% of dietary energy) in a randomized, crossover trial. Insulin sensitivity was assessed by a short insulin tolerance test the following morning. No differences were detected in insulin sensitivity, either for glucose metabolism [Kitt(glucose) (the rate constant for the decline in blood glucose concentrations) for sucrose diet = 3.86%/min, for starch diet = 3.72%/min; pooled SEM = 0.23] or for lipid metabolism [Kitt(NEFA) (the rate constant for the decline in blood fatty acid concentrations) for sucrose diet = 12.9%/min, for starch diet = 11.4%/min; pooled SEM = 1.18]. Profiles for blood glucose and serum insulin concentrations revealed higher peaks and lower troughs with the high-sucrose diet whereas area under the curve for glucose was higher with the high-starch diet (6780 +/- 245 mmol x L/min) than with the high-sucrose diet (6290 +/- 283 mmol x L/min) (P < 0.001). Plasma fatty acid concentrations showed a late postprandial rise with the sucrose-rich diet relative to the starch-rich diet, which was mirrored with a fractionally later peak in triacylglycerol concentrations.},
	Address = {Human Nutrition Research Centre, the Department of Biological and Nutritional Sciences, University of Newcastle upon Tyne, United Kingdom. m.e.daly@ncl.ac.uk},
	Au = {Daly, ME and Vale, C and Walker, M and Littlefield, A and Alberti, KG and Mathers, JC},
	Author = {Daly, M E and Vale, C and Walker, M and Littlefield, A and Alberti, K G and Mathers, J C},
	Cin = {Am J Clin Nutr. 1999 Mar;69(3):575-6. PMID: 10075350},
	Crdt = {1998/06/13 00:00},
	Da = {19980630},
	Date-Added = {2009-02-12 11:48:19 +0100},
	Date-Modified = {2009-02-12 11:48:19 +0100},
	Dcom = {19980630},
	Edat = {1998/06/13},
	Issn = {0002-9165 (Print)},
	Jid = {0376027},
	Journal = {Am J Clin Nutr},
	Jt = {The American journal of clinical nutrition},
	Language = {eng},
	Lr = {20061115},
	Mh = {Adult; Blood Glucose/*drug effects; Circadian Rhythm/*drug effects; Cross-Over Studies; Diet; Dietary Sucrose/administration \& dosage/metabolism/*pharmacology; Fatty Acids, Nonesterified/*blood; Female; Humans; Insulin/*metabolism; Male; Starch/administration \& dosage/metabolism/*pharmacology},
	Mhda = {1998/06/13 00:01},
	Number = {6},
	Own = {NLM},
	Pages = {1186--1196},
	Pl = {UNITED STATES},
	Pmid = {9625092},
	Pst = {ppublish},
	Pt = {Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't},
	Rn = {0 (Blood Glucose); 0 (Dietary Sucrose); 0 (Fatty Acids, Nonesterified); 11061-68-0 (Insulin); 9005-25-8 (Starch)},
	Sb = {AIM; IM},
	So = {Am J Clin Nutr. 1998 Jun;67(6):1186-96.},
	Stat = {MEDLINE},
	Title = {Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet.},
	Volume = {67},
	Year = {1998 Jun},
	Bdsk-File-1 = {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}}

@article{Suckale:2008zi,
	Abstract = {The Islets of Langerhans form a nutrient sensing network spread throughout the pancreas. They are tightly connected to the source organ, the intestine, and the target organs--liver, muscle, and fat cells. The expression of a unique set of proteins enables beta cells, the most frequent islet cell type, to detect elevated blood glucose levels and secrete insulin accordingly. Clustered beta-cells achieve tighter regulation of glucose-induced insulin secretion by coordination through cell surface proteins. They also adjust their secretory capacity and flow to avoid being damaged. The immediate reaction of the beta cell to nutrients is regulated by translational mechanisms, while longer term adaptations involve changes in transcription. Glucose increases overall protein synthesis in beta-cells but selectively boosts translation of some secretory proteins including insulin. This may be mediated through recognition of RNA motifs in the untranslated regions of those messengers. If essential molecular components of this nutrient sensing system are broken or fail due to repeated stress, beta cells malfunction, which on a larger scale manifest as diseases like diabetes mellitus.},
	Address = {Experimental Diabetology, School of Medicine, Dresden University of Technology, Dresden, Germany.},
	Au = {Suckale, J and Solimena, M},
	Author = {Suckale, J and Solimena, M},
	Crdt = {2008/05/30 09:00},
	Da = {20080529},
	Date-Added = {2009-02-12 11:35:35 +0100},
	Date-Modified = {2009-02-12 15:14:40 +0100},
	Dcom = {20080919},
	Dep = {20080501},
	Edat = {2008/05/30 09:00},
	Issn = {1093-4715 (Electronic)},
	Jid = {9709506},
	Journal = {Front Biosci},
	Jt = {Frontiers in bioscience : a journal and virtual library},
	Language = {eng},
	Mh = {Animals; Blood Glucose/metabolism; Digestion; Endoderm/physiology; Humans; Insulin/physiology/secretion; Insulin-Secreting Cells/*physiology; Islets of Langerhans/*cytology/*physiology; Lactates/metabolism; Nutritional Status; Pancreas/embryology; Signal Transduction},
	Mhda = {2008/09/20 09:00},
	Own = {NLM},
	Pages = {7156--7171},
	Pii = {3218},
	Pl = {United States},
	Pmid = {18508724},
	Pst = {epublish},
	Pt = {Journal Article; Review},
	Rf = {152},
	Rn = {0 (Blood Glucose); 0 (Lactates); 11061-68-0 (Insulin)},
	Sb = {IM},
	So = {Front Biosci. 2008 May 1;13:7156-71.},
	Stat = {MEDLINE},
	Title = {Pancreas islets in metabolic signaling--focus on the beta-cell.},
	Volume = {13},
	Year = {2008}}

@article{Zierler:1999fb,
	Abstract = {This review describes major factors that, singly or together, influence the concentration and distribution of D-glucose in mammals, particularly in humans, with emphasis on rest, physical activity, and alimentation. It identifies areas of uncertainty: distribution and concentrations of glucose in interstitial fluid, kinetics and mechanism of transcapillary glucose transport, kinetics and mechanism of glucose transport via its transporters into cells, detailed mechanisms by which hormones, exercise, and hypoxia affect glucose movement across cell membranes, whether translocation of glucose transporters to the cell membrane accounts completely, or even mainly, for insulin-stimulated glucose uptake, whether exercise stimulates release of a circulating insulinomimetic factor, and the relation between muscle glucose uptake and muscle blood flow. The review points out that there is no compartment of glucose in the body at which all glucose is at the same concentration, and that models of glucose metabolism, including effects of insulin on glucose metabolism based on assumptions of concentration homogeneity, cannot be entirely correct. A fresh approach to modeling is needed.},
	Address = {Endocrine and Metabolism Division, Department of Medicine, and Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-4904, USA.},
	Au = {Zierler, K},
	Author = {Zierler, K},
	Crdt = {1999/03/10 00:00},
	Da = {19990415},
	Date-Added = {2009-02-11 16:04:35 +0100},
	Date-Modified = {2009-02-11 16:04:35 +0100},
	Dcom = {19990415},
	Edat = {1999/03/10},
	Issn = {0002-9513 (Print)},
	Jid = {0370511},
	Journal = {Am J Physiol},
	Jt = {The American journal of physiology},
	Language = {eng},
	Lr = {20051116},
	Mh = {Animals; Anoxia/metabolism; Eating/physiology; Exercise/physiology; Glucose/*metabolism; Humans; Monosaccharide Transport Proteins/metabolism; Osmolar Concentration; Tissue Distribution/physiology},
	Mhda = {1999/03/10 00:01},
	Number = {3 Pt 1},
	Own = {NLM},
	Pages = {E409-26},
	Pl = {UNITED STATES},
	Pmid = {10070005},
	Pst = {ppublish},
	Pt = {Journal Article; Review},
	Rf = {137},
	Rn = {0 (Monosaccharide Transport Proteins); 50-99-7 (Glucose)},
	Sb = {IM; S},
	So = {Am J Physiol. 1999 Mar;276(3 Pt 1):E409-26.},
	Stat = {MEDLINE},
	Title = {Whole body glucose metabolism.},
	Volume = {276},
	Year = {1999 Mar},
	Bdsk-File-1 = {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}}

@article{OBrien:1994df,
	Abstract = {Insulin flux was determined in the portal vein and simultaneously arterial blood glucose was measured before and during an oral glucose meal in conscious normal and pancreatic islet cell-autotransplanted dogs to test their insulinogenic reserve. These dogs had previously been chronically instrumented with blood flow probes on the portal vein and carotid artery, and blood sampling catheters in the portal vein, hepatic vein, carotid artery, and right external jugular vein. Such a model permits quantitative portal-peripheral comparisons and assessment of hepatic extraction. Sixteen dogs, 10 normal (N) and six long-term (2 months to 2 yrs) islet cell-transplanted dogs (IT) were fed an oral glucose meal as a test (OMT). Baseline portal vein insulin fluxes (PVF) were similar in both groups (25.6 +/- 0.04 pmol/min in N and 24.7 +/- 19.4 pmol/min in IT). Immediately after OMT, PVF rose to 248.2 +/- 40.9 pmol/min in N, but only to 55.9 +/- 17.9 pmol/min in IT. After 30 min PVF peaked for the second time in N at 156 +/- 35.9 pmol/min, declining slowly to baseline after 3 h. In IT, a similar peak at 30 min was seen (143.7 +/- 22.1 pmol/min), declining to a value not different from baseline after 3 h. However, cumulative insulin PV fluxes in the two groups over 3 h were not different. Differences were also seen in postprandial glucose fluctuations, which reached a maximum excursion of 11.8 +/- 0.45 mM in IT, while never rising above 7.8 +/- 0.33 mM in N. After 3 h both groups had similar glucose values.(ABSTRACT TRUNCATED AT 250 WORDS)},
	Address = {Muttart Diabetes Research and Training Centre, University of Alberta, Edmonton, Canada.},
	Au = {O'Brien, DW and Molnar, GD and O'Brien, DC and Rajotte, RV},
	Author = {O'Brien, D W and Molnar, G D and O'Brien, D C and Rajotte, R V},
	Crdt = {1994/09/01 00:00},
	Da = {19950202},
	Date-Added = {2009-02-11 15:48:43 +0100},
	Date-Modified = {2009-02-11 15:48:43 +0100},
	Dcom = {19950202},
	Edat = {1994/09/01},
	Issn = {0885-3177 (Print)},
	Jid = {8608542},
	Journal = {Pancreas},
	Jt = {Pancreas},
	Language = {eng},
	Lr = {20061115},
	Mh = {Animals; Arteries; Blood Glucose/*metabolism; Dogs; Glucose Tolerance Test; Insulin/*secretion; Islets of Langerhans Transplantation/*physiology; Portal Vein; Transplantation, Autologous},
	Mhda = {1994/09/01 00:01},
	Number = {5},
	Own = {NLM},
	Pages = {543--549},
	Pl = {UNITED STATES},
	Pmid = {7809007},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Blood Glucose); 11061-68-0 (Insulin)},
	Sb = {IM},
	So = {Pancreas. 1994 Sep;9(5):543-9.},
	Stat = {MEDLINE},
	Title = {Portal vein insulin flux and arterial glucose fluctuations in response to an oral meal test in islet cell-transplanted dogs.},
	Volume = {9},
	Year = {1994 Sep}}

@article{Tolic:2000ts,
	Abstract = {A mathematical model of the insulin-glucose feedback regulation in man is used to examine the effects of an oscillatory supply of insulin compared to a constant supply at the same average rate. We show that interactions between the oscillatory insulin supply and the receptor dynamics can be of minute significance only. It is possible, however, to interpret seemingly conflicting results of clinical studies in terms of their different experimental conditions with respect to the hepatic glucose release. If this release is operating near an upper limit, an oscillatory insulin supply will be more efficient in lowering the blood glucose level than a constant supply. If the insulin level is high enough for the hepatic release of glucose to nearly vanish, the opposite effect is observed. For insulin concentrations close to the point of inflection of the insulin-glucose dose-response curve an oscillatory and a constant insulin infusion produce similar effects.},
	Address = {The Rugjer Boskovic Institute, Zagreb, Croatia. itolic{\char64}hsph.harvard.edu},
	Au = {Tolic, IM and Mosekilde, E and Sturis, J},
	Author = {Tolic, I M and Mosekilde, E and Sturis, J},
	Ci = {Copyright 2000 Academic Press.},
	Crdt = {2000/11/18 11:00},
	Da = {20001227},
	Date-Added = {2009-02-10 12:20:23 +0100},
	Date-Modified = {2009-02-10 12:20:23 +0100},
	Dcom = {20010215},
	Doi = {10.1006/jtbi.2000.2180},
	Edat = {2000/11/18 11:00},
	Issn = {0022-5193 (Print)},
	Jid = {0376342},
	Journal = {J Theor Biol},
	Jt = {Journal of theoretical biology},
	Language = {eng},
	Lr = {20061115},
	Mh = {Blood Glucose/*metabolism; Feedback/physiology; Humans; Insulin/*secretion; Liver/metabolism; *Models, Biological; Pulsatile Flow/physiology; Receptor, Insulin/metabolism},
	Mhda = {2001/03/03 10:01},
	Number = {3},
	Own = {NLM},
	Pages = {361--375},
	Pii = {S0022-5193(00)92180-5},
	Pl = {ENGLAND},
	Pmid = {11082306},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't},
	Rn = {0 (Blood Glucose); 11061-68-0 (Insulin); EC 2.7.1.112 (Receptor, Insulin)},
	Sb = {IM},
	So = {J Theor Biol. 2000 Dec 7;207(3):361-75.},
	Stat = {MEDLINE},
	Title = {Modeling the insulin-glucose feedback system: the significance of pulsatile insulin secretion.},
	Volume = {207},
	Year = {2000 Dec 7},
	Bdsk-File-1 = {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},
	Bdsk-Url-1 = {http://dx.doi.org/10.1006/jtbi.2000.2180}}

@article{De-Gaetano:2000zf,
	Abstract = {Several attempts at building a satisfactory model of the glucose-insulin system are recorded in the literature. The minimal model, which is the model currently mostly used in physiological research on the metabolism of glucose, was proposed in the early eighties for the interpretation of the glucose and insulin plasma concentrations following the intravenous glucose tolerance test. It is composed of two parts: the first consists of two differential equations and describes the glucose plasma concentration time-course treating insulin plasma concentration as a known forcing function; the second consists of a single equation and describes the time course of plasma insulin concentration treating glucose plasma concentration as a known forcing function. The two parts are to be separately estimated on the available data. In order to study glucose-insulin homeostasis as a single dynamical system, a unified model would be desirable. To this end, the simple coupling of the original two parts of the minimal model is not appropriate, since it can be shown that, for commonly observed combinations of parameter values, the coupled model would not admit an equilibrium and the concentration of active insulin in the "distant" compartment would be predicted to increase without bounds. For comparison, a simple delay-differential model is introduced, is demonstrated to be globally asymptotically stable around a unique equilibrium point corresponding to the pre-bolus conditions, and is shown to have positive and bounded solutions for all times. The results of fitting the delay-differential model to experimental data from ten healthy volunteers are also shown. It is concluded that a global unified model is both theoretically desirable and practically usable, and that any such model ought to undergo formal analysis to establish its appropriateness and to exclude conflicts with accepted physiological notions.},
	Address = {CNR, Universita Cattolica del Sacro Cuore, Roma, Italy. biomath{\char64}tin.it},
	Au = {De Gaetano, A and Arino, O},
	Author = {De Gaetano, A and Arino, O},
	Crdt = {2000/04/01 09:00},
	Da = {20000425},
	Date-Added = {2009-02-10 11:56:39 +0100},
	Date-Modified = {2011-04-14 13:26:34 +0200},
	Dcom = {20000425},
	Edat = {2000/04/01 09:00},
	Issn = {0303-6812 (Print)},
	Jid = {7502105},
	Journal = {J Math Biol},
	Jt = {Journal of mathematical biology},
	Language = {eng},
	Lr = {20041117},
	Mh = {Adult; Blood Glucose/analysis; Female; Glucose/*metabolism; Glucose Tolerance Test/*statistics \& numerical data; Humans; Insulin/blood; Male; Middle Aged; *Models, Biological},
	Mhda = {2000/04/29 09:00},
	Number = {2},
	Own = {NLM},
	Pages = {136--168},
	Pl = {GERMANY},
	Pmid = {10743599},
	Pst = {ppublish},
	Pt = {Journal Article},
	Rn = {0 (Blood Glucose); 11061-68-0 (Insulin); 50-99-7 (Glucose)},
	Sb = {IM},
	So = {J Math Biol. 2000 Feb;40(2):136-68.},
	Stat = {MEDLINE},
	Title = {Mathematical modelling of the intravenous glucose tolerance test.},
	Volume = {40},
	Year = {2000 Feb},
	Bdsk-File-1 = {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}}

@article{Toffolo:1980vn,
	Abstract = {We propose an approach to quantifying the sensitivity of B cells to glucose in the intact organism, whereby we interpret the complex dynamic plasma insulin response to glucose injection in terms of a minimal mathematical model of posthepatic insulin delivery and insulin clearance. The best model for this purpose was chosen by comparing the ability of a series of proposed models to account precisely for plasma insulin dynamics. Intravenous glucose tolerance tests (IVGTT) (300 mg/kg) were performed on conscious dogs, and blood was sampled frequently until the basal steady state was reestablished. Glucose injection produced variable plasma insulin responses, which were characterized by an early peak (76 microU/ml above basal), a plateau with occasional additional peaks, and by an abrupt return of plasma insulin to basal by 37 min. A set of eight models was examined; one emerged as superior, in that it was able to account for insulin dynamics with the smallest number of physiologically meaningful parameters (N = 4). The chosen (minimal) model assumes that (1) clearance of insulin is of the first order, (2) the initial peak represents a bolus of insulin loaded into the plasma after the glucose injection, and (3) the rate of the secondary rise in insulin is determined by the concentration of glucose in plasma above a specific threshold value. The sensitivity of first phase insulin delivery to glucose (phi 1; 1.28 +/- 0.15 microU/ml per min per mg/dl), the sensitivity of the secondary phase to glucose concentration [phi 2; 0.038 +/- 0.005 (microU/mg) . min-2], and the threshold for glucose stimulation of second phase secretion (h; 125 +/- 8 mg/100 ml) were all precisely estimated from the dynamic insulin responses. These three parameters of insulin kinetics (phi 1, phi 2, and h) can be calculated from a single IVGTT, and they characterize the insulin responsiveness of a single individual. Estimating these characteristic parameters of insulin kinetics from IVGTT data has potential for quantitating the individual factors contributing to glucose-stimulated insulin secretion in intact animal models, and it may be applicable to man.},
	Au = {Toffolo, G and Bergman, RN and Finegood, DT and Bowden, CR and Cobelli, C},
	Author = {Toffolo, G and Bergman, R N and Finegood, D T and Bowden, C R and Cobelli, C},
	Crdt = {1980/12/01 00:00},
	Da = {19810226},
	Date-Added = {2009-02-10 11:54:27 +0100},
	Date-Modified = {2009-02-10 11:54:27 +0100},
	Dcom = {19810226},
	Edat = {1980/12/01},
	Gr = {AM-27619/AM/NIADDK NIH HHS/United States},
	Issn = {0012-1797 (Print)},
	Jid = {0372763},
	Journal = {Diabetes},
	Jt = {Diabetes},
	Language = {eng},
	Lr = {20071114},
	Mh = {Animals; Dogs; Glucose/*pharmacology; Glucose Tolerance Test; Insulin/*blood/secretion; Islets of Langerhans/drug effects/*secretion; Kinetics; Models, Biological},
	Mhda = {1980/12/01 00:01},
	Number = {12},
	Own = {NLM},
	Pages = {979--990},
	Pl = {UNITED STATES},
	Pmid = {7002673},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Rn = {11061-68-0 (Insulin); 50-99-7 (Glucose)},
	Sb = {AIM; IM},
	So = {Diabetes. 1980 Dec;29(12):979-90.},
	Stat = {MEDLINE},
	Title = {Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog.},
	Volume = {29},
	Year = {1980 Dec},
	Bdsk-File-1 = {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}}

@article{Bergman:1979ex,
	Abstract = {We have evaluated the feasibility of using a mathematical model of glucose disappearance to estimate insulin sensitivity. Glucose was injected into conscious dogs at 100, 200, or 300 mg/kg. The measured time course of insulin was regarded as the "input," and the falling glucose concentration as the "output" of the physiological system storing and using glucose. Seven mathematical models of glucose uptake were compared to identify the representation most capable of simulating glucose disappearance. One specific nonlinear model was superior in that it 1) predicted the time course of glucose after glucose injection, 2) had four parameters that could be precisely estimated, and 3) described individual experiments with similar parameter values. Insulin sensitivity index (SI), defined as the dependence of fractional glucose disappearance on plasma insulin, was the ratio of two parameters of the chosen model and could be estimated with good reproducibility from the 300 mg/kg injection experiments (SI = 7.00 X 10(-4) +/- 24% (coefficient of variation) min-1/(microU/ml) (n = 8)). Thus, from a single glucose injection it is possible to obtain a quantitative index of insulin sensitivity that may have clinical applicability.},
	Au = {Bergman, RN and Ider, YZ and Bowden, CR and Cobelli, C},
	Author = {Bergman, R N and Ider, Y Z and Bowden, C R and Cobelli, C},
	Crdt = {1979/06/01 00:00},
	Da = {19790728},
	Date-Added = {2009-02-10 11:48:08 +0100},
	Date-Modified = {2009-02-10 11:48:08 +0100},
	Dcom = {19790728},
	Edat = {1979/06/01},
	Issn = {0002-9513 (Print)},
	Jid = {0370511},
	Journal = {Am J Physiol},
	Jt = {The American journal of physiology},
	Language = {eng},
	Lr = {20061115},
	Mh = {Animals; Blood Glucose/*metabolism; Dogs; Insulin/*pharmacology; Mathematics; *Models, Biological},
	Mhda = {1979/06/01 00:01},
	Number = {6},
	Own = {NLM},
	Pages = {E667-77},
	Pl = {UNITED STATES},
	Pmid = {443421},
	Pst = {ppublish},
	Pt = {Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.},
	Rn = {0 (Blood Glucose); 11061-68-0 (Insulin)},
	Sb = {IM},
	So = {Am J Physiol. 1979 Jun;236(6):E667-77.},
	Stat = {MEDLINE},
	Title = {Quantitative estimation of insulin sensitivity.},
	Volume = {236},
	Year = {1979 Jun},
	Bdsk-File-1 = {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}}

@article{Makroglou:2005,
	Abstract = {An overview of some of the mathematical models appearing in the literature for use in the glucose-insulin regulatory system in relation to diabetes is given, enhanced with a survey on available software. The models are in the form of ordinary differential, partial differential, delay differential and integro-differential equations. Some computational results are also presented.},
	Author = {Makroglou, A and Li, J and Kuang, Y},
	Date-Added = {2009-02-10 11:33:40 +0100},
	Date-Modified = {2009-02-10 11:51:06 +0100},
	Journal = {Applied Numerical Mathematics},
	Pages = {559--573},
	Read = {No},
	Title = {Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview},
	Volume = {56},
	Year = {2006},
	Bdsk-File-1 = {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}}
